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Located in the mesopontine tegmentum, the pedunculopontine tegmental nucleus (PPTg) is 
comprised principally of glutamatergic, cholinergic and GABAergic neurons. In addition to 
being fully integrated into basal ganglia, PPTg projects to thalamus and motor output sites in 
the brainstem. Previous studies have shown a range of behavioural changes after PPTg 
manipulation. Prominent amongst these is an apparent deficit in the ability to learn the 
consequences of actions. PPTg is divisible into a posterior component (pPPTg) in receipt of 
rapid polymodal sensory input and projecting into VTA/SNc dopamine neurons and an anterior 
component (aPPTg) in receipt of basal ganglia outflow and projecting into SNc and lower 
brainstem structures. The research described here assesses the role of the pPPTg in 
instrumental learning. Using a contingency degradation paradigm, it was shown that 
inactivation of the pPPTg (by muscimol microinfusion) specifically blocked the updating of 
associations between actions and outcomes, without the affecting the ability to re-execute 
previously learned instrumental actions. Selective bilateral destruction of pPPTg cholinergic 
neurons (with the fusion toxin diphtheria toxin – urotensin II [Dtx-UII]) resulted in >90% loss of 
pPPTg cholinergic neurons. These lesions produced no detectable changes on any measured 
aspect of an instrumental learning task consisting of various fixed and variable ratio schedules 
of reinforcement and extinction. Subsequent experiments found that the same selective 
cholinergic pPPTg lesions also produced no changes in the locomotor response to nicotine or 
rate of nicotine sensitisation. These results are the first to demonstrate a brainstem role in 
action-outcome learning. Results support the view that PPTg performs a ‘first pass’ analysis on 
incoming sensory data and interfaces salient aspects of this with appropriate basal ganglia and 
brainstem circuitry, with glutamatergic pPPTg projections sending an essential signal and 
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Chapter 1: General introduction 
 
General overview 
The pedunculopontine tegmental nucleus (PPTg) is an evolutionary old structure in the 
upper brainstem. Evidence of the existence of PPTg and its closest interconnected structures is 
apparent in the oldest group of vertebrates (cyclostomes) which existed some 560 million 
years ago (Stephenson-Jones et al., 2011). Remaining well preserved through evolution, all 
‘modern’ species studied (including human) have a PPTg with a remarkably similar structure 
and pattern of connections (Brantley and Bass, 1988; Medina and Reiner, 1994; Manaye et al., 
1999; Wang and Morales, 2009)For reviews see: (Winn, 2008; Martinez-Gonzalez et al., 2011). 
Early description of the PPTg appeared in the first half of the 20th century and prompted 
theories regarding the function of this ‘old’ area of brain which were largely focused on the 
basic mammalian functions of sleep (for review see:(Steriade and McCarley, 1990) and 
locomotion (eg:(Shik et al., 1966). In recent decades the ways in which the possible functions 
of brain regions are considered has changed considerably, moving from an almost 
phrenological approach where one brain region or system is seen as subserving a small range 
of functions, to approaches where the brain is considered as a highly distributed yet highly 
organised set of interconnected systems (for an example of early criticism of the phrenological 
approach see:(Koob, 1982)). Theories regarding the function of the PPTg have advanced in a 
similar manner. While still involved in, but critically not required for sleep (Deurveilher and 
Hennevin, 2001) and locomotion (for review see: (Gut and Winn, 2011), the PPTg is now 
viewed as only one of many structures contributing to these complex and still not well 
understood behaviours. Moreover, the PPTg is no longer considered as a homogenous entity, 
but a heterogeneous structure containing distinct anatomical and neurochemically identifiable 
sub-regions that contribute to different functions (Winn, 2006; Wang and Morales, 2009; 
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Martinez-Gonzalez et al., 2011). Contemporary theories of PPTg function focus on involvement 
in learning (eg:(Alderson et al., 2004), action selection (eg:(Rostron et al., 2008), attention 
(eg:(Inglis et al., 2001), sensory processing (eg:(Diederich and Koch, 2005) and behavioural 
state control (eg:(Mena-Segovia et al., 2008b). While seemingly advanced cognitive or high 
order processes, these are still ‘old’ functions of the brain: indeed the problem of action 
selection (selecting and executing one out of many possible actions in a given situation) is one 
of the most fundamental and essential problems faced by any mammalian brain (or any other 
for that matter). The work conducted and presented in this thesis addresses two questions 
directly raised by contemporary research into PPTg function: (1) what is the involvement of the 
posterior PPTg (pPPTg) in learning the consequences of actions? Previous research strongly 
suggests that the PPTg is critically involved in learning of new associations between actions 
and outcomes; however this has not been conclusively assessed and previous results are open 
to other interpretations; and (2) What is the involvement of cholinergic pPPTg systems in 
learning? Considerable emphasis has been placed on the functions of the cholinergic 
subpopulation of PPTg neurons. However, until recently there has been no method to reliably 
selectively manipulate this neuronal type. Using a novel fusion toxin (Dtx-UII) which can 
selectively destroy cholinergic PPTg neurons, the role of this neuronal subpopulation in 
learning is assessed. The results of these behavioural studies are interpreted in terms of 
considering pedunculopontine as being in a position of influence in both basal ganglia and 
brainstem systems. The experimental results support the view that PPTg rapidly detects and 
extracts salient aspects of incoming sensory information and interfaces these with the 
appropriate basal ganglia or brainstem systems. The role of cholinergic and non-cholinergic 
mesopontine tegmental projections are discussed with reference to reinforcement learning 




PPTg - location and structure 
The PPTg is situated in the mesopontine tegmentum of the upper brainstem, beneath 
the level of the cuneiform nucleus, immediately in front of the parabrachial nuclei and 
stretching forward to the most posterior part of substantia nigra (Paxinos and Watson, 2005; 
Winn, 2006). The PPTg is medially adjacent to the laterodorsal tegmental nucleus (LDTg) 
(discussed in chapter 6) where the posterior PPTg is joined to the LDTg by sparse neurons 
stretching under the fibres of the superior cerebellar peduncle. Taking a very similar form in 
every species studied (for example rat (Honda and Semba, 1995), human (Manaye et al., 1999) 
and monkey (Lavoie and Parent, 1994b), for review see: (Winn, 2008)) it appears to have 
remained well preserved across evolution. The PPTg consists of a interdigitated collection of 
three main neuronal populations: cholinergic (acetylcholine releasing), glutamatergic 
(glutamate releasing) and GABAergic (γ-aminobutyric acid releasing) (Mesulam et al., 1983; 
Lavoie and Parent, 1994b; Charara et al., 1996; Wang and Morales, 2009). While these three 
neuronal types exist in all areas of the PPTg, the distribution of each is not homogenous 
throughout the structure. In the posterior part glutamatergic neurons are the largest neuronal 
population (50%), followed by cholinergic (31%) and then GABAergic (19%) (Wang and 
Morales, 2009). In the anterior section GABAergic neurons are the most numerous (40% of 
aPPTg), followed by glutamatergic (37%) then cholinergic (23%) (Wang and Morales, 2009). 
Over 95% of cholinergic neurons also express nitric oxide as a neurotransmitter (Vincent and 
Kimura, 1992) which in turn is virtually absent in non-cholinergic PPTg neurons. In contrast, 
populations of non-cholinergic PPTg neurons express the calcium binding proteins calbindin 
and calretinin which only have very low levels of expression in cholinergic PPTg neurons (Dun 
et al., 1995; Fortin and Parent, 1999; Martinez-Gonzalez et al., 2012). Various neuropeptides 
are also present in PPTg neurons, including substance P (Vincent et al., 1986), atrial natriuretic 
peptide (Ryan and Gundlach, 1995) and GLW-amide-like peptides (Hamaguchi-Hamada et al., 
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2009) with no known pattern of location or co-expression with neurotransmitters. PPTg 
neurons have been identified as having receptors for: acetylcholine (ACh) (Azam et al., 2003), 
glutamate (Inglis and Semba, 1996), GABA (Saitoh et al., 2003),  glycine (Fort et al., 1993), 
noradrenaline (Williams and Reiner, 1993) and urotensin II (Clark et al., 2001). There is no 
clearly defined pattern of differential expression of receptors across neuronal types, the (so 
far) only known exception to this being the urotensin II receptor, which is exclusively found on 
cholinergic neurons (Clark et al., 2001). There is some debate over the possibility of single PPTg 
neurons co-expressing combinations of acetylcholine, glutamate and γ-aminobutyric acid 
(GABA). Older studies claim that up to 50% of cat PPTg cholinergic neurons are able to co-
express GABA (Jia et al., 2003) and there is evidence that co-expression may occur in the 
monkey brain (Lavoie and Parent, 1994a, b; Charara et al., 1996). However, these studies use 
immunohistochemistry or histochemistry as a marker of transmitter expression. While very 
reliable immunohistochemical markers of cholinergic PPTg neurons exist, 
immunohistochemically marking PPTg glutamate or γ-aminobutyric acid expressing neurons is 
notoriously difficult. Due to the rapid rate of synthesis and release of transmitter, dependant 
on the antibody used, immunohistochemical markers are highly susceptible to both false 
positive and false negative results (see chapter 10 of: Porter (2007) for full discussion, also 
see:(Wang and Morales, 2009)). More recent work using in-situ hybridization (which does have 
reliable markers of the three main PPTg neuronal types) found that only 0.7% of rat cholinergic 
PPTg neurons were able to co-express GABA and 1.2% glutamate (Wang and Morales, 2009). 
Further investigation into the possibility that neurons only co-express under certain conditions 
will hopefully resolve these issues, but the interim conclusion is that co-expression, if it does 
occur, is at a very low rate. While small numbers of other types of neuron have been found in 
some species, for example tyrosine hydroxylase (therefore either dopaminergic or 
noraderenergic) in guinea pig (Leonard et al., 1995), this has not been assessed in all species 
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(Winn, 2006) and even when found comprises only a very small proportion of the entire 
structure. As a result the experimental work on the PPTg focuses almost exclusively on the 
cholinergic, GABAergic and glutamatergic neurons.  
 
PPTg - connections 
The PPTg is highly interconnected with other brain regions. Connections can largely be 
grouped into the following categories: (1) to other structures in the mesopontine tegmentum, 
midbrain, brainstem and spinal cord; (2) to basal ganglia structures and the VTA; (3) to 
thalamus and (4) to prefrontal and cortical areas. 
(1)  PPTg sends a mixture of cholinergic and non-cholinergic projections to the pontine 
reticular formation (Semba et al., 1990; Takakusaki et al., 1996; Rolland et al., 2011), 
areas of the medulla (medioventral medulla (Skinner et al., 1990b), medulla oblongata 
(Nakamura et al., 1989) and rostral ventro-lateral medulla (Yasui et al., 1990)) and the 
motor trigeminal (Fay and Norgren, 1997c, b, a). Projections also target the spinal cord 
itself (Skinner et al., 1990a) but these appear to be predominantly non-cholinergic (for 
review see: (Martinez-Gonzalez et al., 2011). PPTg sends cholinergic (and an un-
quantified smaller quantity of non-cholinergic) innervation to the inferior (Motts and 
Schofield, 2009) and superior (Hall et al., 1989) colliculus. Interestingly, cholinergic 
projections to the inferior colliculus (IC) arise predominantly from the pPPTg, whereas 
non-cholinergic projections arise from the area around the aPPTg (Beninato and 
Spencer, 1986). Projections from the superior colliculus (SC) to the PPTg and 
surrounding area have also been documented (Redgrave et al., 1987). The direction of 
information flow is unclear here (and may be bidirectional): it has been hypothesised 
that SC outflow to PPTg forms a functional part of pre-pulse inhibition pathways 
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(Bosch and Schmid, 2008) (PPI is discussed in more detail in subsequent sections; 
pp18-19). However, in a clever double-tracer triple-stain analysis, Schofield and 
colleagues revealed that neurons in auditory cortex project directly onto the same 
PPTg cholinergic neurons which then innervate the IC, showing that the PPTg is also an 
auditory input to IC (Schofield, 2010). PPTg (particularly aPPTg) is in receipt of output 
from and sends input to the rostromedial tegmental nucleus (RMTg) (Jhou et al., 
2009b). Finally, PPTg is in reciprocal connection with contralateral PPTg and unilateral 
and contralateral LDTg, bed nucleus of the stria terminalis (BNST), central grey and 
receives innervation from the locus coeruleus (LC) (Semba and Fibiger, 1992). 
 
(2) The degree and nature of interconnection between the PPTg and basal ganglia (BG) 
has led to the proposition that it should be considered part of the BG family (Mena-
Segovia et al., 2004a). The PPTg is directly reciprocally connected with the STN, GPe, 
SNr and projects to both the SNc and VTA; through indirect connections, PPTg can 
influence the activity of GPe (via STN) and, importantly, all areas of the striatum (via 
SNc, VTA and the STN - GPe pathways) (Moriizumi and Hattori, 1992; Semba and 
Fibiger, 1992; Lavoie and Parent, 1994b, a). PPTg receives direct connections from SNr 
(predominantly GABAergic) and GPi which in turn can direct striatal outflow towards 
PPTg (see fig 1.1 for connection diagram) (Moriizumi and Hattori, 1992; Semba and 
Fibiger, 1992; Winn et al., 2005; Rolland et al., 2011); for review see:(Mena-Segovia et 
al., 2004a). The projections to the SNc and VTA form a topographical gradient where 
SNc is principally targeted by the aPPTg and the VTA by pPPTg and neighbouring LDTg 
(Oakman et al., 1995b); For review see: (Maskos, 2008). Arising from both cholinergic 
and glutamatergic PPTg neurons (Parent et al., 1999), recent evidence suggests these 
projections may be predominantly glutamatergic (Wang et al., 2010). Likewise, 
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connections to the STN have been shown to be principally non-cholinergic (90%) in 
nature and arising mainly from rostrodorsomedial and caudoventral areas of PPTg 
(Kita and Kita, 2011). What is important to consider is the degree of functional 
interdependence between BG structures and PPTg: PPTg is not simply a relay station 
passing information into and receiving output from BG. Rather, its feed forward and 
feedback circuits place it in a position to influence activity throughout the BG network 
(Mena-Segovia et al., 2004a). Moreover, different regions of PPTg are positioned to 
have differential effects on BG and striatum sub-components, with aPPTg influencing 
SNc and subsequent dorsal striatal processing whereas pPPTg output is also directed 
to the VTA and the ventral striatal stream; see fig 1.1 and further sections (pp40-46) 










Figure 1.1: Schematic of the connections between PPTg and BG: (a) shows interconnections between 
PPTg and other basal ganglia nuclei (b) shows the preferential connection and subsequent projection 





(3) Virtually all of the thalamus receives cholinergic innervation from the PPTg, LDTg and 
nearby parabigeminal nucleus, with some nuclei receiving over half of their cholinergic 
innervation from the PPTg (the centrolateral nucleus receives 78% of its cholinergic 
innervation from PPTg and ventrolateral nucleus 62%) (Hallanger et al., 1987; 
Hallanger and Wainer, 1988; Heckers et al., 1992; Kolmac and Mitrofanis, 1998; 
Capozzo et al., 2003; Holmstrand and Sesack, 2011). It has been hypothesised (and 
seems logical) that these extensive brainstem-thalamic projections form an organised 
topographical system rather than en masse non-specific innervation. However, the 
exact nature of such a system remains undefined – the studies referenced above have 
not uncovered a systematic underlying pattern in the projections. In functional terms, 
unilateral stimulation of PPTg ipsilaterally activated thalamic centrolateral and 
ventrolateral nuclei and caused bilateral activation of the reticular nucleus (Ainge et 
al., 2004). In contrast to this, lesions of the PPTg had no effect on Ach levels in reticular 
nucleus, but caused a decrease of Ach in anterovental nucleus and time dependant 
increase in mediodorsal nucleus (Jenkins et al., 2002). These results have led to the 
conclusion that PPTg-thalamic projections form a “dynamic balance” (Jenkins et al., 
2002) of influence in thalamic activity rather than simple innervation. It should not be 
forgotten that while much emphasis is on the cholinergic projections to thalamus, 
there is also a considerable non-cholinergic component to the projections (Ye et al., 
2010). Despite the uncertainty of the projection pattern, it is clear that PPTg sends 
substantial cholinergic innervation to the thalamus, which in turn can influence 





(4) Much of the literature on the PPTg and cortical innervation is concerned with the 
relationship PPTg cholinergic neurons have with cortical EEG activity and their possible 
role in changing between behavioural states (waking state, slow wave sleep states and 
REM sleep state). Cholinergic PPTg neurons form part of the ascending reticular 
activating system (ARAS) (Moruzzi and Magoun, 1949; Steven R, 2000; Mena-Segovia 
et al., 2008b) which is believed to control levels of cortical activation and the shift 
between behavioural states (for discussion of the history of and one current view of 
ARAS see: (Fuller et al., 2007). Cholinergic PPTg neurons do indeed change their firing 
properties depending on behavioural state (Mena-Segovia et al., 2008b) as do sub-
populations of non-cholinergic PPTg neurons (Ros et al., 2010). However, the 
relationship is not as simple as cholinergic activity driving cortical activity during 
wakefulness and REM sleep, then being at a low level during slow wave sleep (as might 
be predicted by a standard ARAS model). Instead, during periods of experimentally 
induced slow wave sleep, PPTg neurons showed dynamic firing patterns: 80% of 
cholinergic neurons fired at around 1 Hz during the ‘active’ component of slow wave 
sleep (the upstate of cortical slow oscillations) with the remaining 20% showing the 
opposite pattern - firing only during the ‘inactive’ down state and at a significantly 
higher (30 Hz) firing rate. Putative glutamatergic neurons fired reliably during the 
transition from upstate to downstate (Mena-Segovia and Bolam, 2011). A similar time 
locked firing pattern at the transition from down to up state during the SW phase of 
naturally sleeping rats has been observed in the LC (Eschenko et al., 2011). These 
systematic firing patterns during the SW state have been hypothesised to have a role 
in facilitating or gating communication between different neuronal systems during 
now recognised ‘waking like microstates’ present in the SW state (Eschenko et al., 
2011; Mena-Segovia and Bolam, 2011). Excitotoxic lesions of the PPTg do not alter 
10 
 
spontaneously generated REM sleep (Deurveilher and Hennevin, 2001) but 
interestingly do change the response to rebound sleep after periods of sleep 
deprivation. Together, these results show that PPTg activity is related to cortical EEG 
activity in a manner dependant on behavioural state (and sub-components of 
behavioural state), but that PPTg itself is neither critical for the shift between 
behavioural states nor maintenance of normal cortical EEG. Instead, PPTg appears to 
be one of many components of an extended system active during both the change in 
behavioural state and the processes which occur within individual states. The exact 
nature of this involvement remains to be defined.  
Reports of direct connections between PPTg and cortical areas exist but are 
sparse: PPTg projects to medial and sulcal frontal cortical areas (Saper and Loewy, 
1982) and sends cholinergic and non-cholinergic innervation to the nucleus basalis 
magnocellularis (NbM) (which in turn sends considerable cholinergic innervation to 
cortex) (Semba et al., 1988; Losier and Semba, 1993). There is evidence from 
anesthetized rats that the main functional component of this projection may be non-
cholinergic (Rasmusson et al., 1994). Both auditory (Rolland et al., 2011) and motor 
(Matsumura et al., 2000) cortex project to PPTg. Non-cholinergic projections from 
pPPTg target visual cortex in the cat (Higo et al., 1996) but there is only circumstantial 
evidence that visual cortex projects to the PPTg (for discussion of the relatively old 
tracing studies this conclusion is based on, see: (Higo et al., 1996). Reciprocal 
connections exist between PPTg and lateral hypothalamus (LH) (Semba and Fibiger, 




In the pattern of connections reviewed above, there is no systematic difference 
between cholinergic and non-cholinergic projections. Indeed, very few connections seem to be 
entirely composed of, or entirely devoid of, a cholinergic component. However, one striking 
difference between cholinergic and non-cholinergic projections has recently been revealed by 
the excellent juxtacellular labelling and tracing studies of Mena-Segovia and colleagues. This 
technique enables the visual reconstruction of dendritic and axonal pathways of individual 
neurons. Cholinergic axonal projections were found to split into 4 - 6 collaterals, some of which 
diverged down lower into the brainstem while the remainder travelled upwards to basal 
ganglia, thalamic and/or other areas. Individual cholinergic neurons, therefore, formed 
projections to multiple target structures.  In sharp contrast to this, non-cholinergic neurons 
were found to have far simpler projection patterns, typically consisting of one or two branches 
travelling in the same direction - none of these neurons formed nearly as complex a projection 
pattern as the cholinergic neurons (Mena-Segovia et al., 2008b). See figure 1.2). While only a 
small sample of neurons have been identified by this method (10 cholinergic and 6 non-
cholinergic), and it has been known for some time that PPTg neurons send collateral 
projections (Semba et al., 1990; Losier and Semba, 1993; Motts and Schofield, 2009), this may 


















Figure 1.2: Illustration of the connectivity patterns of single cholinergic (red) and non-cholinergic (blue) 
PPTg neurons. Figure shows reconstructions of the dendrites in black and axons in colour and indicates 
the structures targeted by each neuron. Image reproduced from Mena-Segovia et al., (2008b). 
 
PPTg - nomenclature  
While nomenclature may seem a trivial point, a recent neurosurgeons report debating 
whether the terms pedunculopontine nucleus and peripeduncular nucleus (a nearby but 
unrelated structure) had been erroneously confused (Zrinzo and Zrinzo, 2008) highlights the 
importance of precision in terminology. There is no standardised name for the PPTg. This 
laboratory has always used the name pedunculopontine tegmental nucleus (abbreviated to 
PPTg) which is one of the most common names given for it in the literature. It is also the case 
that until recent editions it was the name given in the popular brain atlases of Paxinos and 
colleagues (eg human (Paxinos and Huang, 1995), rat (Paxinos and Watson, 2005) and mouse 
(Paxinos and Franklin, 2003)). However, in the 6th edition of The Rat Brain (Paxinos and 
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Watson, 2007) the structure became pedunculopontine tegmental (no ‘nucleus’) abbreviated 
to PTg (a rather surprising change given that PTg is not found in the literature prior to this and 
nearly all other names used include the term nucleus). Another routinely used term is 
pedunculopontine nucleus (abbreviated to PPN) and within the human literature there is a 
tendency to use this over PPTg. Other variations of the same abbreviations (for example: PPT; 
PPTG; PPTN; PptgN) as well as NTPP (nucleus tegmenti pedunculopontinus) and TPP 
(tegmental pedunculopontine nucleus) also appear with differing degrees of frequency. The 
important point here is that names for the PPTg are interchangeable and refer to the same 
structure. In other brain regions variations of similar terms represent differences in underlying 
anatomy. For example, primates have a separable caudate (Cd) and putamen (Put) whereas in 
the rat these two structures appear as one conjoined complex which is accordingly termed 
caudate-putamen (CPu). The different terms used for the whole PPTg are not reflective or 
indicative of any anatomical or species differences. To describe sub-regions within PPTg, again 
there is no standardised terminology. The cholinergic PPTg neurons are denoted as Ch5 in the 
classification of Mesulam et al. (Mesulam et al., 1983) and this terminology is still evident in 
the literature (with cholinergic neurons of the neighbouring LDTg being Ch6). However, 
perhaps partly due to the increased discussion about non-cholinergic PPTg neurons, it is 
becoming more common to simply name neurons by their transmitter type. To refer to the 
distinction between anterior and posterior PPTg components, the most frequently used terms 
are anterior (aPPTg) and posterior (pPPTg) or caudal and rostral PPTg. Based on the 
distribution of the cholinergic neurons the terms pars dissipates (PPTg-pd) and pars compacta 
(PPTg-pc) have also been used to describe the anterior and posterior PPTg. However, again in 
combination with the increasing discussion of non-cholinergic PPTg components (which do not 




Functions of the PPTg 
Methods of assessing PPTg function 
 Extensive experimental work investigating the functions of the PPTg has been 
performed on a wide range of animal species and humans. Rodents and non-human primates 
are the subjects most frequently used in experimental laboratories. Due to the conserved 
nature of the PPTg, studies in animals carry validity across species meaning evolutionarily 
‘lower’ species can be used without compromising the integrity of the experimental results. 
The rat is thus an excellent choice of experimental subject because it is large enough for 
precise experimental manipulation and behavioural assessment while still being small enough 
for easy housing and care. Non-human primate species are more preferable for some 
behavioural experiments, for example electrophysiological studies involving complex visual 
tasks which could not be performed by rats. However, they are less suited for use in lesion 
studies: the need for precisely sized lesions and group sizes large enough for rigorous 
statistical analysis makes it an unpractical choice; moreover, it raises ethical concerns about 
the number of subjects required. Studies in human (generally post-mortem anatomical, fMRI 
and more recently using deep brain stimulation electrodes implanted for Parkinson’s Disease 
treatment) comprise only a small proportion of the PPTg literature. Located deep in the 
brainstem and with no clear anatomical boundaries, precisely locating the PPTg with fMRI or 
other imaging techniques is challenging. Nonetheless, as advances in both imaging techniques 
and brain atlases continue, it can be expected that there will be improvement in the accuracy 
of imaging in the future.  
The most common laboratory methods of studying the functions of the PPTg are: (1) 
lesion studies (either permanent or transient lesions). Fibre sparing lesions of the PPTg (or 
restricted to aPPTg and pPPTg (eg:(Wilson et al., 2009a) can be made with various excitotoxins 
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including ibotenic acid, kainic acid, quinolinic acid and NMDA, with the most frequently used 
being ibotenic acid. Excitotoxic lesions can be considered as ‘non-selective’ in that while they 
spare fibres of passage, these agents have no specificity for one neuronal type within PPTg 
(while there is some evidence that, for example, quinolinate may be able to preferentially 
damage cholinergic neurons, it remains the case that some level of damage to all neuronal 
population is expected after excitotoxic lesion (Rugg et al., 1992)). In terms of lesions selective 
for one neuronal population, reports that the ethylcholine mustard aziridinium ion (AF64A) 
selectively destroyed PPTg cholinergic neurons looked like a promising emerging lesion 
technique (Sandberg et al., 1985; Lanca et al., 2000b). However, authors have reported (and 
experience in this laboratory has confirmed) that it actually produces non-selective and even 
physical damage at the site of infusion (Rodriguez et al., 1998). Recently, a novel fusion toxin 
Dtx-UII has been developed which is highly selective for PPTg cholinergic neurons (Clark et al., 
2007). This toxin is diphtheria toxin in which the natural targeting domain has been changed to 
urotensin II. Taking advantage of the discovery that in the mesopontine tegmentum only the 
cholinergic neurons express urotensin II receptors (Clark et al., 2001), it selectively binds to, 
then (after internalisation and inducing protein synthesis inhibition) destroys cholinergic 
neurons. Older studies often used electrolytic lesions which in addition to being non-selective 
for neuronal type also damage fibres of passage; however their usage has generally faded. 
Temporary inactivation of the PPTg can be achieved by direct microinfusion of the GABA 
agonist muscimol (eg:(Corrigall et al., 2001) or local anaesthetics such as lidocaine (eg: (Conde 
et al., 1998). These are believed to be non-selective for neuronal population and lidocaine 
appears to also inactivate fibres of passage (see chapter 3, pp68-69 for full discussion of 
inactivation techniques). (2) histological based analysis. A wealth of knowledge has been 
gained from anatomical assessment of the structure (eg: (Wang and Morales, 2009) and 
tracing studies assessing the connections (eg:(Semba and Fibiger, 1992) of the PPTg. Tracing 
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studies are especially powerful when combined with markers selective for the neuronal 
population from which the projection arises or targets (eg:(Kita and Kita, 2011). It is also 
possible to measure changes in recent neuronal activity by the histological assessment of 
post–mortem tissue. Detection of evidence of immediate early gene expression (eg c-fos) is a 
reliable measure of recent neuronal activation (this approach is also discussed in chapter 6, 
pp171-174). While the technique is somewhat limited (for example having to be performed in 
post-mortem tissue means it is only suitable for some experimental designs) it has the 
powerful capability of not only indicating neuronal activity, but through double staining, being 
able to indicate activity levels in different neuronal populations (eg:(Lanca et al., 2000a). (3) 
Electrophysiological recording from single neurons. The activity of single and multiple PPTg 
neurons can be recorded in anesthetized (eg:(Mena-Segovia et al., 2008b) and awake behaving 
animals performing cognitive tasks (eg:(Norton et al., 2011). This is a powerful technique that 
enables the assessment of neuronal responses to environmental changes and/or performance 
during behavioural tasks. While there is no current conclusive way to identify easily from 
which kind of neuron (cholinergic, glutamatergic or GABAergic) is being recorded from during 
the recording session, it is hoped that as knowledge of the different neuronal populations 
develops it will become easier to identify them by their neurophysiological characteristics. 
Indeed, there has already been some progress in this regard (Zhang et al., 2008). (4) Direct 
stimulation. The PPTg can be stimulated pharmacologically (for example with the Ach agonist 
carbachol (eg:(Kinney et al., 1998) or the glutamate uptake inhibitor l-trans-pyrrolidine-2,4-
dicarboxylic acid (Ainge et al., 2004)) and with current delivered from an electrode 
(eg:(Lokwan et al., 1999). Pharmacological stimulation offers a means of restricting the effects 
to those of one receptor type, however electrical stimulation offers considerably more 




PPTg function  
PPTg and basic behaviours 
Rats bearing fibre sparing bilateral excitotoxic PPTg lesions show no changes in basic 
behaviours: consumption of homecage food and drinking water is unaffected by lesion (Inglis 
et al., 1994), as are rates of spontaneous generated locomotion (Inglis et al., 1994; Olmstead 
and Franklin, 1994; Wilson et al., 2009a) and (as discussed earlier) natural sleep (Deurveilher 
and Hennevin, 2001). Likewise, in an open field, lesions of the PPTg did not change locomotor 
or exploratory behaviour (spontaneous horizontal motor activity, rearing and centre activity) in 
either the first test or after repeated exposure to the testing environment (Steiniger and 
Kretschmer, 2004). There was some confusion over the relationship between PPTg and 
anxiety: studies using electrolytic and large NMDA lesions of the PPTg reported increases in 
anxiety-like behaviour (elevated plus maze and social interaction test) (Podhorna and Franklin, 
1999; Podhorna and Franklin, 2000) and even the restoration of normal behaviour after 
treatment with the anxiolytic drug diazepam (Leri and Franklin, 1998). However, this was not 
consistent with other reports of electrolytic PPTg lesions producing no change in anxiety-like 
behaviour on the elevated plus maze (Homs-Ormo et al., 2003). To specifically investigate this 
discrepancy, Susannah Walker and colleagues investigated the effects of ibotenic acid PPTg 
lesions (which destroyed the PPTg but did not consistently extend into other structures), 
NMDA lesions of the PPTg (which frequently encroached on the cuneiform nucleus, which is 
immediately ventral to the PPTg, known to be involved in defensive and anxiety related 
behaviours and furthermore is activated by exposure to the elevated plus maze (Silveira et al., 
1993)) and ibotenic acid lesions of cuneiform nucleus itself. The results were clear: lesions 
restricted to the PPTg produced no indication of increases in anxiety related behaviour, 
whereas both lesions of the cuneiform, and PPTg lesions which extended into the cuneiform, 
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did produce an increase in anxiety related behaviours (Walker and Winn, 2007). PPTg lesioned 
rats also show normal taste perception and contrast effects (response to changes in value of 
freely offered rewards) (Olmstead et al., 1999). 
What these results show is that bilateral lesions of the PPTg do not affect normal 
homecage behaviour or cause an overt behavioural change; this is supported by the anecdotal 
evidence that, solely through observation of rats in their cages, it is not possible reliably to 
distinguish between PPTg lesioned and sham lesioned control rats (or rats that have had no 
surgery at all). 
 
PPTg function – simple and complex behavioural tasks 
 Despite their seemingly normal homecage behaviour, PPTg lesioned rats show a clear 
and enduring deficit in behavioural tasks designed to assess cognitive functioning and 
responses to environmental stimuli. The specific deficits observed will be described here and 
then (starting on p28) interpreted with reference to the broader literature. 
 
PPTg and startle response 
Loud and unexpected sounds induce a characteristic startle response known as the 
acoustic startle response (in the rat this is a freezing and twitch of the facial, neck and limb 
muscles). If this startle inducing sound is preceded by a quieter pulse of sound or other stimuli 
(of insufficient intensity to induce a startle response) this quieter pulse will reduce or abolish 
the normal startle response to a high intensity sound delivered shortly (20 – ~1000 ms) 
afterwards (for review see: (Koch and Schnitzler, 1997; Fendt et al., 2001). This phenomenon, 
known as pre-pulse inhibition (PPI) of the startle response is considered to be an indicator of 
normal sensorimotor gating and thought not to be the result of conditioning or learning (Wu et 
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al., 1984). PPI has attracted much interest in recent years due to being abnormal in both 
schizophrenic patients (Turetsky et al., 2007) and many animal models of schizophrenia 
(Marcotte et al., 2001). Bilateral electrolytic (Swerdlow and Geyer, 1993a), excitotoxic (Koch et 
al., 1993) and muscimol induced transient lesions (Diederich and Koch, 2005) of the PPTg 
reduced PPI of the acoustic startle reflex. This is indicative of impaired sensorimotor gating and 
is believed to the result of loss of cholinergic PPTg innervation of the caudal pontine reticular 
nucleus (PnC), a critical component of the primary startle pathway (Koch et al., 1993; Bosch 
and Schmid, 2008). It should be noted that of the three lesion techniques used in the studies 
described, none of them have selectivity for cholinergic PPTg neurons and so the 
interpretation of results with regard to cholinergic PPTg neurons cannot be conclusive. 
However, there is in vitro evidence that the functional link between PPTg and PnC is 
cholinergic (Bosch and Schmid, 2008) and further support for this being a cholinergic mediated 
behaviour comes from finding showing that PPI was transiently improved in schizophrenic 
patients after nicotine administration (Hong et al., 2008). This is an area where Dtx-UII 
selective cholinergic lesions show promise for significantly advancing understanding of the 
functions of the different PPTg neuronal subpopulations and related circuitry.  
 
PPTg and the radial maze 
On the 8 arm radial maze PPTg lesioned rats performed both the random foraging (all 
arms open and 4 baited with food) and the delayed spatial win shift task (comprised of an 
initial exposure to the maze with 4 baited arms open, then, after a brief delay, re-exposure to 
the maze with all arms open but only the previously closed ones baited) significantly worse 
than sham controls. Indeed, the performance of PPTg lesioned rats remained at around chance 
level (Keating and Winn, 2002). A subsequent experiment used high value and low value 
rewards as bait on the maze. While the performance of PPTg lesioned rats in the high value 
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reward group was better than performance in the low value reward group, it still failed to 
reach the level of controls (Taylor et al., 2004). This improved performance with high value 
rewards confirms lesioned rats were motivated to perform the task. That they were still unable 
to solve it without frequent errors suggests that the defects were in the integration of 
information (spatial information, memory of visited arms, sequencing of which arm to visit), 
learning which arms are baited in each individual trial (baited locations changed daily) or in 
actually selecting which arm to enter. 
 
Learning and performance of operant tasks 
During simple low fixed and low variable ratio schedules of reinforcement (that is, 
when pressing on one lever reliably leads to reward delivery in a predicable manner, typically 
after 1-5 presses) disruption in lever pressing has been found after PPTg lesion for the 
following rewards: amphetamine (Alderson et al., 2004), heroin (Olmstead et al., 1998), 
nicotine (Lanca et al., 2000b; Corrigall et al., 2001; Alderson et al., 2006), ethanol (Samson and 
Chappell, 2001) and food pellets (Alderson et al., 2004; Diederich and Koch, 2005; Wilson et 
al., 2009a). While these studies utilized various different testing and training protocols and 
offered many explanations of the data, a common theme in the results appears to be that 
PPTg lesioned rats showed abnormal behaviour when adapting to new testing conditions in a 
manner that can be interpreted as a learning impairment. If the rats have learned that lever 
pressing is rewarded prior to surgery then they will continue to lever press at normal rates 
after PPTg lesion (Olmstead et al., 1998; Samson and Chappell, 2001; Alderson et al., 2004). 
However, if they have no experience of operant tasks prior to surgery (Olmstead et al., 1998; 
Alderson et al., 2004; Wilson et al., 2009a) or the task changes at some point after surgery 
(Olmstead et al., 1998; Alderson et al., 2004; Diederich and Koch, 2005; Wilson et al., 2009a) 
then lesioned rats fail to acquire normal rates of lever pressing. Alderson and colleagues 
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succinctly show both effects in one experiment: they had two groups of rats, a pre-trained 
group (who learned that lever pressing led to food reward prior to surgery) and a naïve group 
(no pre-training). The rats who had learned that lever pressing was rewarded on a fixed ratio 
(FR) 1 then FR2 schedule of reinforcement prior to lesion had normal rates of lever pressing for 
both food (1 post surgery session) then amphetamine (8 sessions) reward after surgery. 
However, when the reinforcement schedule was subsequently changed to progressive ratio 
(PR) 5 (where the number of correct lever presses required for reward delivery increases by 5 
after each reward) both the pre-trained and naïve lesion groups had significantly lower rates of 
lever pressing than shams (Alderson et al., 2004). These strongly suggest that the underlying 
deficit in PPTg lesioned rats was an inability to form or update an association between action 
(lever press) and outcome (reward). There are two exceptions to this learning impairment 
hypothesis: (1) Samson and colleagues (2001) reported that in rats trained to lever press for 
ethanol reward, subsequent muscimol induced inactivation of the PPTg caused reduced rates 
of lever pressing. However, an examination of the results reveals that of the three doses of 
muscimol used, only the highest (0.15 µg muscimol per hemisphere) caused a reduction in 
lever pressing. This highest dose corresponds to a volume of muscimol that is three times that 
of the standard one used in this laboratory (0.05 µg; see chapter 3 p68). Moreover, it is higher 
than a dose which our unpublished observations have shown causes signs of disorientation 
and motor impairment (Wilson and MacLaren; unpublished pilot study, (2009)). It is therefore 
possible (and acknowledged by the authors themselves) that this high dose may have spread 
to other nearby structures and contributed to the behavioural changes observed (Samson and 
Chappell, 2001). Of their remaining two doses, one is the same as our standard dose and one is 
lower, in the ethanol experiment neither of these produced changes in the performance of the 
previously learned lever pressing task. (2) It is reported that in trained rats lesion and 
inactivation of the PPTg reduces rates of lever pressing for nicotine (but not cocaine in an 
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identical paradigm) under an FR5 schedule of reinforcement (Lanca et al., 2000b; Corrigall et 
al., 2001). It has also been reported that, in rats trained prior to surgery to lever press for food 
reward, responding for nicotine is enhanced after pPPTg lesion and unaffected by aPPTg lesion 
(Alderson et al., 2006). Initially these results seem hard to reconcile. One explanation could be 
in the anatomical differences between lesion location: the response enhancing lesions were 
restricted to the pPPTg (which has strong projections to the VTA, a structure of considerable 
interest in relation to the reinforcing properties of nicotine) and were not seen after aPPTg 
lesions (which does not project to VTA but instead targets the medially adjacent SNc) whereas 
the response reducing lesions and inactivations were targeting the whole PPTg. However, 
without further support this does not seem a satisfactory explanation for such contrasting 
effects. There were also differences in training and testing protocols: the Alderson et al. study 
had a programmed conditioned stimuli (CS) concurrent with nicotine delivery and this alone 
appears to have been sufficient to drive lever pressing (when switched to saline rather than 
nicotine all groups maintained higher levels of pressing on the active than inactive lever) 
whereas there was no programmed CS in studies which found reduced responding to nicotine. 
Given that nicotine in the VTA has been shown to enhance the rewarding effects of 
conditioned stimuli without being a primary reinforcer by itself (Farquhar et al., 2011), it is 
possible the different effects are a product of the presence or absence of a CS in combination 
with disrupted signalling in the VTA caused by loss of innervation from the PPTg. This is clearly 
a tentative hypothesis that requires further investigation. However, regardless of the 
explanation, these diverging effects are highly specific to nicotine and are not evident in lever 
pressing for other reinforces (explicitly shown by Corrigall et al. (2001) who, using identical 
paradigms, showed that in trained rats, rates of lever pressing for cocaine were not affected by 
PPTg inactivation, but rates of lever pressing for nicotine were). 
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In other studies using progressive ratio schedules of reinforcement (PR), it has been 
shown that PPTg lesioned rats have reduced breaking points (the ratio at which the rat is 
deemed to have stopped lever pressing) and reduced rates of lever pressing as the ratio of the 
schedule increases (Olmstead et al., 1998; Alderson et al., 2002; Alderson et al., 2004; 
Diederich and Koch, 2005). While a lower breaking point is often used as an indication of 
reduced motivation, several factors suggest that this is not the case in PPTg lesioned rats: (1) 
as schedule demands increased, lesioned rats made significantly more approaches to the food 
hopper (if they were less motivated no increase in would be predicted) (Alderson et al., 2002); 
(2) as the progressive ratio increased, lesioned rats developed significantly increased rates of 
pressing on the inactive lever, a behaviour they did not show at low ratios on the PR schedule 
(again, reduced motivation would not explain this increase in lever pressing) (Alderson et al., 
2002); (3) lesioned rats had the same latency to collect reward as controls, suggesting that 
once earned, both groups had equal levels of motivation to collect the reward (Alderson et al., 
2002); (4) a closer examination of the pressing rates on the active lever revealed that while 
lesioned rats had reduced rates of pressing during active parts of the task (leading to the lower 
breaking point) they also pressed more during inactive parts of the task (where pressing had 
no consequence) leading to the overall rate of lever pressing during the testing session not 
being significantly different to shams (Diederich and Koch, 2005). Combining these factors, 
rather than being a reduction in motivation (which would not explain the increased pressing 
on the inactive lever, increased approaches to the hopper and high levels of pressing during 
inactive parts of the tasks) a more fitting explanation is that PPTg lesioned rats were unable to 
appropriately adjust behaviour in response to the ever changing task demands of the PR 
schedule. This could either be through a failure to learn the ways in which the task was 
changing, or (perhaps and) a failure to select the appropriate action in response to the ever 
increasing nature of the reinforcement schedule.  
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The results of these studies show a clear pattern – if the rats are trained to lever press 
before PPTg lesion then they can subsequently re-perform the same task at the same rate as 
control rats. However, if there is no pre-training, or when task demands change, PPTg lesion 
reliably causes persistent impairment in task performance. This is highly suggestive of a deficit 
in the forming and updating of associations between actions (lever pressing) and outcomes 
(reward delivery) but not in performance of previously learned action-outcome associations.  
Behavioural changes after PPTg lesion also appear in operant tasks designed to 
measure attention. In a task where rats were required to attend to and then rapidly respond to 
a light presented at unpredictable time intervals, PPTg lesioned showed increased numbers of 
omissions (trials where they failed to respond to the light cue) and increased rates of 
responding during the dark period (where responding had no consequence) (Kozak et al., 
2005). Increasing the time period in which rats could respond to the light significantly 
improved the performance of lesioned rats. One standard interpretation of this would be that 
improved performance in sessions with a longer response time window is a reflection of 
impaired attentional processing – the rats were given longer to notice the light and this 
compensated for impaired attention. However, in a repetition of this experiment, observation 
of the rats during the task showed that lesioned rats had an increase in unconditioned 
behaviour (orientating to the houselight, rearing) in response to the light (activity which was 
not increased during the dark phase of the task) (Rostron et al., 2008). The deficit therefore 
was not simply a failure to respond to the light in a timely manner, but a failure to execute the 
correct response in a timely manner. The increase in time during which rats could respond 
appears to have increased correct responses by giving lesioned rats more time to execute 
various behaviours, including the correct one. Similar results were seen in a task where rats 
were required to hold a lever down until a stimulus (presented at unpredictable time intervals) 
was presented. Bilateral excitotoxic lesions of the PPTg significantly reduced the number of 
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correct responses and, when correct responses were made, increased the time taken to make 
them (Florio et al., 1999). The authors note that PPTg lesions caused “a sharp increase of 
unconditioned responses to the instruction starting each trial” which is strikingly similar to the 
reports from Rostron and colleagues of increases in incorrect behaviours in response to the 
light cue and supports the view that in both experiments rats were noticing and responding to 
the stimuli, but failing to successfully engage in a correct response. It is still possible that there 
was some degree of attentional deficit concurrent with this action selection problem and the 
data from these experiments cannot separate out these two factors. In the 5 choice serial 
reaction time task (which requires the continual detection of and response to briefly presented 
visual stimuli over 5 spatial locations) PPTg lesions decreased accuracy, increased rats of 
omission (failure to respond to a light) and while lesions also increased response latency (the 
time to make a correct response) they did not affect magazine latency (time to collect pellet 
following correct response) (Inglis et al., 2001). Supporting the view that these rats had an 
attentional impairment was the finding that increasing the attentional component of the task 
(by decreasing stimulus brightness and introducing random white noise busts) decreased 
performance of lesioned rats over and above the decrease caused in sham controls. However, 
while being a better assessment of attention than increasing the response window, this also 
does not rule out the possibility of an action selection deficit. For example, depending on the 
cause of deficit, the unexpected noise bursts could be a source of distraction or trigger further 
interference in an action selection mechanism reducing to an even greater degree the ability 
to execute the correct response. The PPTg is well placed to have involvement in both attention 
and action selection processes (see subsequent sections, pp38-46) and it is hoped further 




PPTg and sucrose solution consumption 
 The effect of PPTg lesions on the consumption of sucrose solution warrants its own 
sub-section for two reasons: firstly, the results do not clearly fit into any other sub-section, and 
secondly, despite initially perhaps seeming simply an odd curiosity, it is a strong and easily 
reproducible effect that deserves proper consideration. When offered high concentration 
sucrose solution (12% or above), either in the homecage or a testing environment, PPTg 
lesioned rats will consume significantly more than sham controls (Olmstead et al., 1999; 
Alderson et al., 2001; Ainge et al., 2006). This effect of overconsumption is not observed for 
low concentration (4%), normal drinking water or standard lab chow. Indeed, lesioned rats 
which over-consume sucrose solution subsequently reduce the amount of lab chow they 
consume (presumably to compensate for the increased energy intake from the sucrose) 
(Keating et al., 2002). The simplest interpretation would be that PPTg lesioned rats like, or 
want, sucrose solution more than controls. This has been explicitly tested: when assessed in a 
conditioned place preference (CPP) paradigm, while PPTg lesions caused significant 
overconsumption of 12% and 20% (but not 4%) sucrose solution, the strength of the place 
preference effect for high concentration sucrose was unaffected by the lesion (Alderson et al., 
2001; Keating et al., 2002). When using runway transversal speed to measure motivation, PPTg 
lesioned rats again consumed more 20% (but not 4%) sucrose than controls and while they 
also had reduced run speeds for the higher concentration, this reduction was somewhat lower 
and slower to develop than in controls (Ainge et al., 2006). If PPTg lesioned rats caused an 
increase in the liking or wanting of high concentration sucrose solution it would be expected 
that a stronger CPP and sharply decreased runway times for the higher concentration would 
be seen. Together these results show that PPTg lesions only affect sucrose consumption during 
actual consummatory behaviour, while behaviours connected to the acquisition of sucrose 
solution are unaffected by lesion. An interesting development was the discovery that in 
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addition to over-consuming sucrose solution, PPTg lesioned rats consumed significantly more 
quinine solution that sham controls (Walker and Winn, 2007). Quinine produces aversive 
reactions in rats and is often used to devalue liquid rewards (Berridge and Robinson, 1998); 
rats normally only consume very low amounts of it. One explanation proposed is that once 
engaged in strongly selected behaviours, PPTg lesioned rats find it harder to disengage this 
behaviour and so perserverate in it (Ainge et al., 2006; Walker and Winn, 2007). This could be 
a result of disrupted input to the STN (Ainge et al., 2006) which has been proposed to send a 
“breaking signal” which causes disengagement of the currently selected behaviour (see:(Gillies 
and Willshaw, 1998). The hypothesis here would be that once engaged in drinking of highly 
pleasant (sucrose) or aversive (quinine) solution, PPTg lesioned rats are late in generating the 
break signal, but in normal conditions (drinking water) they perform as normal. A recent 
advance has been the observation that pPPTg lesions, and not aPPTg lesions, cause over-
consumption of 20% sucrose (Wilson et al., 2009a). However, as projections to the STN arise 
from the entire PPTg (but are greatest in central areas and are predominantly non-cholinergic) 
(Kita and Kita, 2011) this recent finding does not explicitly support or refute the STN-breaking 
point hypothesis.  
 
Summary 
To summarise, several patterns of behavioural change emerge after PPTg lesion: (1) 
the motor skills to perform operant and maze tasks and willingness to work for reward is 
intact; (2) while performance of previously learned simple lever pressing tasks is unaffected by 
PPTg lesion, there is clear impairment in changing behaviour in response to changes in the task 
demands, the most likely explanation of this being a learning impairment. A learning 
impairment also explains the poor performance of lesioned rats on the radial maze; (3) in 
complex tasks requiring a timely response to specific unpredictable cues, there is a deficit in 
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executing the correct response at the correct time. This deficit (in part at least) appears to be 
due to impaired or altered attentional processing. However, concurrent with this: (4) lesioned 
rats appear to suffer from behavioural disorganisation or deficits of response selection. They 
respond during unreinforced task periods and omit responses during reinforced periods. 
Moreover, despite selectively increasing activity in response to appropriate cues, this 
increased activity is often in the wrong behaviours. This is indicative of impairment in action 
selection processes, an explanation which also may explain some of the deficits observed on 
the radial maze.   
The extent to which these factors contribute to one another is unclear. While it seems 
reasonable to assume that there is some overlap of deficits it is also the case that careful 
assessment of behaviour can, to a large extent, tease these apart. For example, learning to 
press one active lever on a low schedule of reinforcement has a very low attentional load but a 
high learning component, whereas maintaining performance during subtle changes in stimulus 
brightness has little requirement to learn but dramatically increases attentional demands. 
 
Interpreting the deficits observed 
The role of the PPTg in associative learning 
Associative learning (the process of learning associations between combinations of 
stimuli, actions and events in the environment) can be split into two main sub-types: 
instrumental conditioning (when the agent forms associations between stimuli and actions 
performed) and Pavlovian conditioning (where the agent passively forms associations without 
causing any change in the environment). Instrumental learning can then be further split into 
action-outcome (A-O) (learning that actions produce specific outcomes) and stimulus-response 
(S-R) (forming a habitual response to a particular stimuli). Pavlovian conditioning, also known 
29 
 
as stimulus-outcome (S-O) learning, can in turn be further divided into preparatory and 
consummatory responses (for review see:(Yin et al., 2008). It is believed that, during 
instrumental learning, all of the above learning types develop and have varying degrees of 
contribution to behavioural control. For example, if a rat is placed in an operant box with no 
experience of lever pressing, it will, through exploration and formation of associations 
between actions and outcomes, learn that pressing a lever leads to a pellet being delivered 
simultaneously with the illumination of a bright light. However, concurrent to the 
development of these A-O associations, S-O associations will also be formed: the bright light 
will lead to preparatory S-O responses and, over time, even the slight of the lever itself may do 
so. In addition the lever may also cause the formation of S-R associations such that the sight of 
the lever will then trigger the habitual response of lever pressing. Under certain conditions 
(including repeated performance of the same action, interval schedules of reinforcement and 
particular drugs) instrumental behavioural control becomes increasingly driven by S-R 
associations rather than A-O (Hilario and Costa, 2008; DeRusso et al., 2010). Moreover, in 
addition to this, S-O associations form between the stimuli related to acquiring the outcome 
and the outcome itself, casing automatic preparatory and consummatory responses to these 
stimuli which are believed to facilitate instrumental performance for the associated outcome. 
This process is known as “Pavlovian to instrumental transfer” (PIT) and specifically refers to the 
capacity of a Pavlovian stimulus that predicts reward to elicit or increase instrumental 
responses for the same (or a similar) reward (Holmes et al., 2010) and is believed to be part of 
the process that triggers cravings upon perceiving stimuli associated with particular outcomes 
(Holmes et al., 2010; Belin and Everitt, 2011; Pielock et al., 2011). Combing these effects, 
behaviour which was initially goal directed, can, under certain circumstances, become driven 
by responses to the stimuli related to the action rather than the perceived outcome of the 
action: that is, the behaviour becomes a habit (Everitt and Robbins, 2005). These are natural 
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processes which lead to efficient behavioural control: for example the shift from A-O to S-R 
performance enables the low cognitive demand automatic execution of actions in situations 
where they are frequently performed (and therefore likely to need re-performed often) or the 
rapid execution of habitual responses in emergency situations (Hilario and Costa, 2008; 
Redgrave et al., 2010b; Schwabe and Wolf, 2011). However, maladaptive learning can have 
severe consequences. One notable maladaptive learning pattern is addiction, a core feature of 
which is believed to be the transfer of behavioural control from action-outcome to stimulus-
response performance (see:(Everitt and Robbins, 2005) which is enhanced by the strong PIT 
effects where drug related stimuli trigger cravings and the desire to work (put 
energy/resources into) acquiring drugs. These stimulus driven processes go some way in 
explaining the phenomena where drug addicts report that they “want” drugs despite knowing 
that they no longer “like” them: as their behaviour has become governed by S-R (enhanced 
and perhaps even triggered by S-O) processes rather than A-O, not liking the drug is in itself 
insufficient to strongly influence drug seeking behaviour (Berridge, 2007). Disambiguating the 
different brain processes contributing to learning is therefore of practical as well as theoretical 
importance. Considerable knowledge has already been gained in understanding the neuronal 
basis of these different components of learning. Dopaminergic systems of the midbrain, 
striatum and prefrontal cortex are fundamentally implicated in all of them. More detailed and 
systematic analysis has revealed that action-outcome learning is crucially dependent on a wide 
cortical and subcortical system centered on the posterior dorsal medial striatum (pDMS) (Yin 
et al., 2005a; Yin et al., 2005b; Lex and Hauber, 2010a). In contrast to this the dorsal lateral 
striatum subserves automatic habit driven performance (Featherstone and McDonald, 2004; 
Yin et al., 2004; Featherstone and McDonald, 2005). S-O associations are dependant in the 
integrity of the nucleus accumbens (NAcc) (Parkinson et al., 2000; Dalley et al., 2005) and 
normal instrumental learning (albeit with a reduced level of overall activity) can occur after 
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NAcc lesion (Corbit et al., 2001; de Borchgrave et al., 2002; Lex and Hauber, 2010b). PIT also 
appears dependant on an intact NAcc (Corbit et al., 2001; Wiltgen et al., 2007). Based on these 
and similar findings, Yin and colleagues (2008) have recently proposed the four-part 
subdivision of the striatum shown in fig 1.3. Two important points to make here are: (1) while 
the NAcc is deemed to be involved in Pavlovian conditioning and PIT rather than instrumental 
learning, both of these strongly contribute to and enhance instrumental learning (Lovibond, 
1983; Lex et al., 2011) so it is not possibly to easily separate them; (2) These are far from the 
only structures involved in these behaviours, indeed they form a central part of an extended 
cortico-striatal, cortico-thalamic and subcortical system, the full extent and function of which 








Figure 1.3: Illustration of the major functional domains of the stratum as proposed by Yin et al (2008). 







The reward prediction error signal 
A series of ground-breaking discoveries showed that the activity of midbrain dopamine 
(DA) neurons in the SNc and VTA reliably develop a characteristic response to reward and 
reward-predicting stimuli (Ljungberg et al., 1992; Mirenowicz and Schultz, 1994; Mirenowicz 
and Schultz, 1996); for early review see:(Schultz, 1998). After unexpected reward delivery, 
midbrain DA neurons exhibit a short latency short burst of phasic activity (~70 ms after stimuli 
presentation and lasting 100 – 200 ms) and then return to baseline tonic firing rates. If the 
same reward is delivered in the same circumstance, phasic activity develops in response to 
stimuli that reliably precede the reward (for example a tone) and the response to the reward 
itself diminishes. Once this is established, if the reward preceding stimulus is not followed by 
the expected reward delivery, a reduction in tonic firing occurs at the time of reward delivery 
(see figure 1.4 for illustration) (Schultz, 1999). This has been described as a ‘reward prediction 
error’ (RPE) signal: reward predicting stimuli elicit firing of the RPE signal, and if the reward is 
subsequently presented then tonic firing remains at the normal constant level, indicating the 
situation is as predicted. But if the predicted reward is not delivered then the reduction in 
tonic firing signals unexpected absence of predicted reward – the situation is worse than 
predicted – and  if a larger than expected, or an entirely unexpected reward is delivered, then 
there is a burst increase in firing because the situation is better than predicted. It is 
hypothesised that this signal propagates to the striatum and other BG and cortical systems 
where it is used to drive reinforcement learning (Schultz, 2010). It has even been interpreted 
as fitting the requirements of formal learning theories that predate the discovery of this 
neuronal response (Rescorla and Wagner, 1972); for review see: (Schultz, 2010). While still 
regarded by many as a reward prediction error signal which cortico-striatal systems depend on 
for reward based learning, this view is not unanimously accepted and there are other 
interpretations.   
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Figure 1.4: Illustration of the firing pattern of midbrain DA neurons in response to unpredicted reward 
(top), predicted reward (middle) and absence of predicted reward (bottom). Each line of dots shows one 
trial. Image adapted from: Schultz, W. (1999). 
 
 
Midbrain DA responses – a role in the determination of agency? 
 A second theory of the function of this phasic DA signal draws on aspects of the phasic 
signal which are not well explained by the RPE hypothesis but instead are entirely consistent 
with the idea that the short latency DA signal plays a crucial role in the discovery of agency in 
unpredicted events (including rewards) (Redgrave and Gurney, 2006; Redgrave et al., 2008; 
Redgrave et al., 2010a). That is, determining if the agent (oneself) caused the unexpected 
event, and if so, discovering which specific actions caused it. This is a major problem faced by 
organisms. While the lab rat in the operant box (or primate in primate chair) may have a very 
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limited environment and range of actions that could lead to reward delivery or environmental 
change, the natural world is constantly changing and one can be performing many 
simultaneous actions that might be influencing the environment. Efficiently discovering which 
action leads to something new happening, or a better-than-expected or worse-than-expected 
occurrence, and which events happen independently of ones actions, is an essential adaptive 
process.  
 This argument is supported by the claim that the short latency DA signal (70 - ~100 ms 
after stimulus presentation) occurs at too short a latency for accurate reward prediction error 
calculation due to insufficient information being present at this latency. For example, in 
visually guided tasks (which are frequently used in electrophysiological recording 
experiments), the main cortical and striatal areas which assemble a detailed visual 
representation and subserve object identification do not complete this until after the midbrain 
DA systems have responded (the temporal cortex and temporal-occipital cortex identify 
objects at 70 - 90 ms and 80 – 100 ms respectively (Rousselet et al., 2004); the amygdala at a 
mean of 120 ms (Sugase-Miyamoto and Richmond, 2005) and within BG itself the caudate 
nucleus does not response until 100 - 200 ms after stimulus presentation (Hikosaka et al., 
1989) (reviewed in:(Redgrave et al., 2008)). This highlights the critical point that the short 
latency DA response must be dependent on a very short latency input and that in general 
highly processed cortical inputs would arrive at midbrain DA too late to be useful. Based on 
this it is argued that the DA response must be using very short latency midbrain and brainstem 
inputs, of which one prominent source of visual input is the SC (May et al., 2009). However, 
the SC has a relatively poor representation of the visual environment and is specialised in 
rapidly detecting transient visual events (such as movement induced changes in luminance 
within a spatial area) rather than identifying objects or familiar surroundings. Therefore SC 
indicates that something has occurred, where in the visual field this is, to a certain extent 
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whether it was predicted, but it does not identify what it is. SC responses are also related to 
reward and predictability – they rapidly habituate to repeated neutral events but increase 
their response when the stimulus coincides with reward delivery (Ikeda and Hikosaka, 2003). If 
this is the main source of visual input to midbrain DA it is unclear how a refined reward 
predicting signal could be calculated on the basis of such limited information. Rather than 
midbrain DA system being reward predicting error calculators, it is instead argued that 
midbrain DA signal might be a “sensory prediction error” (May et al., 2009) which converges in 
the striatum with concurrent contextual and motor signals and reinforces the repetition of 
actions which immediately preceded an unpredicted salient environmental event. Thus, the 
agent will soon discover if any of the recently executed actions caused the unexpected event 
(including reward) to occur. This system is made efficient by working at a short latency: the 
more time that passes the more likely it is that unrelated motor events will have been 
performed leading to interference in discovering the actual casual action. 
 This theory highlights a fundamental prerequisite for the reward prediction error 
hypothesis: for the theory to be valid, there must be enough information present in DA 
systems, and present at the right timepoint, for such a calculation to occur. The possibility of 
other short latency sources of inputs to midbrain DA systems will be returned to shortly. 
 What the RPE and determination of agency theories have in common is that the firing 
of midbrain DA systems drives learning. Be it a detailed reward prediction signal that 
propagates throughout brain or a sensory prediction error that triggers the instruction to 
repeat immediately those motor actions recently executed, learning and discovering the 
consequences of actions and what stimuli in the environment do and do not lead to salient 
changes, is driven by it. Moreover, absence or abnormality of this signal would disrupt normal 
learning.   
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The relationship between the PPTg and the midbrain DA phasic firing 
It has long being hypothesised that the cholinergic and glutamatergic projections from 
PPTg to midbrain DA neurons have a modulatory or controlling influence, but the exact nature 
of this has remained unclear (Charara et al., 1996; Maskos, 2008; Mena-Segovia et al., 2008a). 
ACh plays a key role in the regulation of DA burst firing: in mice genetically altered to lack the 
nicotinic acetylcholine receptor (nAChR) β2 receptor subunit (therefore blocking some of the 
effects of endogenous ACh) VTA burst firing was virtually absent. However, in a clever 
experimental setup, the knocked out nAChRs were re-expressed in the VTA by means of a 
lentiviral vector and subsequently VTA DA burst firing developed (Maskos et al., 2005; Maskos, 
2007). Uwe Maskos used these findings to hypothesise that the cholinergic neurons of the 
mesopontine tegmentum (one of their major sources of cholinergic innervation) serve as a 
“master modulator” of the midbrain dopaminergic system, essential for glutamate driven 
switching to burst firing (Maskos, 2008). Indeed, stimulation of the PPTg reliably leads to an 
increase burst firing activity of midbrain DA neurons, with this increase being restricted to 
already active neurons (PPTg stimulation does not seem to be able to activate inactive 
neurons, something LDTg stimulation can do) (Scarnati et al., 1984; Floresco et al., 2003) and 
there is also some evidence that the PPTg driven increase in bursting is predominantly 
mediated by stimulation of glutamatergic projections (Scarnati et al., 1986). Inactivation of the 
neighbouring LDTg blocks the ability of PPTg stimulation to elicit DA burst firing (Lodge and 
Grace, 2006), leading to the hypothesis that LDTg is a ‘gate’ which can enable of block the 
ability of PPTg to drive DA bursting (Grace et al., 2007). These studies clearly show a close 
functional link between PPTg/LDTg and midbrain DA systems, raising the question of what 
function might this link have? In rats trained to predict what cues signal upcoming reward 
delivery, a reliable VTA DA phasic firing pattern developed in response to these cues. Unilateral 
inactivation of the PPTg then suppressed the conditioned phasic DA response without having 
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an effect on the overall rate of spontaneously active VTA neurons. That is, PPTg inactivation 
selectively attenuated the phasic DA response without altering baseline DA firing rates (Pan 
and Hyland, 2005). In a primate visually guided reward based task, analysing the firing 
characteristics of PPTg neurons revealed that different populations of PPTg neurons fired in 
response to stimuli predicting reward and to actual reward delivery itself (Okada et al., 2009). 
Furthermore, firing rate was dependent on reward magnitude – stimuli predicting large reward 
led to greater firing than stimuli predicting small reward. There was no evidence of habituation 
or reduction in PPTg responses over time, but adaptation to a reversal of the stimulus-reward 
size pairing occurred rapidly after reversal (conforming that PPTg was responding to the 
magnitude of the reward, rather than simply having different firing patters to different stimuli) 
(Okada et al., 2011). Populations of PPTg neurons responded to reward predicting stimuli and 
reward itself at latencies shorter than those of midbrain DA neurons (Pan and Hyland, 2005; 
Okada et al., 2009), which is consistent with other studies showing PPTg has very short latency 
responses to sensory inputs (Reese et al., 1995; Dormont et al., 1998). It is therefore 
reasonable to consider that PPTg may be supplying midbrain DA systems with salient aspects 
of sensory information (reward predicting stimuli, reward itself, magnitude of reward) which in 
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Figure 1.5: Schematic of the firing pattern of midbrain DA (top), PPTg “reward prediction type” (middle) 
and PPTg “reward type” (bottom) neurons, with responses before training on the left and after training 
on the right. Image adapted from: Kobayashi and Okada, (2007). (Kobayashi and Okada, 2007) 
 
 
The PPTg and attention 
Attention is a notoriously difficult term to define. In the psychological literature it has 
been split into many sub-types (including top down, bottom up, split, divided, sustained, 
selective, voluntary, executive as well as numerous sensory divisions such as auditory, visual, 
spatial) which only in some cases map easily onto neuroscientific findings. A general consensus 
is that attention refers to the ability for selective perception, such that an organism with 
limited resources can focus on particular (relevant) aspects of the environment while ignoring 
other (irrelevant) aspects of it. Clearly, the ability to decide what is relevant (and therefore 
worth attending to) rather than irrelevant is key for successful adaptive behaviour. Despite the 
lack of agreement over the exact types of attention, there are some clear common 
components and brain systems strongly linked to these. One of the most enduring 
classifications is the distinction between top down (deliberately maintaining attention on 
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particular stimuli) and bottom up (where stimuli interrupt ongoing behaviour and direct 
attention onto them). Most further sub divisions of attention can be assigned to one of these 
categories. Of course it is also the case that bottom up processes can trigger the engagement 
of top down attentional systems. Top down attention is believed to originate in prefrontal 
cortical areas, with bottom up beginning with the sensory areas associated with the stimulus 
modality and subsequently progressing by various routes through brainstem and midbrain 
areas into thalamus and cortical systems (see:(Sarter et al., 2001; Meck and Benson, 2002; 
Saalmann et al., 2007; Wykowska and Schubo, 2010; Knudsen, 2011). Indeed, while once 
regarded as simply a relay station, the thalamus, with intricate modality specific sub regions 
and extensive cortical, subcortical and sensory inputs, is now regarded as a ‘hub’ for both 
bottom up and top down sensory processing and as the sensory gateway to cerebral cortex 
(McAlonan et al., 2000; Petrof, 2007; Baluch and Itti, 2011). The patterns of deficits observed 
in PPTg lesioned rats during tasks of sustained attention have several possible interpretations. 
The cholinergic innervation of thalamus is a key route for possible disrupted attention after 
PPTg lesion. PPTg lesion could block the input of sensory information into thalamus and 
subsequent thalamo-cortical (or, for that matter, thalamo-striatal or thalamo-cortico-striatal) 
loops. Additionally, ACh is believed to depolarise and disinhibit thalamic neurons, directly 
increasing thalamic activity and facilitating sensory processing (Steriade et al., 1991; Parent 
and Descarries, 2008). In support of this, stimulation of brainstem innervation to the lateral 
geniculate nucleus (LGN) has been shown to enhance its response to sensory stimuli (Uhlrich 
et al., 1995). It is therefore also reasonable to consider that loss of cholinergic innervation 
could impair thalamic activity and sensory processing. Projections from PPTg to the NbM (a 
structure with heavy cholinergic cortical projections which are critical for sustained attention 
(McGaughy et al., 1996)) initially appeared a likely route of interest in the role of the PPTg in 
attentional processing (Kozak et al., 2005). However, in the same behavioural task, the deficits 
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observed after PPTg lesion were different to those produced by NbM lesion, suggesting that 
the PPTg effects are not simply due to disrupted input into NbM (Rostron et al., 2008). At a 
more global level, the role of cholinergic PPTg systems in cortical activation has also been 
hypothesised to have an influence on the level of top down attention (Rostron et al., 2008): 
Electrical stimulation of PPTg induced a 350% increase in cerebral cortex ACh levels 
(Rasmusson et al., 1994) which is likely to enhance cortical inputs and induce a general 
increase in cortical activity (McCormick and Prince, 1986; Dringenberg and Olmstead, 2003) 
and therefore possibly subsequent increased cortical top-down control of 
behaviour/attentional processes. Finally, while not always being presented in attentional 
terms, the effects of PPTg lesion on PPI can, at least in part, be considered attentional in 
nature in that PPI is a measure of responses to the environment / vigilance. The role of the 
PPTg in attention remains rather unclear, and indeed it is not certain to what extent deficits 
observed can be explained by strictly attentional impairments or other factors such as action 
selection. For example, is it the case that PPTg lesioned rats perform poorly on attentional 
tasks due to deficits in the selective perception of salient stimuli (attentional impairment) or 
due to failure in executing the correct behaviour in response to salient stimuli (action-selection 
impairment)? One promising avenue of future work is the use of selective cholinergic PPTg 
lesions. Combining targeted lesions with refined attentional tasks (separating out attentional, 
learning and action selection aspects) will hopefully reveal the nature of the contributions of 
the PPTg to attentional processing. 
 
The PPTg and action selection 
 Action selection (also known as response selection) is the processes of selecting one 
action out of a repertoire of many possible actions. Generally these possible actions will be 
mutually exclusive (turn left or turn right?) and in many cases the consequences of the action 
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executed (freeze or flee?) will have dire repercussions if the less favourable action is chosen. 
The ability to only execute one action at a time has been referred to as “the final common 
motor path” (Redgrave et al., 1999) and selecting the correct path is an evolutionary ancient 
problem faced by brains. Indeed, any creature that can execute more than one movement is 
faced with the recurrent question of what to do and when to do it. It is believed that the basal 
ganglia and connected structures have evolved to address this problem (see:(Kamali Sarvestani 
et al., 2011; Redgrave et al., 2011; Stephenson-Jones et al., 2011; Stephenson-Jones et al., 
2012). Evidence for this is strong: (1) the basal ganglia are as old as the problem itself, and, in a 
similar manner to the problem, have remained well conserved through evolution, which 
suggests a stable need for these structures; (2) the basal ganglia have the necessary 
anatomical connections to fulfil such a function; (3) disorders of motor selection (that is, 
disorders where the primary deficit is in selecting the right motor action at the right time, 
rather than for example, motor disorders such as paralysis) are closely linked to basal ganglia 
dysfunction. The most notable of these being Parkinson’s Disease (Obeso et al., 2008), 
addiction (Pierce and Vanderschuren, 2010) and obsessive-compulsive disorder (Cavedini et 
al., 2006). A full review of basal ganglia in motor control is beyond the scope of this thesis and 
would largely be redundant due to the excellent existing reviews which should be consulted 
for further reading (see:(Steiner and Tseng, 2010). Briefly, the basal ganglia are a collection of 
interconnected nuclei at the base of the forebrain and midbrain. Long standing descriptions 
describe the BG as being comprised of the striatum (further subdivided into caudate and 
putamen in primate with corresponding caudate-putamen in non-primate brains), the globus 
pallidus (further subdivided into external and internal segments, GPe and GPi), the 
subthalamic nucleus and substantia nigra (sub divided into pars compacta (SNc) and pars 
reticulata (SNr)) (Anton, 2010; Gerfen and Bolam, 2010). See figure 1.6. This classical definition 
of the BG has been extended to include the PPTg (Mena-Segovia et al., 2004a) and, while not 
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formally argued for inclusion, the VTA and NAcc are built into some authors descriptions of the 
BG (eg:(Yin and Knowlton, 2006). While there is a highly organised set of interconnections 
between BG structures (see fig 1.6) there are relatively few entry and exit points from this 
system. The major entry points include the striatum and the STN (receiving projections from 
cerebral cortex, thalamus and limbic structures) and to a lesser extent the SNc/VTA. The major 
output sites of the BG are the SNr and GPi, which project to thalamus, PPTg and brainstem 









Figure 1.6: Illustration of the structures and main connections of the classical basal ganglia architecture. 
Image adapted from Yin et al. (2006). See fig 1.1 for PPTg connections to BG nuclei. 
 
 
The ability of information to enter BG from cortex, process through BG and be output 
to thalamus and subsequently return back to cortex leads to the formation of functional 
“loops”. These are known as cortico-basal ganglia-thalamic-cortical loops and it has been 
proposed that, depending on the information they process and the particular sites in BG and 
cortex which they target, that they can be split into largely segregated loops in a tripartite 
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manner (Alexander et al., 1986; Joel and Weiner, 2000; Voorn et al., 2004; Wilson et al., 
2009b): (1) “limbic loops” connecting medial and orbital prefrontal cortex to ventromedial 
striatum and are involved in the processing of motivational information; (2) “cognitive loops” 
connecting dorsolateral prefrontal cortex to central and dorsal striatum which are involved in 
so called “executive processes” such as working memory, top-down attention and planning; (3) 
“motor loops” which connect premotor, presupplementary motor and cingulate cortical areas 
to dorsolateral striatum. These loops mirror the distinction made previously between action-
outcome and stimulus response processing, with “motor loops” processing stimulus response 
information to and from the DLS and cognitive/limbic loops conveying information through the 
DMS and NAcc. Loops are bi-directional and there is also a degree of transfer across loops 
(both by convergence of neurons at loop end points and crossing of axons along loops). It has 
been argued that loops are in competition for final motor control with organised decision 
making having control pass from limbic loops (what do I want to do?) to cognitive loops (how 
do I do that?) and finally into motor loops which initiate the downstream process of execution 
of the appropriate behaviour. However, in certain situations this neat hierarchy breaks down 
and motor loops can seize final control more easily (Everitt and Robbins, 2005; Pierce and 
Vanderschuren, 2010). Again this mirrors the distinction between A-O and S-R control, with 
behaviour dominated by S-R processes being an example of motor loops executing behaviour 
without contributions from limbic or cognitive loops. In addition to these cortical loops, there 
are also closed loops to subcortical structures which link the PPTg, SC, periaqueductal grey, 
cuneiform and parabrachial nuclei to BG structures (McHaffie et al., 2005; Redgrave and 
Coizet, 2007; Winn et al., 2010). These loops give BG access to and influence over brainstem 
sensory and motor structures independently of thalamo-cortico-striatal loops. The exact 
nature of BG loops and the methods by which information can transfer across and between 
them is a topic of much debate. Therefore, these descriptions are used here to serve as 
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general framework - rather than a strict definition – from which to consider BG function. The 
role of the PPTg in action selection is closely linked to the notion that PPTg can control BG 
systems, interface information between BG and brainstem structures, and interact with 
brainstem independently of other BG structures. More specifically, PPTg can: (1) control and 
gate information entering BG and subsequent transfer of it through BG and cortical loops. 
PPTg can integrate fast sensory information into midbrain DA systems and thalamus (which 
may in turn affect the level of cortico-basal ganglia-cortical looped activity). Moreover, PPTg 
can exercise control role over other BG sites, for example altered modulation of STN which 
may affect the “breaking” of on-going BG activity; (2) control and gate information leaving BG. 
SNr is a major BG output site, not just to thalamocortical neurons but also extensively to 
midbrain and brainstem structures, many of which in turn project to the reticular formation 
and other brainstem motor output sites. The SNr output is predominantly inhibitory and it is 
believed that release from this inhibition triggers motor action. PPTg (which receives this 
outflow from SNr) is in a position to control this as it leaves BG; (3) potentially function 
independently of other major BG sites and interact with brainstem nuclei to initiate and select 
actions. Evidence for this comes from decerebrate animals (where all major BG sites except 
PPTg and depending on decerebration method, SN, are removed). These animals are able to 
engage in and switch between different simple behaviours such as orienting to sound, 
grooming and performing lever press actions that are previously known to lead to reward 
(actions which while basic, are considerably more sophisticated than simple reflexes) 
(see:(Humphries et al., 2007; Wilson et al., 2009b). While these animals may be rather clumsy 
in these actions and the ability to switch between them, this ability clearly shows a degree of 
action selection independent of a fully intact BG. This has been argued to occur via the medial 
reticular formation which, due to having neuronal clusters representing components of co-
ordinated action (rather than of a sensory or muscular-motoric topographic arrangement) 
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could be able to execute reasonably complex action sequences through co-activation of a small 
set of clusters. This has been proposed as a possible “brainstem substrate for action selection” 
(Humphries et al., 2007). PPTg, with extensive output to the mRF, is in a position to induce and 
control such activation (Wilson et al., 2009b; Winn et al., 2010). The idea that there is a 
brainstem substrate for action selection ‘underneath’ that of the BG speaks strongly for a 
layered evolutionary development of action selection systems (Prescott et al., 1999; 
Humphries et al., 2007; Wullimann, 2011). What is critically important to consider is that 
rather than overriding and rendering them obsolete, advanced levels build on and interact 
with still functioning lower levels (Anton, 2010; Stephenson-Jones et al., 2011). Therefore, it is 
essential to consider the functions, contributions and interactions of early systems of action 
selection even when considering seemingly complex and advanced processes. It is also 
important to consider the role of different PPTg subregions in action selection processes. 
Sensory input to PPTg target predominantly the posterior region, and it is this region which 
outputs to VTA (and subsequently onwards into ventral striatal and cognitive/limbic circuitry). 
In contrast to this, PPTg projections to the mRF arise from the aPPTg, which is also the region 
bi-directionally connected to the SN which in turn is closely associated with dorsolateral 
striatum (DLS) and motor cortices. This leads to the conclusion that manipulation of pPPTg is 
likely to affect input to BG and the processing of sensory events, whereas aPPTg damage 















Figure 1.7: Illustration of the main connections between the PPTg and cortico-striatal circuitry, the basal 
ganglia, brainstem sensory inputs and effectors. Arrows which project into a box indicate the pathway 
targets a specific area of the structure, arrows which target the edge of a box indicate the pathway 
projections to all of (or to undefined areas of) the whole structure. Image modified from figure 1 of 
Wilson, MacLaren and Winn (2009). 
 
Summary and aims 
Concise summary 
Rats bearing excitotoxic lesions of the PPTg have various separable yet potentially 
related deficits in operant tasks. To summarise briefly: (1) there is a clear learning impairment 
in naïve rats and in trained rats when testing schedules change; (2) attention may be impaired 
in tasks with a high attentional component; (3) while the ability to execute the motor actions 
required by operant and maze tasks appears intact, the ability to select the correct action or 
inhibit incorrect actions may be disrupted. Largely due to the lack of ability to manipulate 
different neuronal populations within PPTg, very few studies have been able to relate the 
deficits observed in behaviour to one of the three main neuronal populations within PPTg 
(cholinergic, glutamatergic and GABAergic). However, there has been progress in establishing 
the functions of different PPTg subregions: lesions of the posterior portion impair operant 
learning while anterior lesions do not affect learning rate but do produce signs of behavioural 
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disinhibition. These differing effects are believed to be the result of disruption of the different 
pattern of connections of PPTg subregions: aPPTg targets SNc midbrain DA neurons, receives 
output from SNr and targets motor output sites in the brainstem. In contrast, pPPTg is in 
receipt of fast sensory information and targets the midbrain DA systems.  
 
Specific aims 
The aims of this thesis are to advance the conclusions reached above by establishing 
the nature of the learning impairment seen after PPTg lesion and relating this to the functions 
of cholinergic and non-cholinergic PPTg neurons. 
The learning impairments seen after pPPTg (and indeed PPTg) lesion have been 
interpreted as being most likely to be an impairment in forming and updating associations 
between actions and outcomes. However, none of the behavioural tests have explicitly 
assessed this. Moreover, on the basis of the conclusions of Yin et al (2008) one could 
hypothesize that the main impairment seen after pPPTg lesion would be expected to be in the 
formation of Pavlovian rather than instrumental associations (because much of the focus of 
pPPTg is on projections to the VTA and subsequent NAcc systems which are viewed as having a 
more restricted role in Pavlovian associations), whereas aPPTg lesions are more likely to 
disrupt instrumental learning (due to aPPTg projections to SNc which subsequently targets 
DMS and DLS - structures critically involved in instrumental learning). This conclusion is not 
immediately compatible with the previous behavioural results and interpretations. Due to the 
design of the previously used learning tests, learning and performance could be impaired (at 
least to some extent) by deficits in the formation of Pavlovian associations and PIT. Therefore, 
this is clearly a point requiring clarification and in turn explanation. Chapter 3 discuses 
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methods of assessing action-outcome (A-O) learning and implements two of these in order to 
fully assess the role of the pPPTg in action outcome learning and performance.  
From this point on the focus of the experimental work is on investigating the role of 
the cholinergic pPPTg neurons in instrumental learning and interactions with the VTA. There 
are strong cholinergic projections from PPTg to midbrain DA (forming a topographical gradient 
where aPPTg targets SNc, pPPTg targets both VTA and SNc and the neighbouring LDTg targets 
VTA) which have been hypothesised to be a ‘master modulator’ of midbrain DA systems. In 
chapter 4 a protocol is refined for using the newly developed Dtx-UII fusion toxin to create 
highly selective bilateral lesions of the cholinergic pPPTg. The feasibility of these lesions and 
their effects on locomotion and sucrose consumption are then assessed. Following on from 
this, in chapter 5 the ability of rats with selective bilateral lesions in cholinergic pPPTg to learn 
and perform a range of fixed and variable operant reinforcement schedules is assessed. In 
chapter 6, the relationship between the cholinergic pPPTg and VTA is probed by assessing the 
rate of nicotine sensitisation in rats with selective cholinergic lesions in pPPTg. The last 
experimental study, in chapter 7, investigates the possibility of causing further disruption to 
cholinergic innervation of midbrain DA systems by assessing the feasibility of combined pPPTg 
and LDTg selective cholinergic lesions. 
Finally, the results of all the experimental studies are discussed in chapter 8. The 
implications of the findings are related to the broader literature on the source of input to 
midbrain DA systems. A theory of PPTg as being a structure which extracts salient aspects from 
incoming sensory information and interfaces these with appropriate basal ganglia and 
brainstem systems is discussed. Additionally, the possible functions of cholinergic and non-
cholinergic projections to midbrain DA systems are discussed with reference to instrumental 
learning and the role of Ach agonists in reinforcement enhancement.  
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All experiments were carried out on experimentally naive adult male Lister-Hooded 
rats (Harlan Olac Ltd, Bicester, UK). Rats were housed in a temperature and humidity controlled 
room where lights were on a 12-h light/dark cycle. All behavioural testing was conducted 
during the light phase. Rats were housed in solid base plastic cages with a wire mesh top, 
measuring either 25 cm × 45 cm × 15 cm or 36 cm × 56 cm × 26 cm (size depending on 
availability of cages, with a preference for the larger ones). Wherever possible rats were pair 
housed; the main exception to this being rats with cannula implant assemblies (chapter 3) 
which were always single housed. Cages were environmentally enriched with a perspex tube 
and disposable toy (changed twice weekly). However, during the days after headcap 
implantation, tubes were temporarily removed while the rats became accustomed to having 
the implant. Water was available ad-libitum in the homecage. Food restriction was used in 
chapters 3 and 5 to motivate rats to work for food reward (details of restriction given in the 
chapters) and apart from these times standard lab chow was also available ad-libitum in the 
homecage. Group sizes and weight ranges are stated in each chapter; in general the target 
surgery weight for lesion experiments (chapters 4 - 7) was 330 g and for cannulae implantation 
(chapter 3) it was 400 g. The heavier weights used for cannulae implants was an attempt to 
increase headcap stability by using rats with thicker skulls. All experiments were carried out in 
compliance with the Animals (Scientific Procedures) Act 1986, the European Communities 
Council Directive of 24/11/86 (86/609/EEC) and, where appropriate, the local ethical review 










Rats were anaesthetized using isoflurane (Abbot Laboratories Ltd, Maidenhead, UK) by 
placing them in an induction box being fed with 4 L / min O2. After 1 min isoflurane was added 
to the O2. This was started at a concentration of 1% and increased by 1% approximately every 
minute until the final concentration of 5% was reached. This was maintained for 1.5 min before 
the rat was removed from the induction box. The timings were approximate and adjusted such 
that total loss of righting reflex was observed before increasing the concentration beyond 3% 
and deep steady breathing observed before removing the rat from the induction box. Once in 
the stereotaxic frame (David Kopf, Tujunga CA, USA) anaesthesia was maintained via a 
facemask mounted on the incisor bar. During scalp incision and cleaning, 2.5% isoflurane in 1.4 
L/min O2 was delivered through the facemask, after which maintenance was achieved with 
2.0% isoflurane in 1.2 L/min O2. This was adjusted appropriately if reflexes were observed or if 
breathing became very shallow. Death from anesthesia was rare (<1% of surgeries). 
 
Stereotaxic surgery 
All stereotaxic surgery was performed on “Model 900” Kopf stereotaxic frames (David 
Kopf, Tujunga, CA, USA) in a clean surgical environment. 
 
Cannulae implantation 
 Once anaesthetized and secured in the stereotaxic frame, a pre-surgical analgesic dose 
of Rimadyl (0.05 mL/rat; 5% w/v carprofen; Pfizer Ltd, Kent, UK) was injected subcutaneously. 
The scalp was shaved with electric clippers, a midline incision made with a scalpel and the skull 
cleaned of tissue before the incision was held open with artery clamps. The height of the 
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incisor bar was then adjusted such that the dorsoventral (DV) measurements at lambda and 
bregma were equal (flat skull position). Craniotomies were made with a hand held dental drill 
at the following co-ordinates: +0.4 mm from interaural line (IAL); ±1.9 mm from the midline 
(measured from skull surface). Six stainless steel round-head machine screws with sharply cut 
threads (0-80 x 1/16 or 0-80 x 3/32 or  0-80 x 1/8; see chapter 3 for details; Plastics One, 
Roanoke, VA, USA) were fixed onto the skull, two behind the craniotomies, two in front and a 
further two in front of lambda. Bilateral guide cannulae (22 ga, 3.8 mm apart, protruding 5.0 
mm below skull surface; Plastics One) were lowered in place using a mounting holder on the 
stereotaxic arm (Plastics One) and fixed onto the skull and screws using a methyl methacrylate 
based dental acrylic (Simplex Rapid, Kemdent Works, Wiltshire, UK). Internal dummy cannula 
(3.8 mm apart, protruding 1.0 mm from the guide cannulae; Plastics One) were inserted into 
the implanted cannulae and a dust cap (Plastics One) screwed on top. The wound behind the 
headcap assembly was closed with sutures (Ethicon, Edinburgh, UK). Once removed from the 
stereotaxic frame rats were given an i.p injection of Hartmann’s solution to aid recovery (1 mL, 
Baxter Healthcare Ltd, Norfolk, UK). Rats were placed in a heated recovery cage and monitored 
until they had recovered from anesthesia before being returned to their homecage. Every 1 - 2 
days, dummy cannulae were changed with clean replacements. Rats were given at least 7 days 
to recover prior to the start of behavioural training. 
 
Toxin microinfusion 
 Once anaesthetized and secured in the stereotaxic frame, a pre-surgical analgesic dose 
of Rimadyl (0.05 mL/rat; 5% w/v carprofen; Pfizer Ltd, Kent, UK) was injected subcutaneously. 
The scalp was shaved with electric clippers, a midline incision made with a scalpel and the skull 
cleaned of tissue before the incision was held open with artery clamps. The height of the 
incisor bar was then elevated such that the horizontal angle between the incisor bar and the 
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interaural line was 8°29 ̕(achieved by multiplying the distance between the IAL and the back of 
the incisors by the sine of 8°29 ̕(0.147), as described by (Whishaw et al., 1977)). Craniotomies 
were made with a hand held dental drill above the location of the final infusion co-ordinates 
(appropriate co-ordinates given in individual chapters). Dtx-UII toxin (or sterile phosphate 
buffer (PB) in for sham controls) was backfilled into a fine tipped (40 - 50 µm) glass pipette 
which was then secured into an electrode holder on the stereotaxic frame (pipettes were 
manufactured in-house from borosilicate capillary tubes (1.16 – 1.19 mm o.d.; 0.49 mm i.d.) 
pulled into pipettes with a pipette puller (Model 720 Needle Pipette Puller, David Kopf, 
Tujunga, CA, USA) before having tips manipulated to 40 – 50 µm diameters under a light 
microscope). Measurements were then re-taken to allow the pipette to be advanced to the 
required co-ordinate. After measurement, dura was cut with the bent tip of a 29 gauge needle 
to ensure that penetration of dura did not damage the pipette tip. Toxin was delivered by 
pressure injection from a 10 mL plastic syringed connected to the pipette by polythene tubing 
(containing air). Pressure was applied to the syringe by hand. Manually covering a small hole 
drilled in the syringe maintained air pressure during infusion and enabled the immediate 
release of pressure from the infusion system when the required toxin volume (indicated by a 
scale attached to the pipette) had been infused. After infusion the pipette was left in-situ for 5 
min to allow diffusion from the tip before being slowly removed. After all infusions had been 
made, the skull was cleaned with saline and the wound closed with Michel clips. Once removed 
from the frame rats were given 1 mL of Hartmann’s solution (Baxter Healthcare Ltd, Norfolk, 
UK) to aid recovery. Rats were placed in a heated recovery cage and monitored until they had 







Operant training and testing 
Operant testing was conducted in 12 Med-PC operant chambers individually housed in 
sound and light attenuating boxes (Med-Associates, St Albans, Vermont, USA). These chambers 
were monitored and controlled by a computer system running Med-PC software (Med-
Associates, St Albans, Vermont, USA). Each operant chamber had two retractable levers either 
side of a reward magazine. This magazine contained a trough into which pellets could be 
delivered from a dispenser located outside the chamber and a cup (0.1 mL) which could be 
filled with liquid reward by a dipper mechanism which lowered the cup into a reservoir below 
the hopper. One of the levers had a light above it (1.5W) and there was a houselight located on 
the upper central portion of the opposing wall. A fan installed inside the sound attenuating 
boxes provided airflow and also served as low level constant background noise. 
 
Locomotor testing 
Locomotor monitoring was conducted in 6 perspex cages (45.7 cm x 24.1 cm) situated 
inside “SmartFrame™ Cage Rack Stations” (LED rearing 7x15 High Density, Hamilton Kinder LLC, 
Poway CA, USA). These contained a 7 x 15 grid of infra-red beams at the height of the rats body 
and an additional 7 x 0 grid of beams at a height only reached when the rat reared. All stations 
were interfaced with a computer system running “Motor Monitor” software (Hamilton Kinder 
LLC, Poway CA, USA) which recorded all beam breaks made in the cages. The following 
measures were recorded by the software: basic movements (total of all recorded beam breaks 
at the rats body level); fine movements (number of beam breaks caused while rat not changing 
its whole body position – that is, as would be caused by forepaw grooming) and rearing 
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(number of beam breaks across the higher level of infra-red beams). Locomotor testing was 
conducted in a dimly lit room. 
 
Microinfusion of muscimol/saline into the pPPTg 
Prior to surgery rats in microinfusion experiments (chapter 3) were handled and 
habituated to the light restraint that would subsequently be used during the microinfusion 
procedure. This involved holding the rat to the experimenters chest such that all paws were 
supported and body movement greatly restricted without forceful pressure or restraint being 
necessary. Microinfusions into the pPPTg were made via bilateral cannulae (3.8 mm apart, 
protruding 7.5 mm from the base; Plastics One) that were inserted into the previously 
implanted guide cannulae while the rats were lightly restrained. Injectors were attached by 
polyethylene tubing (PE50 thin wall; Plastics One) to 2 syringes (1 µL, 23 ga needle, SGE 
Analytical Science, Victoria, Australia) driven by a syringe pump (PHD 2000, Harvard Apparatus, 
Holliston, MA, USA). The pump setup was placed and tubing cut such that tubing length could 
be of as short as possible, and all infusions were done with tubing of the same length. This was 
to try and prevent pressure buildup in the tubing and to ensure that if this did occur, it was as 
constant as possible. Infusions of 0.3 µL of muscimol (0.05 µg muscimol; Tocris Bioscience, 
Bristol, UK in 0.3 µL saline; Baxter Healthcare Ltd) or saline (0.3 µL; Baxter Healthcare Ltd.) 
were made over 1 min and injectors were left in situ for 1 min post-infusion before being 
removed and replaced with dummy cannulae.  
 
Histological procedures 
Transcardial perfusion with fixative 
Rats were prepared for perfusion by being given a lethal i.p. injection of sodium 
pentobarbitone (0.6 - 0.8 mL per rat; 200 mg/mL sodium pentobarbitone. Depending on 
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availability either: Dolethal; Univet Ltd, Oxford, UK or Euthatal; Merial Animal Health Ltd, 
Harlow, UK). Once deeply anaesthetized they were immediately transcardially perfused with 
phosphate buffered saline followed by approximately 300 mL of fixative (4 % 
paraformaldehyde in 0.1 M phosphate buffer) at a flow rate of ~14 mL / min. Completion of 
perfusion and successful fixation was judged by inspection of the rat rather than the the 
quantity of fixative used. Following perfusion brains were left to post-fix in situ for around 60 
min before being removed and stored in sucrose solution (20 % sucrose in 0.1 M PB) in a 
refrigerator. 
 
Tissue preparation and sectioning 
Coronal 30 µm sections were cut on a freezing microtome. The left side of the brain 
was marked by penetration with a needle though an area not considered relevant to the 
studies being conducted. Sections to be processed immediately were stored in PBS in a 
refrigerator; remaining sections were stored in ethylene glycol based cryoprotectant at -20 C.  
Immunohistochemical staining 
All immunohistochemistry was performed at room temperature on free floating 
sections on a flatbed shaker. Both choline acetyltransferase (ChAT) and neuron specific nuclear 
protein (NeuN) staining followed the same protocol. To reduce the risk of cross-contamination 
of antibodies (details below) the two stains were not conducted in parallel. 
 
NeuN/cresyl 
 In the central nervous system (CNS) antibodies against neuron-specific nuclear protein 
(NeuN) react strongly with neuronal nuclei and to a lesser extent with cytoplasm. This reaction 
occurs regardless of the neurotransmitter type expressed by neurons. Therefore, NeuN can be 
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successfully used as a non-selective marker of the presence (and density) of neurons. It is used 
here (see details below) to assess the selectivity of cholinergic mesopontine tegmentum 
lesions. Cresyl violet staining marks both Nissl bodies and reactive gliosis (which develops in 
response to CNS injury) a dark purple colour. While reactive gliosis is frequently observed after 
excitotoxic lesions, it is seldom detected after Dtx-UII lesions. However, track damage from the 
pipettes used for microinfusion can cause small amounts of gliosis. The primary use of the 




Choline acetyltransferase (ChAT) is an enzyme required for the synthesis of ACh, it is 
found in both the nuclei and terminals of ACh expressing (cholinergic) neurons and, 
importantly, not in neurons that do not express Ach. Immunohistochemical staining with ChAT 
antibodies is therefore an effective and reliable method for selectively staining cholinergic 
neurons. It is used here (see details below) to quantify the extent of cholinergic neurons within 
the PPTg/LDTg. 
Immunohistochemical protocol  
Sections were washed by being rinsed for > 5 min in each of > 3 trays of clean PBS 
solution. They were then placed in blocking solution (20 % normal serum; 79.9 % PBS; 0.1 % 
Triton X-100) for 60 min. After washing (as before) sections were placed in antibody diluting 
solution (ADS) (98.9% PBS; 1% Triton X-100; 1% normal serum) containing the primary antibody 
and incubated overnight. The following day sections were processed using a Vector Labs Elite 
ABC kit (Vector Laboratories, Peterborough, UK). The first step of this process was to wash 
sections (as before) and incubate them for 90 min in a biotinylated secondary antibody (IgG, 
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1:200 concentration in ADS) and then (after washing, as before) incubate them in avidin-biotin 
complx (ABC, 1:50 concentration in ADS) for 45 min. After washing (as before) the staining was 
revealed with 3,3 diaminobenzidine tetrahydrochloride (Sigma Fast DAB; Sigma-Aldrich, 
Gillingham, UK) before a final set of washing. ChAT stained sections were then mounted on 
glass slides and coverslipped using glass coverslips and DPX mounting medium (Sigma-Aldrich, 
Gillingham, UK). NeuN stained sections were mounted onto gelatin coated glass slides and 




The serum used for the blocking solution and ADS construction in the ChAT stain was 
normal rabbit serum. The primary antibody was a goat derived polyclonal antibody (Chemicon 
International Inc, Temecula, CA, USA) diluted in ADS to a final concentration of 1:500. The goat 
version of the Vector Labs Elite ABC kits (Vector Laboratories, Peterborough, UK) was used for 
the secondary antibody and avidin-biotin complex. Sections were stained in the Sigma Fast DAB 
peroxidase substrate (Sigma-Aldrich, Gillingham, UK) for 10 min.  
 
NeuN 
The serum used for the blocking solution and ADS in the NeuN stain was normal goat 
serum. The primary antibody was a mouse derived monoclonal antibody (Chemicon 
International Inc, Temecula, CA, USA), diluted in ADS to a final concentration of 1:20,000. The 
mouse version of the Vector Labs Elite ABC kits (Vector Laboratories, Peterborough, UK) was 
used for the secondary antibody and avidin-biotin complex. Sections were stained in the Sigma 
Fast DAB (Sigma-Aldrich, Gillingham, UK) peroxidase substrate for 7 min.  
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Cressyl violet counterstain 
 NeuN stained sections mounted onto gelatin coated slides were dried overnight in a 
gas chamber containing paraformaldehyde. Slides were placed in xylene for 3 min and 
rehydrated through graded alcohol (100%; 50%; 0% ethanol in water) before being thoroughly 
rinsed in running tap water. Slides were then placed in cresyl violet stain for 60 sec, rinsed in 
running tap water for 5 min and dehydrated through graded alcohol (0%; 50% 100% ethanol in 
water). After soaking in xylene for < 3 min slides were coverslipped with glass coverslips and 
DPX mounting medium (Sigma-Aldrich, Gillingham, UK). 
 
Microscopy 
Slides were examined under a light microscope. This was either a Leica DM LB2 
microscope connected to a desktop computer system by a Leica DFC320 high resolution 
camera or a Leica Diaplan microscope (both: Leica Microsystems, Milton Keynes, UK) 
connected to a high resolution monitor with a Sony DXC-300P camera.  
 
Cannula tip location 
Cannulae tip location in microinjection experiments (chapter 3) was determined by 




 Analysis of selective cholinergic pPPTg (chapters 4,5,6) and LDTg/pPPTg (chapter 7) 
lesions was performed by examining the NeuN stain to assess the selectivity of the lesion and 
60 
 




 The NeuN/cresyl stained sections were examined for possible damage in and around 
the location of the PPTg (the area from and including the trigeminal of the motor nucleus 
through to and including substantia nigra was examined). Cell loss on the NeuN stain is evident 
by a lack of or reduction in the density of stained neuronal nuclei. Within the pPPTg the 
cholinergic neurons are highly interdigitated with the non-cholinergic neurons. Therefore, 
selective loss of cholinergic pPPTg neurons (which comprise 31% of pPPTg and 23% of aPPTg 
neurons) causes only a slight reduction in overall level of NeuN staining which, due to the 
larger size of cholinergic rather than non-cholinergic neurons, should be most marked in large 
stained nuclei. Importantly, any indication of an area with no stained nuclei is a clear sign of 
non-selective damage.  
 
PPTg ChAT+ cell counting 
In order to quantify the number of ChAT+ neurons within the PPTg, software assisted 
manual counts of ChAT+ PPTg neurons were performed. Each ChAT stained PPTg section was 
photographed with the Leica DM LB2 microscope connected to a computer system with the 
Leica DFC320 camera. Images were then loaded into the Image-J (U. S. National Institutes of 
Health, Bethesda, Maryland, USA) analysis program with the additional Cell Counter plugin 
installed. Once the image was loaded, every ChAT+ neuron within the PPTg was manually 
tagged by the experimenter and the total number of neurons on each section was was 
recorded by the program. This enabled the subsequent creation of a spreadsheet containing 
the number of ChAT+ neurons along the anterior-posterior plane of the PPTg in each 
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hemisphere. As the distance between the 1:4 series of sections (120 µm) is considerably 
greater than the diameter of mesopontine cholinergic neurons (believed to be no larger than 
50 µm (Takakusaki et al., 1996)) the risk of counting the same neuron twice was considered low 
and therefore no correction to the raw count values was performed. It should be noted that 
cell counting was to provide an estimate of lesion size, not an exact number of neurons 
present. While photographing and counting the ChAT+ sections with the experimenter blind as 
to whether the rat was a lesion or sham appears a tight control, due to the lesions generally 
being extensive it would quickly be apparent from the sections themselves if the rat had a 
successful lesion or not. Therefore, while during counting no deliberate attempt was made to 
match the rat number to treatment group, slides and images were also not camouflaged with 
respect to rat number.  
 
Behavioural Data Analysis 
Statistical analysis was performed in SPSS versions 14.0 - 18.0 (SPSS Inc., Chicago, 
Illinois USA). The exact details of particular tests used are given in each chapter. For operant 
data (chapters 3 and 5) and locomotor data (chapters 4 and 6) various univariate and repeated 
measures ANOVAs were performed. Significant interactions were further investigated with a 
variety of post hoc tests or planned pairwise comparisons, where appropriate. The Huynh-Feldt 
correction was used to decrease the effect of heterogeneity of variance (assessed by Levene's 
test) and log 10 transformations were used to adjust for skew in the data (identified by the 
Shapiro-Wilk test). When used, these adjustments are always stated. T-tests were used to 
compare smaller single data sets (for example sucrose solution consumption in chapter 4), with 
particular details again always being given in individual chapters. All effects were considered 
statistically significant when p ≤ 0.05. 
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Concise summary of action-outcome learning 
Action-outcome (A-O) learning is the ability to form and update a relationship between 
the actions one performs and the outcomes (events) these actions produce. Once these 
associations have been formed, the actions can then be re-executed with the goal-directed 
aim of obtaining the outcome. As discussed in the general introduction this is an essential kind 
of learning (indeed, it is perhaps what is thought of first when considering learning). However, 
it is only one of several interacting and competing learning types, the main other one being 
stimulus-response (S-R) learning. S-R learning is the formation of automatically executed 
associations between stimuli and actions. Once the association is formed, the stimuli trigger 
the habitual execution of the actions without influence from factors such as the expected 
consequence or desirability of the outcomes these actions produce. Many brain systems are 
known to be involved in A-O learning and performance, central to which are the basal ganglia 
(Balleine et al., 2009) (of which the posterior dorsomedial striatum is critical (Yin et al., 
2005b)), prelimbic cortex (Corbit and Balleine, 2003); mediodorsal thalamus (Corbit et al., 
2003) and entrorhinal cortex (Corbit et al., 2002). These are all parts of an extended cortico-
striatal circuitry critical for developing appropriate responses to new stimuli as well as the 
maintenance of habitual responding and the selection of appropriate actions in situations 
where there are multiple choices (Everitt and Robbins, 2005; Redgrave et al., 2011). 
 
The PPTg and action-outcome learning  
While numerous studies have reported learning deficits after PPTg lesion (see general 
introduction, pp20-24), two studies in particular are relevant in terms of action-outcome 
learning. Alderson et al. (2004) showed that rats with excitotoxic PPTg lesions and no prior 
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experience of operant tasks did not learn to lever press to receive an intravenous infusion of d-
amphetamine. However, they showed no impairment if they had learned that lever pressing 
was rewarded (with food pellet) prior to lesion (Alderson et al., 2004). Wilson et al. (2009) 
found that pPPTg lesioned (but not aPPTg lesioned) rats were impaired at learning a FR1 
schedule of reinforcement for food pellet reward, but that with significantly more training 
sessions than sham rats they were ultimately able to learn this task. However, when the 
reinforcement schedules changed to FR5, pPPTg lesioned rats were again slow to adjust their 
rates of lever pressing (Wilson et al., 2009a). What these results have in common is that the 
main deficits seen were at points where the formation (the naive group in the Alderson et al. 
(2004) study; the first FR1 testing sessions in the Wilson et al. study (2009)) and updating 
(immediately after schedule change in the Wilson et al study) of associations occurred. This 
strongly suggests that the core deficit in these rats is impairment in the formation and 
updating of action-outcome associations. However, these tasks are not well designed 
specifically to assess action-outcome learning. For example, both tasks (and indeed the 
majority of all instrumental leaning operant tasks) employ a light above the active lever which 
illuminates simultaneously with reward delivery. This light is deliberately used to aid learning 
by causing a salient change in the testing environment and signaling that the reward is now 
available. However, additions of cues such as this complicate the interpretation of the results 
as, for example, impairment in forming a stimulus-outcome association between the light and 
reward delivery would impair learning of the whole task. Indeed, the pPPTg lesioned rats in the 
Wilson et al. (2009) study showed increased ‘late presses’ (presses made after illumination of 
the lever light but before collecting the reward), perhaps suggesting that they were not 
successfully utilizing or responding to the light cue. Therefore, while these results strongly 
suggest an action-outcome impairment, the possibility that impairments other than those of 
action-outcome might have contributed to the poor performance of pPPTg lesioned rats 
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means clear assessment of the role of the PPTg in action-outcome learning cannot be drawn 
from these studies alone.  
 
Assessing action-outcome learning 
Within the rodent (and also used in primate and human) literature (eg:(Shanks and 
Dickinson, 1991; Yin et al., 2005b; Liljeholm et al., 2011) two experimental paradigms have 
become standard use in the assessment of action-outcome learning. These are referred to as 
‘outcome devaluation’ and ‘contingency degradation’.  
 
Outcome devaluation 
In outcome devaluation experiments the aim is to assess the effects of manipulating 
the value of a reward on the level of behavior performed in order to obtain the reward. This is 
based on the premise that if behaviour is governed by goal directed action-outcome processes 
then devaluation of the reward will lead to a subsequent reduction in the performance of 
behaviour to obtain the reward. However, if this behaviour is governed by stimulus-response 
processes (and therefore not performed with the intent of obtaining the reward) then the 
behaviour will be insensitive to changes in reward value. There are many different versions of 
this paradigm, but they all share common features. Typically subjects are trained to perform 
an operant response (lever press) to receive an outcome (reward pellet or liquid). The value of 
this outcome is then reduced, either through satiation (induced by a free exposure session) or 
pairing with an aversive outcome (associating the reward with lithium chloride induced illness 
for example). Subjects’ willingness to work for the reward is then re-tested; a reduction in 
lever pressing is taken as demonstrating intact action-outcome processing, whereas 
unchanged lever pressing is indicative of behaviour which is governed by stimulus-response 
mechanisms. A particularly elegant version of this paradigm involves training the subjects to 
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press on two different levers, each of which delivers a different and distinct reward (Yin et al., 
2005b). One of these rewards is then devalued immediately before giving the subjects a free 
choice extinction session where the rates of lever pressing for both the devalued and valued 
(not manipulated) rewards are measured. This design allows for a tight within-subjects control: 
rather than comparing the effects of devaluation between a devalued and control group, the 
effects can be compared between the devalued and control reward within each subject.  
 
Contingency degradation 
 The aim of contingency degradation is to manipulate the strength of the relationship 
between action and outcome, typically by delivery of rewards not contingent on action 
performance. This is based on the premise that if behaviour is governed by action-outcome 
processes then the delivery of ‘free’ rewards not dependent on any action will cause a 
reduction in actions associated with being required to obtain that reward. In other words: 
realizing that the reward no longer needs work to obtain it leads to a reduction in the amount 
of work done. As with outcome devaluation, there are many subtly different versions of this 
task. Typically subjects are trained to lever press for reward delivery on a very variable 
schedule of reinforcement (which maintains a degree of uncertainty between action and 
outcome). Once stable levels of performance are reached, the experimental manipulation is 
performed (for example lesion or, more commonly, temporary inactivation) and the subjects 
tested under conditions of reduced contingency between lever press and reward delivery (for 
example, by the random delivery of rewards not dependent on action). Subjects are then 
tested in an extinction test. The hypothesis here is that subjects with intact monitoring of the 
actions they perform and the outcomes they produce will be sensitive to this disjunction 
between action and outcome and accordingly reduce the number of lever presses they make. 
Subjects with impaired action-outcome updating will continue pressing the lever and continue 
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getting the outcome, but not notice that these two events are no longer linked. Again, and 
pioneered by the same laboratory as the outcome devaluation test described above, a 
particularly appealing version of this task exists. In this version subjects are trained with two 
levers, each giving one distinctive reward. The contingency between one lever and reward is 
then degraded, while the other lever-reward association is maintained (Yin et al., 2005b). 
Comparison of rates of lever pressing on the contingent versus non-contingent lever allows for 
a tight within-subjects assessment of performance.  
In both of these paradigms attempts are made to reduce possible contributions from 
stimulus-response and other learning types. This involves using no programmed conditioned 
stimuli (for example lights or retraction of levers upon reward delivery) and keeping the testing 
and training regime as succinct as possible. The emphasis on keeping the training period short 
is due to extended or distributed training being known to induce habitual responding (Adams, 
1982). As both of these paradigms require training to be conducted before the brain region of 
interest is manipulated, they are more suited to temporary inactivation (for example by the 
direct microinjection of the GABA agonist muscimol) than permanent lesions. Cannulae can be 
permanently implanted prior to any training and infusions of inactivating agents then made at 
the appropriate points within the testing regime. While it is possible to pre-train animals prior 




The aim of this chapter was to specifically assess the role of the pPPTg in action-
outcome learning using the outcome devaluation and contingency degradation paradigms 
developed by Balleine and colleagues (Yin et al., 2005b). Inactivation of the pPPTg was 
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achieved by means of direct microinjection of muscimol. The data for experiment 1 (outcome 
devaluation) were collected with Dr David Wilson; experiment 2 (contingency degradation) 
was conducted independently.  
 
Inactivating the pPPTg 
Various pharmacological agents have been reported successfully to inactivate the 
PPTg. Of these, the local anesthetics lidocaine (Pan and Hyland, 2005) and procaine (Nowacka 
et al., 2002) and the GABA agonist muscimol (Samson and Chappell, 2001; Diederich and Koch, 
2005) are the most commonly used. There is concern that local anesthetics inactivate fibers of 
passage (Levy et al., 2001) which are unaffected by muscimol (Majchrzak and Di Scala, 2000). 
In addition muscimol also has a more constant and stable field of action than anesthetic agents 
(Martin, 1991). Muscimol, therefore, is a clear preference for use. There is a wide range of 
doses of muscimol reported in the PPTg literature (for example within one paper both 0.05 µg 
and 0.5 µg are used (Diederich and Koch, 2005)). This laboratory has recently developed a 
muscimol pPPTg infusion procedure which causes over-consumption of 20% sucrose solution 
but no detectable locomotor impairment (measured in photocell cages) (Wilson and 
MacLaren, unpublished data, (2008)). This dose of 0.05 ug in 0.3 uL saline is at the conservative 
end of the range of previously reported doses. However, as the effects on sucrose 
consumption and locomotion mirror those seen after ibotenic pPPTg lesion (Wilson et al., 
2009a) and as higher doses caused a clear motor and orientating impairment (not seen after 
ibotenic lesion), this dose is believed to be the most effective and will be used here. Because 
muscimol is a full GABA-A, full GABA-C and partial GABA-B receptor agonist its effects are 
generally believed non-specific for neuronal type within PPTg. However, one laboratory has 
reported the interesting claim that within PPTg GAGA agonists may predominantly affect non-
cholinergic neurons (Torterolo et al., 2002). They support this claim with reference to another 
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paper from their laboratory. Despite extensive searching of online and physical libraries, the 
journals archive and the personal webpages of the authors, no other record of this paper or 
another paper with a similar title has been found. Contacting all the authors resulted in no 
response. The current Editor-in-Chief of the journal (Sleep) confirmed that the referenced 
paper is not in the journal archives (Dinges DF, Personal communication, (2010)). In contrast to 
this, work in slice preparation (albeit from juvenile rather than adult rat) has shown that 
muscimol affects both cholinergic and non-cholinergic PPTg neurons (Bay et al., 2007). Other 
authors have also concluded that muscimol is likely to affect all PPTg neuronal sub-populations 
(Diederich and Koch, 2005). Therefore the evidence suggests that muscimol should inactivate 
the pPPTg without preference for one neuronal type. 
 
Chapter 3, experiment 1: outcome devaluation 
Experiment overview: 
The behavioural training and testing protocol is illustrated in figure 3.1. Rats were 
implanted with guide cannulae aimed at the pPPTg prior to operant training. They were then 
trained to press on two levers (left and right) which both delivered the same low value pellet 
reward from the same reward magazine within the operant box. Once stable performance was 
reached they were infused with either saline or muscimol prior to an acquisition session where 
each lever lead to the delivery of a distinctive high value reward (sweet pellets and 20% 
sucrose solution). The following day one of these rewards (counterbalanced across rats) was 
devalued by giving free exposure to it in the homecage for 60 min. Immediately after this rats 
were tested (without microinjection) in an extinction session where no rewards were 
delivered. The rationale is that prior to the acquisition session rats learned that both levers 
were rewarded equally. They then had only one session (the acquisition session itself where 
70 
 
muscimol was active) to learn that the lever-reward associations had changed and each lever 
now delivered a unique reward. Devaluing one of the rewards should, in rats who had learned 
the lever-reward association and were governed by action-outcome processes, cause them to 






Figure 3.1: Schematic of the outcome devaluation paradigm. 
 
Materials and Methods 
Subjects 
24 male Lister-Hooded rats (Harlan Olac Ltd, Bicester, UK) were used in this 
experiment. Rats had a mean weight of 440g at the start of the experiment and were housed as 
described in the general methods. Seven days prior to behavioural testing food was restricted 
to 15 - 16 g/rat/day standard lab chow, 7 days a week. Throughout testing bodyweight was 




Rats were anaesthetized with isoflurane and placed in a stereotaxic frame as described 
in the general methods. Bilateral guide cannulae (22 ga, 3.8 mm apart, protruding 5.0 mm from 
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pedestal base; Plastics One, Roanoke, VA, USA) aimed at the pPPTg were implanted (as 
described in the general methods) at the following co-ordinates: +0.4 mm from the IAL; ±1.9 
mm from the midline; 5.0 mm ventral from the dorsal surface of skull. Every 1 - 2 days 
following surgery dummy cannulae were removed and changed with clean replacements. Rats 
were given at least 7 days to recover from surgery prior to the start of operant training. 
 
Operant Training 
Operant training was conducted in the operant chambers described in the general 
methods. The features of the chambers used in these experiments were the 2 retractable 
levers on either side of the reward magazine, the reward magazine itself (which contained a 
food trough and a liquid solution cup allowing the delivery of both pellets and solution 
rewards) and the houselight on the top of the wall opposite to the levers and reward magazine.  
Three days prior to testing rats were given 2 g of the reward which would be used as 
the low value training reward (grain pellets; Noyes Precision rodent food pellets, Formula A/I, 
45 mg, Research Diets Inc., Brunswick, NJ, USA) in a small bowl in their homecage. This 
exposure was an attempt to reduce neophobia to the pellets. Operant training began the next 
day; the first session lasted 30 min and during this time pellets were delivered randomly at a 
rate of 1 pellet per min (Random Time [RT] 60). This was to familiarize the rats with the operant 
box and learn the location of the reward magazine. The following day instrumental training 
began. Rats were trained in 2 30 minute sessions a day (morning and afternoon) during which 
only 1 lever was present (counterbalanced across sessions). Starting with fixed-ratio 1 (FR1) 
schedule (where 1 lever press always produced a food pellet) they were advanced (once having 
met criteria, see table 3.1) onto a RR5 (Random Ratio 5: 0.2 probability of reward per lever 












    Table 3.1: Reinforcement schedules and criteria for advancement through schedules. 
 
Learning of novel action-outcome associations 
In an attempt to reduce neophobia to the high value rewards which would be used in 
the novel outcome acquisition session, the day before this session rats were given both of the 
novel outcomes (15 mL sucrose solution [20% sugar in water] and 2 g sweetened food pellets 
[Test Diet purified rodent tablet 5TUL, Sandown Scientific, Middlesex, UK]) in their homecage. 
On the day of the novel action-outcome acquisition session rats received 
microinfusions into the pPPTg 20 min prior to the start of the operant session. Bilateral 
infusions of either muscimol (0.05µg in 0.3µL saline; Tocris Bioscience, Bristol, UK) or saline 
(0.3µL; Baxter Healthcare Ltd.) were made via bilateral internal cannulae injectors (3.8mm 
apart, protruding 7.5 mm from the base; Plastics One) using the infusion method described in 
the general methods. Following microinjection, rats were placed in their homecage (in the 
infusion room) for 20 min during which time they had no access to food or water before being 
taken to their operant box for the acquisition session. 
During the acquisition session only 1 lever was extended at any time with left and right 
levers being automatically alternated every 5 min. Both levers were programmed on a RR10 
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schedule of reinforcement, one lever delivered 20% sucrose solution (0.1 mL) and the other a 
sweet reward pellet. The acquisition session lasted for 90 min, after which rats which had 
previously been infused with muscimol were infused bilaterally with saline, and rats previously 
infused with saline were infused bilaterally with muscimol (using the infusion procedure 
described in the general methods). Thus all rats received muscimol in the acquisition day; 
however half received it before, and half after, the acquisition session (for convenience, the 
group who received muscimol before the acquisition session and saline after it are referred to 
as the muscimol group; the group who received saline before and muscimol after the 
acquisition session are referred to as the saline group). 
 
Outcome Devaluation 
The following day rats were given 1 h of unlimited exposure to one of the high value 
rewards in their homecage. No infusions were given on this day: half of each previous 
treatment group (muscimol or saline) received 20% sucrose solution, the other half received 
sweet pellets. Pellets were given in full small bowl and sucrose solution in a full glass drinking 
bottle. Consumption of each of the rewards was measured by weighing the bottle/bowl before 
and after exposure. Immediately following exposure to one reward, rats were tested in a 5 min 
operant test under conditions of extinction where both levers were extended and no outcomes 
delivered. The number of lever presses on each lever was recorded and allowed both the 
measurement of presses on levers associated with sweet pellets and sucrose solution as well as 
the calculation of presses on levers associated with the devalued and the valued reward. 
 
Histology 
All histological procedures were performed as described in the general methods. After 
completing behavioural testing rats were transcardially perfused with fixative and brains stored 
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in sucrose solution. Subsequently, 30µm coronal sections were cut through the area of the 
PPTg and ~1mm beyond in anterior-posterior plane. Parallel 1:4 series were processed 
immunohistochemically for ChAT reactivity and mounted onto glass slides. Slides were viewed 
under a light microscope (Leitz Diaplan) and cannulae tip locations judged with reference to the 
densely packed cholinergic neurons of the pPPTg. Only rats where injector tips were located 
within the pPPTg were included in the subsequent analysis. 
 
Behavioural Data Analysis 
Statistical analysis was performed in PSAW 18.0 (SPSS Inc., Chicago, Illinois USA). 
ANOVAs were performed to compare lever pressing rates for pellet and solution levers, 
consumption during the free exposure session and pressing for valued versus devalued rewards 
(all within-subjects factors). These were compared across the between subjects factor of 
infusion group (muscimol versus saline) and outcome devalued (sweet pellets versus sucrose 
solution). When necessary the Huynh-Feldt correction was used to decrease the effect of 
heterogeneity of variance. Where significant interactions were found, these were investigated 




Of the rats that completed the behavioural paradigm all injector tips were found to be 
located within the pPPTg. Figure 3.2 shows the location of injector tips. Ten rats were excluded 
from analysis for either loss of headcap (n=6); due to developing erratic movements post-
surgery (n=3); or due to being tested with faulty equipment for an unknown number of 
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Figure 3.2: Illustration of the location of the bilateral injector 
tips, shown on coronal sections adapted from the stereotaxic 
atlas of Paxinos and Watson (2005). The location of each 
saline injector tip is represented by an open circle and each 
muscimol injector tip by a closed circle. The PPTg is outlined 




Training to lever press on low value rewards 
During initial training all rats quickly learnt to lever press for grain pellets and reached 
criterion level of performance on the RR10 with a mean total training of 8 days. Once assigned 
to groups (saline, muscimol) multivariate ANOVA confirmed there were no pre-existing pre-
infusion significant differences in the overall rate of lever pressing between groups or in the 
preference for either lever (effect of lever (F1,12 = 1.44; p = 0.254); lever * group (F1,12 = 0.47; p 
= 0.51); group (F1,12 = 0.03; p = 0.96). 
 
Lever pressing during acquisition session 
During the acquisition session, where muscimol was active and the new rewards 
(sweet pellets and sucrose solution) were assigned to individual levers, a two way mixed 
ANOVA revealed a significant of lever (F1,12 = 11.99; p = 0.005) and a lever x group interaction 
(F1,12 = 4.98; p = 0.046) and no main effect of group (F1,12 = 0.228; p = 0.64). Post hoc t-tests 
confirm that saline treated rats pressed significantly more on the pellet versus solution lever 
(t6 = -2.98; p = 0.048) whereas muscimol treated rats showed no significant differential 





Figure 3.3: Lever pressing during the 
acquisition session. Graph shows group 
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Consumption during free exposure 




The amount of each reward consumed during the 1 hour free exposure session in the 
homecage is shown in figure 3.4. One way ANOVAs found no significant difference between 
the saline and muscimol groups in consumption of either sweet pellets (F1,5 = 0.62; p = 0.46) or 








Figure 3.4: Consumption (in g) during the free exposure session. Graph shows group means ± SEM. See 




Rates of lever pressing during the extinction session were calculated for both pressing 
on the lever associated with particular rewards (sweet pellet and sucrose solution) and reward 
value (devalued = free exposure to reward in homecage; valued = no free exposure in 
homecage). These results are shown in figure 3.5. For the analysis of pressing for reward type 
(sweet pellet and sucrose solution), a two way mixed ANOVA revealed a significant of lever 
(F1,12 = 14.37; p = 0.003) a significant lever x group interaction (F1,12 = 9.02; p = 0.011) and no 
78 
 
main effect of group (F1,12 = 0.13; p = 0.73). Post hoc t-tests confirm that rats in the saline 
group pressed significantly more on the pellet versus solution lever (t6 = -3.63; p = 0.01) in 
contrast to rats in the muscimol group which showed no significant differential pressing (t6 = -
1.13; p = 0.30). For the analysis of pressing for reward value (valued and devalued), a two way 
mixed ANOVA found no significant effects (lever value (F1,12 = 0.00; p=1.0) lever value x group 
(F1,12 = 0.411; p = 0.53) group (F1,12 = 0.13; p = 0.73). Additional t-tests confirm that neither rats 
in the saline or muscimol group pressed significantly more on either lever (saline: t6 = 0.32; p = 










Figure 3.5: Lever pressing during the extinction session. The left graph shows pressing on the lever 
associated with sweet pellets or sucrose solution, the right graph shows pressing on the lever associated 













































Summary of results 
During the acquisition session saline treated rats developed significantly higher rates 
of pressing on the lever associated with the pellets compared to sucrose solution. Inactivation 
of the pPPTg had no effect on the overall rate of lever pressing but blocked the development 
of differential lever pressing: muscimol treated rats pressed equally on both levers. During the 
extinction session (when all rats were drug free) the same pattern was found, there was no 
effect of previous infusion treatment on the overall rate of lever pressing but saline treated 
rates again pressed significantly more on the sweet pellet associated lever compared to the 
sucrose solution lever, whereas muscimol treated rats displayed no difference between rate of 
pressing on either lever. Exposure to one reward in the homecage did not alter subsequent 
rates of lever pressing for valued or devalued rewards in either the saline or muscimol group.  
 
Experiment discussion: 
No effect of outcome devaluation 
The most striking result is that the attempt to devalue one of the outcomes by giving 
free exposure in the homecage prior to the extinction test did not create an outcome 
devaluation effect in the saline treated rats. The standard interpretation of insensitivity to 
outcome devaluation is that the behavior has become habitual action governed by stimulus-
response rather than action-outcome processes. However, a careful examination of the saline 
treated group suggests this is unlikely here. Prior to the acquisition session, rats were trained 
to press each of the two levers for a low value grain pellet reward and at this point they had 
equal rates of pressing on both levers. It was only during the 90 min acquisition session and 
subsequent extinction test that the pattern of preferential pressing on the lever now 
associated with the sweet pellets developed. If this were a stimulus-response habit then then 
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it must have formed for the pellet associated lever in the 90 min acquisition session. The rapid 
formation of a habit during this session but not during previous sessions seems highly unlikely, 
but cannot be excluded from the data here. However, another interpretation is that the rats 
preferred the sweet pellets over the sucrose solution, and once they had learned which lever 
delivered which reward, pressed significantly more on the lever associated with the sweet 
pellet reward. There are some arguments to suggest that the rats would prefer the sweet 
pellets to the sucrose solution. The sweet pellets were the same shape, size and texture as the 
low value pellet rewards used throughout training. They were simply a nice version of what 
the rats were used to. Moreover, they were delivered from the same location in the reward 
magazine as the training pellets. The sucrose solution was a new reward type (that the rats 
have only briefly experienced once in the homecage prior to the acquisition session) delivered 
from a different mechanism within the reward magazine. In the operant boxes used here, the 
rat must reach with his head into the entry of the reward magazine to collect the pellet or 
access (in a different location within the magazine) the recessed cup containing liquid. It has 
been shown that rats prefer to consume food from a familiar rather than novel food container 
(Mitchell, 1976) and observation of the rats when learning the reward location revealed that 
when equipped with a cannulae headcap assembly there was very little room for the rat to 
easily collect the reward without collision between the headcap and top of the reward 
magazine (this anecdotal evidence is supported by 3 rats losing their headcap assemblies in 
the operant boxes). Therefore, it is possible that rats were “anxious” about (or even did not 
notice) the new reward location and preferred to continue collecting the reward type they 
were familiar with collecting. The MED-PC equipment used does not have a means of verifying 
that the solution was consumed when delivered, so it is unknown if the rats found the solution 
after every (or any) delivery.  Stronger evidence that the rats formed a preference for the 
reward type they were trained with comes from earlier unpublished work from this laboratory 
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(Wilson, D and MacLaren, D; unpublished results). We attempted the same experiment 
described here using a different reward combination. Rats were initially trained to lever press 
on both levers for 20% sucrose solution reward (rather than the grain pellets used here) and 
subsequently we used blackcurrant flavored Ribena and sweet pellets as the novel high value 
rewards. During the extinction test we found a significant preference for the lever that was 
associated with Ribena, and this preference was not affected by the free exposure to Ribena in 
the homecage prior to the extinction test. Thus, we saw the same preference for the reward 
type used during training and a lack of effect of attempted reward devaluation, but for the 
opposite (liquid rather than dry) reward type.  
 
Why did the devaluation effect not replicate? 
There are 2 main possible reasons for the lack of devaluation effect. (1) It is possible 
that the preference formed for the pellets during training and the acquisition session was 
strong enough to override the effects of devaluation through exposure in the homecage. While 
the use of two distinct rewards is a powerful paradigm, it requires that the consumption which 
occurs during the devaluation exposure session in the homecage satiates the rat specifically on 
that one reward (sensory specific satiation) rather than inducing general satiation for all 
calorific/sweet rewards. Moreover, it requires that sensory specific satiation induced in the 
homecage is maintained in the operant box. From the early days of assessment of outcome 
devaluation, issues with sensory specific satiation have been evident. It has been found that in 
rats trained to lever press for saccharin reward, free exposure to saccharin in the homecage 
had no effect on the subsequent rates of lever pressing on a saccharin associated lever, 
however, free exposure to dextrose (which had never been presented in the operant box, 
these rats were also trained on saccharin) significantly reduced rates of lever pressing on the 
saccharin lever (Holman, 1975). This effect cannot be explained by general satiation induced 
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by the calorific dextrose, as when saccharin consumption was measured in the homecage, 
previous pre-exposure to either saccharin or dextrose both reduced (and reduced equally) the 
amount of saccharin subsequently consumed. These results show that satiation can reduce 
levels of lever pressing, but highlight that the specificity of the satiation is hard to predict. (2) It 
is possible that the rewards used in this experiment were not sufficiently different to induce 
sensory specific satiation. The exact rewards used in the original experiment are not available 
in the United Kingdom (hence the substitution for seemingly similar rewards) which may have 
inadvertently compromised the reliability of the devaluation effect. However, the finding of 
development of a reward preference for the reward type used during training in this and the 
earlier attempt using different rewards suggests it is a systematic problem of the experimental 
paradigm rather than an unfortunate choice of mal-matched rewards.1  
 
Effects of inactivation of the pPPTg 
 
Notwithstanding the attempted devaluation having no effect on sham rats subsequent 
rates of lever pressing, these rats did develop clear differential pressing in both the acquisition 
and extinction test, an effect that was completely blocked by inactivation of the pPPTg. Three 
interpretations of this effect are possible: (1) inactivation blocked the formation of a S-R habit 
in response to the sweet pellet associated lever; (2) inactivation blocked the preference for 
sweet pellets, rendering both rewards equally desirable; and (3) inactivation blocked learning 
that the action of lever pressing now led to the outcome of different rewards being delivered. 
Option (1) can be discounted using the argument above – that the formation of a S-R habit 
during the acquisition session does not appear to be a satisfactory explanation of the effect 
seen in the saline treated rats. Option (2) is possible, but previous lesion data show that PPTg 
                                                          
1 At the 2010 (San Diego) Society for Neuroscience conference I spoke with 1 and at the 2011 (Washington DC) 
Society for Neuroscience conference I spoke with 2 other researchers who were attempting the same outcome 
devaluation behavioural paradigm and had also encountered the problem of control rats forming preferential lever 
pressing that was insensitive to reward devaluation. 
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lesion does not affect reward discrimination, perceived reward value or contrast effects 
(Olmstead et al., 1999; Taylor et al., 2004) suggesting that PPTg inactivation is unlikely to affect 
reward preference formation. The third interpretation – that pPPTg inactivation blocked 
learning that the levers were now associated with different rewards – is the interpretation 
most in keeping with previous studies showing clear learning impairment after pPPTg lesion. If 
rats with pPPTg inactivation were unable to learn that the lever-outcome associations had 
changed they would continue pressing equally on each lever (as they had done during training) 
– which is exactly what was found here. 
 
Experiment conclusions 
 A full assessment of the role of the pPPTg in action-outcome learning cannot be made 
on the basis of the results of this experiment. However, these results show that inactivation of 
the pPPTg blocks the behavioural changes in response to modifications in the relationship 
between actions and outcomes without affecting the expression of previously learnt action-
reward associations. The most parsimonious interpretation of this being that rats with pPPTg 
inactivation were unable to learn that the lever-reward associations had now changed.  
In order to address fully the role of the pPPTg in action-outcome learning, two 
possibilities emerge: either attempting to modify the outcome devaluation paradigm, or 
running another behavioural task (for example a contingency degradation experiment). It is 
possible that with different rewards and even a different reward delivery mechanism that no 
preferential lever pressing would develop and the standard outcome devaluation effect would 
be seen. In order to enhance the devaluation effect an additional option would be to pair one 
reward with illness induced by lithium chloride (Adams and Dickinson, 1981). However, 
subjecting rats to lithium induced malaise when other measurements of action-outcome 
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learning exist seems an unnecessary step. In contingency degradation experiments all the 
training and manipulations are conducted in the operant box so there is no need to induce 
sensory specific satiation in the homecage. While the version of this task used by Balleine and 
colleagues again has two levers associated with two distinct rewards (Yin et al, 2005), it should 
be possible to modify this experiment by using one reward and a between-subjects rather than 
within-subjects design. In this modification all rats are trained with one reward, and in certain 
groups of rats the contingency between lever pressing and reward delivery is degraded before 
all rats are tested in an extinction test. As this successfully addresses the two main issues 
experienced with the outcome devaluation experiment, and as contingency degradation is a 
valid and widely used measure of action-outcome learning, it was considered preferable to 
attempting to modify the outcome devaluation paradigm.  
 
Chapter 3, experiment 2: contingency degradation 
Experiment overview: 
The contingency degradation paradigm used here is a modification of that used by Yin 
et al. (2005). Rats are implanted with guide cannulae before operant training begins. After 
recovery from surgery, training starts with a FR1 schedule and, once criterion performance has 
been reached (see table 3.2 for details) rats are advanced through ever increasing RR 
schedules until stable performance on a RR20 schedule is reached. At this point rats are split 
into control and inactivation groups and further split into contingent and non-contingent 
groups (see figure 3.6 for schematic of experimental design). Rats are then tested in 3 
contingency degradation sessions where they are infused with muscimol or saline prior to 
being trained on a contingent or non-contingent reinforcement schedule (according to group 
designation). The contingent schedule is the same RR20 schedule as the final training session, 
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in the non-contingent schedule a comparable number of pellets are delivered throughout the 
session, but delivered in a non-contingent manner such that the probability of pellet delivery 
in each second is equally likely whether the rat has responded appropriately or not. Finally, all 













Figure 3.6: Schematic of the contingency degradation paradigm. 
 
 
Materials and Methods 
Subjects 
48 male Lister Hooded rats (Harlan Olac Ltd, Bicester, UK) with a mean surgery weight 
of 404g were used in this experiment. Rats were maintained as described in the general 
methods. Prior to surgery and during recovery rats had free access to food and water. Four 
days prior to behavioural testing food was restricted to 15 g/rat/day standard lab chow, 7 days 
Implantation of cannulae aimed at pPPTg 
Train to RR20  





a week. Throughout testing bodyweight was monitored daily to ensure it did not fall to below 
85% of free-food weight. 
 
Surgery 
Rats were anaesthetized with isoflurane and placed in a stereotaxic frame as described 
in the general methods. Bilateral guide cannulae (22 ga, 3.8 mm apart, protruding 5.0 mm from 
pedestal base; Plastics One, Roanoke, VA, USA) aimed at the pPPTg were implanted (as 
described in the general methods) at the following co-ordinates: +0.4 mm from the IAL; ±1.9 
mm from the midline; 5.0 mm ventral from the dorsal surface of skull. Every 1 - 2 days 
following surgery dummy cannulae were removed and changed with clean replacements. Rats 
were given at least seven days to recover from surgery prior to the start of operant training. In 
order to try and overcome the high loss of headcaps experienced in experiment 1 of this 
chapter, new screw types were used in an attempt to add more support to the headcap 
assembly. These were 2 x 0-80 X 3/32 stainless steel mounting screws (Plastics One, Roanoke, 
VA, USA) in front and behind the cannula pedestal and 2 x 0-80 X 1/8 stainless steel mounting 
screws (same supplier) in front of bregma. Despite being longer than the previous screws, care 
was taken to ensure they did not penetrate further through the skull. This modification 
appeared successful as no further headcaps were lost. 
 
Operant Training 
Operant testing was conducted in the operant chambers described in the general 
methods. The features of the chambers used in this experiment were the 2 retractable levers 
either side of the reward delivery magazine and the houselight on the top of the wall opposite 
the levers and magazine.  
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Two days prior to training each rat twice received 1 g of testing pellets (Test Diet 
purified rodent tablet 5TUL, Sandown Scientific, Middlesex, UK) in a small bowl in their 
homecage in an attempt to reduce neophobia to the pellets. On the first day of operant 
training, 25 pellets were freely available in the reward magazine, no levers were extended and 
the doors to the sound and light attenuating boxes were left open. Once all the pellets were 
consumed (~20min) rats were returned to their homecage. This allowed the rats to become 
familiar with the operant box and learn the location of the reward delivery. Daily training 
sessions (40 min duration) began the following day, starting with a FR1 schedule. Once rats had 
met the criteria for performance on FR1 (see table 3.2) they were advanced onto a random-
ratio 5 schedule (RR5; a 1:5 probability that a single pellet would be delivered per lever press), 
then onto random-ratio 10 (RR10) and random-ratio 20 (RR20) schedules. Pressing on the 
inactive lever (side counterbalanced across rats) was recorded but had no programmed 
consequence.  
 
Contingency degradation testing 
Once rats had met criteria on the RR20 schedule they were randomly assigned to either 
the saline or muscimol group, then further assigned to a contingent or non-contingent 
subgroup. Thus final groups were: (1) Saline – contingent. (2) Saline – non-contingent. (3) 
Muscimol – contingent. (4) Muscimol – non-contingent. The ‘contingent’ groups were 
subsequently trained in a regime where pellet delivery was still dependent on lever pressing on 
a RR20 schedule (i.e. no change in contingency from previous training). The ‘non-contingent’ 
groups were trained in a regime where pellet delivery was not dependent on lever pressing. 
Each second there was a 1:34 probability of pellet delivery whether the rat responded 
appropriately or not. Training sessions lasted 20 min and were started 15 min after the 
appropriate saline / muscimol infusion. Infusions were made as described in the general 
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methods. Training during these sessions was conducted every other day to ensure full 






Table 3.2: Training regime and criteria for advancing through schedules. 
 
Extinction test 
In the session after the third contingency training session rats were tested, without 
infusion, in a 20 min extinction test. In the same manner as all training and testing sessions 




All histological procedures were performed as described in the general methods. After 
completing behavioural testing rats were transcardially perfused with fixative and brains stored 
in sucrose solution. Subsequently, 30 µm coronal sections were cut through the area of the 
PPTg and ~1mm beyond in anterior-posterior plane. Parallel 1:4 series were processed 
immunohistochemically for ChAT reactivity and mounted onto glass slides. Slides were viewed 
under a light microscope (Leica DM LB2) connected to a desktop computer system by a high 
resolution camera (Leica DFC320). Cannulae tip locations were judged with reference to the 
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densely packed cholinergic neurons of the pPPTg. Only rats where injector tips were located 
within the pPPTg were included in the subsequent analysis. 
 
Behavioural Data Analysis 
Statistical analysis was performed in PASW 18.0 (SPSS Inc., Chicago, Illinois USA). 
Repeated measures ANOVA were performed across the degradation training sessions. 
Univariate ANOVAs were performed to compare pressing rates between the saline and 
muscimol contingent and non-contingent groups on the final day of pre-training and during the 
extinction test. In cases of significant group differences or interactions, these were investigated 
with univariate ANOVAs, protected planned pairwise comparisons and Bonferroni corrected t-




Of the rats which completed behavioural testing, 29 were found to have cannulae tips 
located within the pPPTg, giving final group sizes of: saline n = 14 (contingent n = 7; non-
contingent n = 7); muscimol n = 15 (contingent n = 8; non-contingent n = 7) The location of 
cannulae tips is depicted in fig 3.7. The remaining rats were excluded from all analysis due to: 
complications with infusions (n = 4); tissue damage causing lesion (n = 4); cannulae missing the 






























Figure 3.7: Illustration of the location of the bilateral injector tips, shown on coronal sections adapted 
from the stereotaxic atlas of Paxinos and Watson (2005). The location of each injector tip is represented 
by a closed circle (contingent group) or an open circle (non-contingent group) with saline treated rats in 
the left column and muscimol treated rats on the right. The PPTg is outlined in bold, numbers indicate 






Rats reached criteria level on the RR20 training schedule in a mean of 11 (S.E. 0.27) 
sessions. Multivariate ANOVA confirmed there were no group differences at this pre-infusion 
point.  
 
Contingency degradation testing 
Repeated measures ANOVA across the three degradation training sessions found no 
main effect of group, but a significant effect of session (F2,50 = 3.56; p = 0.036) and a group x 
session interaction (F6,50 = 3.30; p = 0.008). To investigate the effect of session, corrected 
paired samples t-tests were performed comparing rates of lever pressing on the first and last 
session. These found that pressing in the saline non-contingent group was significantly less 
during session 3 compared to 1 (t6 = 5.39; p = 0.008), but that no other groups had a significant 
change in rate of lever pressing. Univariate ANOVA of the last session found a main effect of 
group (F3,25 = 3.53, p = 0.029) and restricted pairwise comparisons revealed that the difference 
between saline contingent and non-contingent lever pressing was significant (p = 0.005) 
whereas the difference between the muscimol contingent and non-contingent pressing was 
not significant (p = 0.294). Furthermore, the difference between saline and muscimol 















Figure 3.8: Mean number of lever presses on the active lever for each group during each of the three 
contingency degradation training sessions. Error bars show SEM.    
 
Extinction test 
Performance during the extinction test is shown in figure 3.9. Univariate ANOVA 
showed a main effect of group (F3,25 = 4.61, p = 0.011),  restricted pairwise comparisons 
confirm that saline non-contingent lever pressing was significantly lower than saline 
contingent (p = 0.018) and that in muscimol treated rats the difference between contingent 
and non-continent pressing was not significant (p = 0.906). The difference between saline 












Figure 3.9: Mean number of lever presses on the active lever for each group during the extinction test. 








Table 3.3: summary of main results, “—“ indicates no significant effect. 
 
These results show that inactivation of the pPPTg blocks sensitivity to contingency 
degradation, both during degradation training and the extinction test, while having no effect 
























 This chapter was conducted with the aim of assessing the role of the pPPTg in action-
outcome learning. Experiment 1 used an outcome devaluation paradigm. While this failed to 
show an outcome devaluation effect in control rats, it successfully demonstrated that 
inactivation of the pPPTg had no effect on overall rates of lever pressing but did block the 
development of preferential lever pressing in response to changes in lever-reward 
associations. The most parsimonious explanation of this is that inactivation of the pPPTg 
blocked the formation of new associations between lever pressing and reward delivery. 
However, the lack of reward devaluation effect in the control rats and possibility of other 
explanations meant that conclusive interpretations about the role of the pPPTg in action-
outcome learning could not be made solely on the results of that experiment. Experiment 2 
used a contingency degradation paradigm. Saline treated rats were highly sensitive to 
degradation of instrumental contingency, reducing their rates of non-contingent lever pressing 
across degradation training sessions and in the extinction test. Inactivation of the pPPTg 
completely blocked this sensitivity to degradation of contingency, with rates of lever pressing 
in pPPTg inactivated rats remaining unchanged across degradation training sessions and in the 
extinction test. As in experiment 1, inactivation of the pPPTg had no effect on overall levels of 
lever pressing, and there was no difference between saline contingent and muscimol 
contingent lever pressing. This shows that pPPTg inactivation did not produce a general deficit 
in lever pressing but instead specifically blocked the modification of an established pattern of 
lever pressing in response to changes in the relationship between lever pressing and reward 
delivery. More specifically, inactivation of the pPPTg blocked the updating of action-outcome 
associations, but had no effect on task performance in conditions where these associations 
remained unchanged.  
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 Having established the involvement of the pPPTg in action-outcome learning, before 
fully interpreting these results in the broader literature a further question will be addressed: 
which neuronal sub-populations of pPPTg neurons are involved in learning? As discussed in 
chapter 1 (pp5-10) the pPPTg is comprised of an interdigitated collection of cholinergic, 
glutamatergic and GABAergic neurons. Of particular interest in the assessment of learning are 
the projections to midbrain DA, which are predominantly cholinergic and glutamatergic. As the 
muscimol induced inactivation used in these experiments is likely to have affected all neuronal 
populations, conclusions about neuronal type are not possible. No agent for creating a 
selective transient inactivation of one neuronal PPTg subtype exits. However, the development 
of the fusion toxin Dtx-UII has enabled the creation of selective cholinergic PPTg lesions (see 
general introduction, p15). The contingency degradation paradigm used here, while successful 
for assessing action-outcome learning, is not well suited for lesion studies due to the need to 
create the lesion at a specific point in the testing protocol. Moreover, as the Dtx-UII selective 
cholinergic lesion takes 21 days to develop fully, the interruption in testing would therefore be 
longer than the overall testing regime. Given that one aim of the assessment of action-
outcome learning is to keep behavioural training short (to reduce the possibility of 
interference from other learning systems which have been shown to develop over distributed 
training (Adams, 1982)) this delay would compromise the interpretation of the results.  
While not suited for contingency degradation studies, the Dtx-UII lesions are suited for 
assessing instrumental learning in more conventional paradigms where the lesion is performed 
before any behavioural training begins and rats subsequent performance in learning is 
assessed. The behavioural protocol of that used by Wilson et al. (2009) has several advantages 
over others: (1) This protocol involves initially training rats (post-surgery) on an FR1 
reinforcement schedule, and then once criteria levels of performance have been reached, 
advancing them through increasing fixed and variable ratio schedules. This allows for a 
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detailed assessment of initial learning rate; the rate of behavioural change in response to 
changes in the relationship between lever pressing and reward delivery and the effects of the 
systematic introduction of variability into this relationship; (2) This is one of the few published 
studies with separate lesions of pPPTg and aPPTg. pPPTg (but not aPPTg) lesions produced a 
clear learning impairment during FR1 and after the switch FR5. While pPPTg lesioned rats did 
ultimately perform this schedule at the same level as shames, when they were then switched 
to higher variable schedules (VR10-30) persistently low levels of performance were evident. By 
replicating this behavioural assessment with pPPTg Dtx-UII lesions, direct comparison between 
selective cholinergic and the previous results with non-selective excitotoxic lesions can be 
made and from that conclusions about the role of the cholinergic neurons in learning may be 
drawn; (3) I conducted the Wilson et al. (2009) experiment with Dr David Wilson as part of my 
Research Assistant position at the University of St Andrews, therefore I am very familiar with 
the experimental procedure and the data. 
However, before conducting a behavioural experiment with Dtx-UII lesions, it was 
necessary to modify the lesion technique. As is discussed in the next chapter, published results 
with Dtx-UII lesions show a successful unilateral lesion of the whole (anterior and posterior) 
PPTg (Clark et al., 2007). Results of attempts at bilateral lesions were mixed, with cell loss 
being low and often unequal between hemispheres (Rostron et al., 2007). In the subsequent 
experiment this technique was refined with the aim of creating highly selective bilateral 




Chapter 4: Development of a procedure for making bilateral selective cholinergic neuron 








Selective cholinergic lesions within PPTg 
 As discussed in the general introduction (p15), the fusion of diphtheria toxin to 
urotensin-II created a toxin (Dtx-UII) which, when microinjected directly into the PPTg, 
selectively destroyed (through internalisation and protein synthesis inhibition) cholinergic 
neurons while leaving surrounding non-cholinergic neurons intact (Clark et al., 2007). This is 
the toxin which will be used in subsequent experiments in this thesis. However, before 
conducting any behavioural tests the correct infusion technique for creating selective bilateral 
cholinergic pPPTg lesions needs to be established.  
 
The need for bilateral lesions with a high neuronal loss 
Current lesion methods 
The Clark et al. (2007) study reported highly selective unilateral lesions of around 85% 
of cholinergic PPTg neurons with minimal non-selective damage. There are currently no 
published reports of bilateral Dtx-UII lesions. Prior experience from this laboratory of making 
bilateral lesions using the same technique of multiple infusions along the length of PPTg has 
resulted in substantial cholinergic PPTg loss, but also often considerable non-selective damage. 
Adjustment of the technique by reducing the number of infusions and concentration of toxin 
reduced the extent of non-selective damage, but also the amount of cholinergic loss (with 30-
50% cholinergic survival frequently found) and increased the proportion of rats which had no 
indication of any lesion. Unpublished studies (conducted as part of my undergraduate project) 
found that rats with lesions of this size had no impairment in the delayed spatial win shift task 
on the 8 arm radial maze (MacLaren et al., 2007). This task is badly affected by bilateral 
ibotenate lesions of the PPTg (Keating and Winn, 2002). However, because of the level of 
cholinergic survival and small final group sizes (a result of many rats having no sign of lesion) 
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the results of the study were largely inconclusive. It could not be determined if these lesions 
produced no deficit or if behavioural changes were masked by compensatory mechanisms as a 
result of only partial cell lesions and/or low statistical power due to the small post-histology 
group size. Consequently, in order to assess more fully the role of cholinergic pPPTg neurons it 
is essential that the lesions are highly destructive to cholinergic pPPTg neurons (while 
maintaining selectivity) and the possibility of functional compensation should be considered.  
 
The need for bilateral lesions 
 One solution to the problem of creating selective cholinergic bilateral PPTg lesions 
would be to return to the Clark et al. (2007) method and create unilateral PPTg lesions. 
However, there are very few reports of behavioural changes after unilateral PPTg lesion. 
Where reported (eg (Dunbar et al., 1992) these changes are in drug induced locomotion rather 
than cognitive tasks. It has been shown that unilateral ibotenic lesion of the PPTg had no effect 
on learning the 2-way active avoidance task, but the addition of a contralateral (but not 
ipsilateral) MPTP lesion of the SNc produced a pronounced impairment (Bortolanza et al., 
2010). In cases where authors intending bilateral PPTg lesions have reported a detailed 
assessment of both histological and behavioural results, this has also often revealed that 
essentially unilateral PPTg lesions (due to failure to achieve a bilateral lesion, for example by 
missing PPTg in one hemisphere) produced no deficit in a reinforcement based operant task 
(Olmstead et al., 1998) and only a mild impairment on the 5-choice serial reaction time task 
(Inglis et al., 2001); tasks which were both affected by bilateral PPTg lesions. This is not entirely 
surprising, the extensive contralateral projections within PPTg and to afferent and efferent 
structures mean that a unilateral PPTg lesion is likely to leave no target structure entirely 
without connection to contralateral PPTg (Winn, 2006). Thus, while the lesion may be nearly 
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complete in one hemisphere of the PPTg, in terms of effects on function it may be comparable 
to a bilateral partial lesion.  
 
The need for extensive lesions 
The effects of compensatory mechanisms as a result of incomplete lesion are of 
considerable concern. Little is known about compensation as a result of PPTg cholinergic loss. 
However, using another brain system – the dopaminergic nigrostriatal pathway – as a model, 
the likelihood of compensation can be considered. The dopaminergic system has been widely 
studied due in substantial part to its involvement in Parkinson’s Disease (PD). PD is 
characterised by progressive loss of DA cells in the SNc, and while far from the only pathology 
of this condition, it is the most studied (Halliday et al., 2011). One striking feature is the extent 
of DA cell loss before behavioural effect is evident. It is estimated that in humans symptoms do 
not show until >80% of SNc DA cells have degenerated (Singh et al., 2007). Animal models 
confirm this, selective depletion of the DA nigrostriatal pathway (with the catecholamine 
selective neurotoxin 6-hydroxydopamine (6-OHDA)) produces a condition very similar to 
idiopathic PD (bradykinesia, sensorimotor neglect, aphagia, adipsia, short-step locomotion, 
postural abnormalities, and cognitive dysfunction) only when cell loss is near complete 
(Castaneda et al., 1990; Perez et al., 2008). Smaller lesions produce a transient deficit after 
which the animal recovers many behavioural functions (Robinson et al., 1994). Three stages of 
lesion and compensation have been suggested (Robinson et al., 1990): (1)  lesions smaller than 
80% have been found to leave striatal DA levels no different to controls, with the proposed 
compensatory mechanism being an increase in DA output from remaining cells. (2) Lesions in 
the range of 80-95% produced more marked and long lasting behavioural effects and, while 
there was some recovery of function, there was also persistent impairment. This recovery is 
believed to be a result of both pre-synaptic (increased DA output) and post-synaptic 
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(supersensitivity of DA receptors, reduction in DA reuptake and increased permeability of DA) 
compensation, leading no near normal levels of post-synaptic DA. (3) Lesions greater than 95% 
showed little evidence of successful compensation: behaviourally rats never regained normal 
function and neurochemically DA levels were significantly below those of smaller lesions and 
sham controls. It is believed that with lesions of this size no amount of pre- and post-synaptic 
plasticity can compensate for the number of DA cells lost. Less is known about compensatory 
mechanisms in the cholinergic system. However, evidence from selective cholinergic lesions of 
the cholinergic basal forebrain suggests that very similar compensatory mechanisms might 
develop. Small and large lesions of cholinergic NbM resulted in much smaller loss of Ach in 
efferent structures than would be predicted from lesion size alone, with the compensation 
developing over time and with more effective compensation arising from smaller rather than 
substantial lesions (de Lacalle et al., 1998; Waite and Chen, 2001). These studies highlight the 
need for substantial lesions in the region of >80% loss of neurons and for the proper 
consideration of compensation even to large lesions. Moreover, they emphasise that surviving 
cell number in the lesion site is not necessarily a reliable indicator of post-synaptic 
neurotransmitter level. Direct measures of assessing residual transmitter level include 
microdialysis (Robinson et al., 1994), voltammetry (Blaha et al., 1996; Perez et al., 2008), and 
tissue punching (Jenkins et al., 2002). Frequently used indirect measures of upregulation and 
other compensatory changes include analysing the response to a drug challenge, for example 
by administering a receptor agonist and comparing the behavioural changes in sham and 
lesioned rats (Hudson et al., 1993; Alderson et al., 2008) . Chapter 6 utilises such a paradigm to 





Area of PPTg to target 
Rather than creating selective cholinergic lesions of the whole PPTg, there are 
compelling reasons to target only the pPPTg: (1) the pPPTg is the region of particular interest 
in this thesis: behaviourally it is known that the aPPTg and pPPTg are involved in different 
functions, the behaviours which will subsequently be investigated with Dtx-UII lesions are 
affected by ibotenate lesions of the posterior, but not anterior PPTg (Alderson et al., 2008; 
Wilson et al., 2009a). The subsequent experiments also relate to and extend the results of 
chapter 3, which again focused on the pPPTg. (2) With ibotenic acid the pPPTg can be targeted 
with a single toxin infusion in each hemisphere (Wilson et al., 2009a). There is some 
(anecdotal) evidence from this laboratory that part of the problem with non-selective damage 
experienced after Dtx-UII lesions is due to the overlapping of infusions and subsequent high 
concentrations of toxin when delivered into several sites in close proximity along the PPTg. 
Targeting the pPPTg with one infusion removes this possibility of toxin accumulation.  
 
Chapter aim 
The following experiments are an attempt to further refine the selective cholinergic 
PPTg lesion procedure. The specific aim is to establish a method of creating bilateral selective 
cholinergic pPPTg lesions in the region of 90+% loss of ChAT cells with group sizes large enough 
for rigorous behavioural analysis.  
 
Toxin pilot study 1 
Recent experience with creating only very small cholinergic PPTg lesions with the stock 
of Dtx-UII held in St Andrews raised concern about its potency. Having been stored at -20⁰C 
rather than the recommended -70⁰C (due to lack of suitable equipment) for a period of over 2 
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years it was considered to be in too poor condition to use. A fresh supply of freeze-dried Dtx-
UII was acquired from SD Clark (Department of Pharmacology, University of California, Irvine, 
CA, USA) reconstituted as per the recommended method and stored at -70⁰C. The co-ordinates 
for the pPPTg that will be used are those which we also used for ibotenic acid in the Wilson et 
al. (2007) study. These co-ordinates are somewhat unusual in the PPTg literature in that rather 
than fixing the rat in the flat skill position they involve angling the rats nose upwards in the 
stereotaxic frame. This builds on pilot work conducted by Dr Claire Rostron and involves 
calculating the height to raise the incisor bar to by measuring the distance between the IAL 
and the incisor bar and multiplying this value by the sine of 8˚ 29’ (as described by (Whishaw et 
al., 1977). Determining the height to raise the incisor bar individually for each rat maintains a 
constant angle of elevation across rats of varying sizes. The main advantage of infusing toxin 
from this angle is that the craniotomy and toxin infusion are further away from the superior 
sagittal sinus which sits above the pPPTg in the flat skull position, and therefore reduces the 
risk of surgical complications arising from severe blood loss. However, it is also hypothesised 
that because of the shape of the pPPTg, targeting it from this angle increases the likelihood of 
being able to destroy the entire pPPTg (several years after conducting these pilot studies 
another laboratory directly investigated the differences between the flat skull and raised nose 
co-ordinate systems and concluded that the raised nose system does indeed lead to greater 
cholinergic cell loss and fewer surgical complications (Cyr et al., 2011)). In order to establish an 
effective concentration and volume of toxin, the first experiment of this chapter tested a range 
of volumes and concentrations covering and extending those used by Clark et al. (2007). When 
using excitotoxins, the PPTg is generally targeted in two unilateral procedures in an attempt to 
reduce post-surgery mortality during the recovery period (Wilson et al., 2009a). As Dtx-UII is a 
protein synthesis inhibitor based toxin, cell death occurs gradually and does not progress 
rapidly until several days after surgery (Clark et al., 2007). Therefore, the surgical recovery 
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period is not noticeably different to that of a sham infused animal and so with Dtx-UII both 
hemispheres are infused during the same surgical procedure. It is plausible that during the 
period of maximal cell loss (7-14 days post-surgery) adverse health effects would become 
evident and therefore the rats were monitored closely during this period.  
 
Toxin pilot study 1: methods 
12 adult male Lister-Hooded rats were used with a mean surgery weight of 364g (S.D. 
22.2; range 330-397g). Rats were housed, anaesthetised and lesion surgery performed as 
described in the general methods. The co-ordinate for the pPPTg was: -0.8 mm from the IAL, ± 
1.9 mm from the midline, -6.5 mm below dura and the order of infusion (left hemisphere, right 
hemisphere) was alternated across rats. 
 
Doses of toxin 













All rats recovered well from the surgical procedure. By 7 days post-surgery several rats 
were losing bodyweight and required additional wet mash and sucrose solution to maintain 
weight at >85% of pre-surgery weight. All of these rats were from the 4.0% and 5.0% Dtx-UII 
group. At 14 days post-surgery these rats were unable to maintain a stable body weight and 
were displaying clear signs of stress (porphyrin discharge around the eyes). At this point all rats 
were perfused (as described in the general methods). The initial aim was to perfuse at 21 days 
post-surgery as is it is reported that the lesion is not fully formed until this point (Clark et al., 
2007). However, due to problems maintaining bodyweight and the ethical concerns of the 
stress signs it was necessary to euthanize these rats before day 21. While it would have been 
possible to only perfuse the rats with low weight, in order to directly compare the effects of 
different doses of toxin it is necessary that all rats are perfused at the same time point post-
surgery, otherwise the effects of a longer lesion formation period cannot be separated from 
the effects of a higher concentration of toxin with shorter lesion formation period. 
 
Histology 
Following the procedures described in the general methods, rats were transcardially 
perfused with fixative and brains stored in sucrose solution. Subsequently, 30 µm coronal 
sections were cut through the area of the PPTg and ~1mm beyond in anterior-posterior plane. 
Parallel 1:4 series were processed immunohistochemically for ChAT and NeuN reactivity. NeuN 
stained sections were then counterstained with cresyl violet and all stained sections mounted 
onto glass slides and viewed under a light microscope. Software assisted counts of ChAT+ 
neurons throughout the PPTg enabled quantification of the cholinergic lesions. Non-cholinergic 





Of the 20 infusions, 17 hit the pPPTg; the remaining 3 were too posterior (n = 2) or too 
dorsal (n = 1). A clear relationship between concentration of toxin and lesion was found and is 
illustrated in figure 4.1. In the 5.0% toxin group extensive non-selective damage was seen in 
and around the pPPTg on the NeuN/cresyl stain, more extensive that that seen after ibotenic 
pPPTg lesions (180nL of 0.12M concentration) (Wilson et al., 2009a) indicating a highly non-
specific lesion. In these rats the ChAT stain revealed that the cholinergic pPPTg was almost 
entirely destroyed (estimated <2% cells surviving). The 4% Dtx-UII group displayed signs of less 
severe but nonetheless extensive non-selective damage and again near total loss of ChAT+ 
neurons. Within the 3% toxin group, the 600nL volume produced considerably less damage on 
the NeuN stain than the higher concentrations, and the 400nL volume produced only small or 
no signs of non-selective damage. Analysis of the ChAT stain showed that, as with the higher 


































































Characterisation of the lesion 
The number of cholinergic neurons throughout the PPTg of the 400nL 3% Dtx-UII group 
(ie the group with selective cholinergic lesions) was quantified (as described in the general 
methods) and compared to that of a control group (comprised of the 2 control rats in this pilot 
study and 2 shams from the subsequent pilot in this chapter). The distribution of surviving 
cholinergic neurons along the anterior-posterior plane is shown in figure 4.2. The 3.0% 400 nL 
group were found to have a 96% loss of ChAT+ pPPTg neurons (when calculated for the whole 









Figure 4.2: Distribution of ChAT+ neurons along the anterior-posterior plane of the 3.0%/400nL lesion 
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Conclusions of pilot study 1 
This pilot study verified that the new batch of Dtx-UII, delivered from a glass pipette 
with rats’ noses elevated in stereotaxic frame, can successfully create selective bilateral 
cholinergic pPPTg lesions. That total near total ChAT+ pPPTg cell loss (96% in the 3.0% group 
which had selective lesions) was seen at 14 days post-surgery suggests this method is more 
successful at destroying cholinergic neurons than previous attempts, which only reduced 
unilateral cell count by ~85% after 21 days (Clark et al., 2007). Moreover, this study confirms 
that bilateral infusions of 3.0% toxin can be performed in the same surgical procedure without 
adverse effects during recovery (the problems with significant weight loss in the lesion 
formation period were only in rats with non-selective lesions in the 4.0% and 5.0% toxin 
groups). Having established an effective concentration of toxin, the next aim was to verify that 
this can be reproduced in a larger group size.  
 
Toxin pilot study 2 
Pilot study 1 revealed that 3.0% toxin can create selective cholinergic pPPTg lesions. It 
also suggested that the volume of toxin infused was important, with 600nL causing evidence of 
non-selective damage and 400nL producing largely selective lesions. However, due to the small 
group sizes and short (14 day) survival period a full analysis of the lesion and the effects of 
volume infused was not possible. To establish the reliability and reproducibility of these lesions 
the second pilot study used a larger group size and ensured the lesion formation period was > 
21 days. To further investigate the effects of the infusion volume and to try and eliminate non-
selective damage the previous 400nL and a new 300nL volume were used. Furthermore, 
simple behavioural tests (consumption of sucrose solution and measurement of spontaneously 
generated locomotion) were performed. It has been shown that excitotoxic pPPTg and whole 
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PPTg lesions caused overconsumption of 20% sucrose solution and no locomotor impairment 
(measured in photocell cages) (Alderson et al., 2001; Winn, 2006; Wilson et al., 2009a) and it 
was of interest if the same pattern emerged after selective cholinergic pPPTg lesions. It was 
predicted that locomotion would be unaffected by the lesion; there were no clear predictions 
as to whether sucrose consumption would be affected. 
 
Methods 
28 adult male Lister-Hooded rats were used in this experiment, with a mean surgery 
weight of 313.4g (S.D. 13.9; range 286-339g). Rats were housed, anaesthetised and lesion 
surgery performed as described in the general methods. The co-ordinate for the pPPTg was: -
0.8 mm from the IAL, ± 1.9 mm from the midline, -6.5 mm below dura (the same as pilot 
experiment 1) and the order of infusion (left hemisphere, right hemisphere) was alternated 
across rats. 
 
Doses of toxin 
 













All rats recovered well from the surgical procedure. During the 21 day lesion formation 
period 3 rats (2 from the 400nL group and 1 from the 300nL) required wet mash to maintain a 
stable body weight. Inspection of these rats revealed that their lower incisor teeth were 
considerably longer than normal and were pressing into their upper jaw. The named veterinary 
surgeon was contacted and clipped elongated teeth back to normal length. Two of these rats 
then started eating wet mash and maintained a stable weight; the third rat (which had the 




Spontaneously generated locomotion was measured in the photocell cages described 
in the general methods. Testing sessions lasted 40 min and each rat was tested on 2 
consecutive days. Testing was conducted under dim illumination during the rats light phase.  
  
Sucrose solution consumption test 
Rats were individually housed and given access to a bottle containing 20% w/v sucrose 
solution (in tap water) alongside their standard water bottle. Sucrose solution and water 
consumption were measured over 18 h. 
 
Histology 
Following the procedures described in the general methods, rats were transcardially 
perfused with fixative and brains stored in sucrose solution. Subsequently, 30µm coronal 
sections were cut through the area of the PPTg and ~1mm beyond in anterior-posterior plane. 
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Parallel 1:4 series were processed immunohistochemically for ChAT and NeuN reactivity. NeuN 
stained sections were then counterstained with cresyl violet and all stained sections mounted 
onto glass slides and viewed under a light microscope. Software assisted counts of ChAT+ 
neurons throughout the PPTg enabled quantification of the cholinergic lesions. Non-cholinergic 
damage was assessed by visual inspection of the NeuN/cresyl stained sections. 
 
Behavioural data analysis  
Behavioural data were statistically analysed using SPSS 14.0 for Windows (SPSS Inc., 
Chicago, Illinois USA). Locomotor data were square root transformed to correct for positive 
skew and analysed with a repeated measures ANOVA with day and group as factors. Sucrose 
solution consumption data were analysed with a one way ANOVA. All results were considered 




6 rats had bilateral cholinergic lesions of the pPPTg with either very small or no 
indications of non-selective damage on the NeuN sections. Within these 6 rats there was 
considerable variance in the extent of the lesions which ranged from 96% to 55% cell loss. 4 of 
these rats had received 300nL of toxin per hemisphere and 2 had received 400nL per 
hemisphere (see table 4.4 for summary). A more detailed analysis revealed that rather than 
forming a gradient of different lesion sizes across the 55-96% range, two clear patterns of 
lesion emerged: lesions were either highly destructive (destroying ~95% ChAT pPPTg neurons) 
or were only moderately destructive (destroying 20-55% ChAT+ pPPTg neurons). See figures 
4.4 and 4.5. Of the remaining rats, 11 had bilateral pPPTg cholinergic lesions with non-selective 
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damage either in or immediately behind the pPPTg, of these 8 had received 400nL of toxin per 
hemisphere and 3 had received 300nL. 3 rats had a unilateral or partial lesion, all had received 
300nl of toxin. There was no indication of lesion of in any sham operated rat. Only data from 












Table 4.4: Summary of toxin pilot 2 histological results. 
 
Characterisation of the lesion 
 The distribution of ChAT+ neurons throughout the PPTg of the rats with successful 













Figure 4.3: Distribution of ChAT+ neurons along the anterior-posterior plane of the 3.0% / 400nL lesion 
and control groups. ChAT counts = Numbers of ChAT+ neurons. Graph shows group means ±SEM. 
 
 The mean pPPTg ChAT cell loss in the lesion group was 62%. However, the lesion group was 
further split into lesions which produced substantial ChAT+ cell loss (>90) or only partial ChAT loss (20-









Figure 4.4: Distribution of ChAT+ neurons along the anterior-posterior plane of substantial, partial and 
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Figure 4.5: Percentage of ChAT+ pPPTg neurons in the partial, substantial and combined (all lesion) 



























































The mean number of beam breaks (SQRT transformed) made during 2 locomotor 
testing sessions are shown in figure 4.6. Repeated measures ANOVA found no effect of day 
(F(1,12) = 0.126, p = 0.729) group (F(1,12 )= 0.683, p = 0.425) or day x group interaction (F(1,12) = 
0.124, p=0.731). Rats with selective cholinergic pPPTg lesions had the same levels of 
spontaneous locomotion as sham controls.  
 
 










Figure 4.7: Consumption of 20% sucrose solution in the homecage. Graph shows group means ±SEM. 
 
The amount of sucrose solution consumed during exposure in the homecage is shown 
in figure 4.7. A univariate ANOVA confirmed that there were no significant differences 
between the groups (F(1,12  = 0.284, p = 0.604). 
 
 
Conclusions from pilot study 2 
Feasibility of selective bilateral pPPTg lesions 
 Of the rats which had bilateral selective cholinergic lesions of the pPPTg all recovered 
well from surgery and maintained health throughout the lesion formation and testing period, 
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confirming that that bilateral selective cholinergic lesions can be made without adverse effects 
on health. The 3 rats which struggled to maintain bodyweight and developed abnormal tooth 
shape were all found to have non-selective damage in and around the pPPTg. The tooth 
growth was a curious effect. Apart from the long teeth and weight loss these rats displayed no 
other signs of ill health or stress (confirmed by the unit NACWO). One possible explanation is 
that through reduced orofacial movement (caused by reduced eating and tooth grinding) the 
teeth grew without being worn away. However, the named veterinary surgeon advised that he 
has never seen tooth growth that rapid, even in rats that are not eating. That 2/3 of the rats 
resumed eating as soon as the teeth were clipped also suggests that the long teeth were 
preventing eating rather than the lack of desire to eat causing the teeth to grow. A second 
explanation was that the teeth were inadvertently damaged in surgery when fixing the rat in 
the raised incisor bar. However, that this tooth growth was only seen after Dtx-UII infusion 
(moreover only in rats with non-selective Dtx-UII lesions), and never after sham (or in separate 
experiments not reported here, ibotenic acid) infusion using the same procedure suggests that 
it was the lesion rather than surgery itself which was the cause. This tooth growth was seen to 
some extent in subsequent batches of surgery, but in parallel with also creating lesions with 
less non-selective damage it became less frequent and less severe. It does however remain an 
unexplained phenomenon.  
 
Extent of partial lesions and non-selective damage 
While the second pilot study confirmed that 3.0% Dtx-UII can reliably create highly 
selective cholinergic lesions of the pPPTg, the persistence of occasional partial lesion and non-
selective damage in some rats was a disappointment. There is a clear pattern for 300nL of 
toxin per hemisphere to produce less non-selective damage than 400nL, however even in this 
group 30% of rats had unusably high levels of damage on the NeuN stain. In order to try and 
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further reduce the amount of non-selective damage future experiments used 300 nL and a 
lower volume of 200 nL. There is concern that at some point the volume will be too low to 
cover the entire pPPTg, however as 180 nL of ibotenic acid can destroy the pPPTg (Wilson et 
al., 2009a) 200 nL, at least in terms of spread, should still be sufficient to cover the pPPTg. 
There is no clear explanation as to why some lesions produced a partial loss (20-55%) of ChAT+ 
neurons rather than the extensive loss (~95%) seen in the remainder of the rats. It is possible 
that this was due to mis-placement of the pipette, but, where detectable, the pipettes appear 
to have hit the pPPTg. There appears to be no solution to the conflicting problems of non-
selective damage and partial lesions – increasing the volume or concentration to reduce the 
number of partial lesions is likely to increase the degree of non-selective damage and 
conversely decreasing the concentration in an attempt to reduce the non-selective damage is 
likely to increase the occurrence of partial lesions. Nonetheless, the majority of 3.0% 
concentration infusions resulted in extensive cholinergic pPPTg lesions, making this a 
successful lesion technique. However, it is essential when designing experiments to consider 
that a small yet nonetheless appreciable proportion of rats are likely to be excluded from 
analysis on the basis of histology, therefore the initial lesion group sizes should be large 
enough to incorporate this subsequent loss after histological analysis.  
 
Behavioural effects 
Ibotenic acid lesions restricted to the pPPTg have been shown to cause rats to over-
consume 20% sucrose solution (Wilson et al., 2009a), this is a curious effect also repeatedly 
found after whole-PPTg lesions (Olmstead et al., 1999; Alderson et al., 2001; Keating et al., 
2002; Ainge et al., 2006) with no clear explanation, though it has been suggested to be the 
result of disordered response control or perseveration (Ainge et al., 2006; Walker and Winn, 
2007). The finding that selective cholinergic pPPTg lesions caused no change in the amount of 
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sucrose consumed suggests that the process underlying overconsumption in ibotenic lesioned 
rats are not cholinergic mediated. As pPPTg ibotenic lesions do not affect spontaneously 
generated locomotion (Alderson et al., 2008; Wilson et al., 2009a) the finding that selective 
cholinergic pPPTg lesions also do not produce locomotor changes was expected.  
 
Overall chapter conclusions 
The experiments conducted in this chapter established that 300nL of 3.0% Dtx-UII, 
delivered from a glass pipette with the rats nose elevated in the stereotaxic frame, can create 
highly selective bilateral cholinergic pPPTg lesions. No surgical or recovery complications were 
encountered with successful selective lesions even when the toxin was infused in both 
hemispheres in the same surgical procedure. Moreover, these lesions are reliable enough for 
creating groups suitable for behavioural analysis. Problems with non-selective damage were 
not eliminated, but it is hoped use of a lower volume of toxin in subsequent experiments with 
reduce this problem. Having established the lesion procedure, the next chapter assesses the 










As discussed in chapter 1, rats bearing excitotoxic lesions of the PPTg have various 
separable yet potentially related deficits in operant tasks. To summarise briefly: (1) there is a 
clear learning impairment in naïve rats and in trained rats when testing schedules change. The 
results of chapter 3 show that part of this deficit is a specific impairment in the updating of 
associations between actions and outcomes; (2) attention may be impaired in tasks with a high 
attentional component; (3) while the ability to execute the motor actions required by these 
tasks appears intact, the ability to select the correct action or inhibit incorrect actions may be 
disrupted.  
In terms of subregions within the PPTg involved in these deficits, the learning 
impairments are closely associated with the posterior rather than anterior PPTg. Excitotoxic 
lesions of pPPTg but not aPPTg impaired initial instrumental learning and adaptation to 
changes in reinforcement schedules (Wilson et al., 2009a) and the impairment in action-
outcome learning found in chapter 3 was during inactivation centred on the pPPTg. Despite 
these advances in functionally dissecting subregions within the PPTg, because of the lack of 
manipulation specific for one neuronal type, these previous studies cannot address one key 
question: in what ways are cholinergic, glutamatergic and GABAergic PPTg neurons involved in 
learning? This chapter specifically addresses this question by assessing operant learning in rats 
bearing highly selective bilateral cholinergic lesions of the pPPTg.  
 
The operant task 
 The operant task used here is a replication of the instrumental learning regime used by 
Wilson et al. (2009). It involves training rats on an FR1 schedule of reinforcement, and once 
they have learned this to a predefined criterion level, advancing them through increasing fixed 
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and variable rate schedules of reinforcement before testing the rats under conditions of 
extinction where no rewards are delivered. This experimental design enables the assessment 
of initial instrumental learning, adaptation to changes in previously learned associations and 
also the response to the systematic introduction of variability in the association between lever 
press and reward delivery. By replicating a paradigm which produced clear impairment in 
excitotoxic pPPTg lesioned rats a comparison between any deficits seen after selective 
cholinergic pPPTg lesions and excitotoxic lesions can be made. Moreover, as the Wilson et al. 
(2009) study comprised part of my work as a research assistant at the University of St 
Andrews, I am very familiar with the details of both the experimental protocol and the 





Twenty four adult male Lister-Hooded rats (Harlan Olac Ltd, Bicester, UK) were used, 
with a mean weight of 338g (range 310-361g) at the time of surgery. Animals were housed and 
maintained as described in the general methods. Three days prior to behavioural testing food 
was restricted to 17-19g/rat/day standard lab chow. Weights were monitored to ensure they 
never fell below 85% of free food weight at any point in the experiment. The food restriction 
was to motivate the rats by ensuring they were hungry at the time of testing. This is achievable 
without causing a dramatic reduction in bodyweight and therefore after an initial adjustment 






Anaesthesia was induced and lesion surgery performed as described in the general 
methods. The co-ordinate for the pPPTg was: -0.8 from IAL; ± 1.9 from midline; -6.5 from dura 
(the same as used in chapter 4) and the order of infusion (left hemisphere, right hemisphere) 
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was counterbalanced across rats. In the lesion group rats were infused bilaterally with either 
200 nL (n = 8) or 300 nL (n = 8) of 3.0% Dtx-UII and in the sham group (n = 8) rats were infused 
with sterile PB (300nL and 200 nL; 4 of each). 300 nL of 3.0% Dtx-UII is the volume of toxin 
which proved most successful in chapter 4, the introduction of the 200 nL group was an 
attempt to further reduce non-selective damage. During the lesion formation period rats were 
monitored daily for signs of ill health or other lesion-related complications.  
 
Behavioural testing 
To allow for lesion formation, behavioural testing began >21 days post-surgery. Testing 
was conducted in the operant testing apparatus described in the general methods. Each rat 
was always tested in the same operant box and testing was conducted at approximately the 
same time every day. Food restriction began 3 days prior to behavioural testing. Two days 
prior to testing rats were given 2 g of 45 mg testing pellets (Test Diet purified rodent tablet 
5TUL, Sandown Scientific, Middlesex, UK) in a bowl in their homecage. The following day rats 
were placed in operant boxes where 40 reward pellets were available in the pellet dispenser, 
no levers were extended and the sound attenuating doors were left open. Once all pellets 
were consumed (~20 min) rats were returned to their homecage. These procedures were used 
to reduce neophobia to the reward pellets and allow rats to familiarise themselves with 
reward delivery location in the operant testing chamber. Rats were then tested daily in 40 min 
testing sessions where pressing on the ‘correct lever’ (the side of which was counterbalanced 
across rats) the required number of times led to a pellet being delivered. All presses on the 
second lever (the ‘incorrect lever’) and approaches to the reward delivery magazine were 
recorded but had no programmed consequence. At the start of the testing session both levers 
were extended and the houselight illuminated. Initially rats were trained on FR1 where one 
press on the correct lever triggered pellet delivery and the simultaneous illumination of the 
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light located above the active lever. This light remained illuminated for 10 sec and during this 
time (defined as the inter-trial-interval, ITI) pressing on the correct lever had no programmed 
consequence. After the 10 sec ITI the lever-light was extinguished and the next trial began. 
Rats were advanced through a variety of fixed ratio (FR) and variable ratio (VR) testing 
schedules (see table 5.1) depending on their individual performance. Each trial in every session 
followed the same format, except that correct presses up to the final press in the schedules 
above FR1 did not trigger pellet delivery. In the extinction schedule the trials were programed 
in the format of VR30 but no pellets were delivered.  
 

























Table 5.1: schedules of reinforcement and criteria for advancement. 
 
Behavioural measures 
Throughout all sessions all lever presses and approaches to the food hopper were 
recorded, allowing the following behavioural measurements to be calculated: correct presses – 
the total number of presses on the correct lever during a schedule; incorrect presses – the total 
number of presses on the incorrect lever; late pressing ratio - the ratio of presses on the 
correct lever between reward delivery and approach to the food hopper to correct presses; 
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reward collection latency - the latency to collect the pellet after delivery; early pressing ratio - 
the ratio of correct lever presses between reward collection and the start of the next trial to 
correct presses; post-reinforcement pause - the latency from the start of the trial to first lever 
press; approaches – number of approaches to the reward delivery hopper. 
 
Histology 
All histological procedures followed the methods described in the general methods. 
Briefly, following completion of behavioural testing rats were transcardially perfused with 
fixative and brains stored in sucrose solution. Subsequently, 30 µm coronal sections were cut 
through the area of the PPTg and ~1mm beyond in anterior-posterior plane. Parallel 1:4 series 
were processed immunohistochemically for ChAT and NeuN reactivity. NeuN stained sections 
were then counterstained with cresyl violet and all stained sections mounted onto glass slides 
and viewed under a light microscope. Software assisted counts of ChAT+ neurons throughout 
the PPTg enabled quantification of the cholinergic lesions, non-cholinergic damage was 
assessed by visual inspection of the NeuN/Cresyl stained sections. A lesion was considered 
acceptable if >~80% of ChAT+ pPPTg neurons were destroyed bilaterally and there was 
minimal, if any, non-selective damage evident on the NeuN/cresyl sections. Due to poor 
fixation and subsequent poor staining, one sham rat was excluded from the ChAT cell count 
analysis, but included in all other analyses.  
  
Behavioural data analysis 
Data were statistically analysed using PASW 18 for Windows (SPSS Inc., Chicago, Illinois 
USA). Various univariate and repeated measures ANOVAs were performed across schedule 
(reinforcement schedule; within subjects factor) and between lesion group (lesion, sham; 
between subjects factor). Details of each test, subsequent post hoc tests (Sidak corrected 
planned pairwise comparisons) and investigations of interactions are given in the appropriate 
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results sub-section. The Huynh-Felt correction was applied where the data were not 
homogeneous; skew in the data was identified by the Shapiro-Wilk test and corrected by log10 
transformation (reported in the text when performed). Details of other tests are reported 






All rats initially recovered well from the surgical procedure. During the 21 day lesion 
formation period 3 rats struggled to maintain stable bodyweight. One of these rats responded 
well to wet mash and a few days later was able to consume dry pellets again. The remaining 2 
rats continued to lose weight and developed the rapid tooth growth described in chapter 4 
(p112 + p118). The named veterinary surgeon clipped their teeth 3 times; despite this (and 
additional hand feeding with babyfood (various flavours; Boots PLC, Nottingham, UK)) they still 
failed to maintain a stable bodyweight. These 2 rats were perfused (as described in the general 
methods) 29 and 31 days post-surgery. Subsequent examination of ChAT and NeuN stained 
PPTg sections revealed both had bilateral, large, non-selective lesions centred on the pPPTg. Of 
the rats which were subsequently found to have bilateral selective cholinergic pPPTg lesions all 
recovered well from surgery with the only noticeable effect being a small transient, yet 














































Figure 5.1: Post-surgery bodyweight of sham control and successful selective cholinergic pPPTg lesioned 
rats. Graph shows group means ± SEM. * indicates significant difference between sham and lesion group 




Analysis of the change in post-surgery bodyweight by repeated measures ANOVA 
found a significant effect of day post-surgery (F19,247 = 35.72 p < 0.001) a significant effect of 
lesion group (F1,13 = 8.17 p = 0.013) and a significant lesion group x day post-surgery interaction 
(F19,247 = 12.41 p < 0.001). Significant differences between sham and lesion groups within each 
day are indicated by a * on figure 5.1. 
 
Lesion 
Seven rats had selective bilateral lesions of the cholinergic pPPTg. These lesions 
destroyed a mean of 93% of ChAT+ pPPTg neurons (range 87.8% to 98.2%). Five of these rats 
had evidence of some level of non-selective damage on the NeuN/Cresyl stain, generally this 
was a small area on the NeuN stain present on around 2 sections which displayed signs of 
having fewer than expected neurons present. In 3 of these rats these areas were located 
outside the pPPTg and were in a non-consistent pattern across animals: there was no single 
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structure affected or standard pattern of non-selective damage in the lesion group. In 2 of 
these rats there were trace amounts of unilateral non-selective damage within the PPTg (see 
figure 5.2; this shows the type of non-selective damage found and the largest amount deemed 
acceptable within pPPTg). The remaining rats in the lesion group were excluded from all 
analysis due to having no clear sign of any lesion (n = 2); unilateral or partially unilateral lesions 
(n = 3); due to having partial non-selective damage in or around pPPTg, predominantly 
unilaterally (n = 2) or due to having extensive non-selective damage destroying the entire 
pPPTg and spreading into surrounding structures in both hemispheres (n = 2). These 2 rats 
with extensive non-selective damage destroying the entire pPPTg and encroaching on 
surrounding structures were the 2 rats which were perfused prior to behavioural testing due to 
ill health and weight loss (see p127). This is unfortunate as their behavioural data would have 
made a valuable control group allowing a direct comparison between the effects of Dtx-UII 
induced damage to the pPPTg which was selective for cholinergic neurons verses that which 






Example sections from a Dtx‐UII and a sham lesioned rat. Rows A – C show ChAT (boxes 1,2,5,6) and
NeuN/Cresyl (boxes 3,4,7,8) stained sections of anterior PPTg (rows A), central PPTg (rows B) and posterior
PPTg (rows C). Black dotted arrows indicate the location of the PPTg. The red arrow in box C8 indicates the


















































Characterisation of lesion 
 
 The number of ChAT cells at each level of the PPTg for the sham and lesion group is 














Figure 5.3: Counts of ChAT+ neurons throughout the PPTg along the anterior-posterior axis. ChAT counts 
















Figure 5.4: Remaining ChAT+ pPPTg neurons in the lesion group displayed as a percentage of the sham 
























ChAT +ve cell counts through PPTg 
Sham
Lesion
 <                      anterior                         >     <                       posterior                      > 
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Analysis of lesion 
T-tests (on raw count values, not percentages) confirm that the lesion group had 
significantly fewer ChAT+ neurons than sham controls in both the left (t6.9 = 17.75 p < 0.001) 
and right (t7.8 = 16.58 p < 0.001) hemispheres. A comparison between the lesioned rats which 
received 300 nL and 200 nL of toxin found no detectable difference between the levels of 
cholinergic cell loss nor the number of cases of non-selective damage. However, where non-





The primary question addressed was whether selective cholinergic lesions of the 
pPPTg caused impairment in operant learning. This was evaluated in two ways: firstly by 
performing a detailed analysis of behavioural measures during initial operant learning of the 
FR1 schedule, then by subsequently analysing the behavioural changes in response to the 
systematic increase in reinforcement schedules and during extinction. Rather than presenting 
every dependant variable recorded by the operant software, particular attention was paid to 
the following variables: number of correct lever presses; days to reach criterion level of 
performance; reward collection latency; post-reinforcement pause and the number of 
approaches to the reward delivery magazine. These variables were chosen as they allow a 
rigorous assessment of both the learning rate (correct pressing and days to criteria) and 
provide a general assessment of the rats behaviour (time to collect reward, delay before 
starting a trial, number of approaches to the food hopper). They are also the variables most 
affected by ibotenic acid pPPTg lesions (Wilson et al., 2009a). Analysis of the remaining 




Initial learning of FR1 
 
Figure 5.5 shows the mean number of correct lever presses when learning FR1. 
Repeated measures ANOVA showed a significant effect of session (F2,26 = 100.38 p < 0.001) no 
significant effect of lesion group (F1,13 = 1.94 p = 0.187) and no significant lesion group x session 
interaction (F2,26 = 0.45 p = 0.643). Planned pairwise comparisons found that the overall rate of 
correct pressing in session 2 was higher than session 1 (p < 0.001) and higher in session 3 than 
session 2 (p = 0.001). Fig 5.5 shows the number of days required to reach criterion level of 
performance (two consecutive days of >80 correct trials) on FR1. A T-test found no significant 
difference between the sham and lesion groups (t13 = -1.31, p = 0.211) in the number of days 













Figure 5.5: Number of correct lever presses made in each session while learning FR1. Graph shows group 

















































Fig 5.6: Number of days taken to reach criterion level on FR1. Graph shows group means ± SEM. See text 
for statistical analysis. 
 
 
Reward collection latency while learning FR1 
Figure 5.7 shows the reward collection latency (RCL) of each group during FR1 (log10 
transformed to correct for positive skew). Repeated measures ANOVA found a significant 
effect of session (F2,26 = 181.00 p < 0.001) no significant effect of lesion group (F1,13 = 0.163 p = 
0.693) and no significant lesion group x session interaction (F2,26 = 0.088 p = 0.916). Planned 
pairwise comparisons found that the overall RCL in session 2 was lower than session 1 (p < 








































Post-reinforcement pause when learning FR1 
Figure 5.8 shows the post reinforcement pause (PRP) for each group during FR1 (log10 
transformed to correct for positive skew). Repeated measures ANOVA found a significant 
effect of session (F2,15 = 118.04 p < 0.001) no significant effect of lesion group (F1,13 = 1.58  p = 
0.231) and no significant lesion group x session interaction (F2,26 = 0.437 p = 0.651). Planned 
pairwise comparisons found that the overall PRP in session 2 was lower than session 1 (p < 

















Approaches when learning FR1 
Figure 5.9 shows the number of approaches to the food hopper made during the 
testing schedule by each group during FR1. Repeated measures ANOVA found a significant 
effect of session (F2,26 = 15.49 p < 0.001) a significant effect of lesion group (F1,13 = 6.13 p = 
0.028) and no significant lesion group x session interaction (F2,26 = 0.399 p = 0.675). Planned 






























than session 2 or 3 (p < 0.001 and p = 0.007 respectively) and that the lesion group made fewer 




















In order to investigate whether the number of approaches per session correlates 
strongly with the number of trials completed, the number of approaches per trial was 
calculated and analysed. This is shown in figure 5.10. Repeated measures ANOVA found a 
significant effect of session (F1.4,17.6 = 77.50 p < 0.001) no significant effect of lesion group (F1,13 
= 0.018 p =0.896) and no significant lesion group x session interaction (F1.4.17.6 = 0.143 p 
=0.784). Planned pairwise comparisons found the overall number of approaches per session in 










































Figure 5.10: Number of approaches made per trial during FR1. Graph shows group means ±SEM. See text 




Learning of new fixed and variable schedules of reinforcement 
 Having completed the analysis of learning during FR1, the analysis now turned to the 
subsequent learning of new fixed and variable ratio schedules. This was achieved by assessing 
performance on the first and last day of each schedule. This gives an assessment of response 
to a new schedule (change from last day of one to 1st day of next schedule) and adaptation 



























Correct lever pressing 
The total number of presses on the correct lever during the first and last session of 












Figure 5.11: Rate of correct lever pressing across schedules. Graph shows group means ± SEM. See text 
for statistical analysis.  
 
 
Repeated measures ANOVA found a significant effect of schedule (F6.9,90.4 = 96.92 p < 
0.001) no significant effect of lesion group (F1,13 = 0.01 p = 0.924) and no significant lesion 
group x schedule interaction (F6.9,90.4 = 0.96 p = 0.468). The results of the planned pairwise 






Table 5.2: Table of significant changes in overall 



























































Reward collection latency 
The reward collection latency (log10 transformed to correct for positive skew) during 















Repeated measures ANOVA found a significant effect of schedule (F1.2,15.0 = 10.66 p = 
0.004) no significant effect of lesion group (F1,13 = 0.113 p = 0.743) and no significant lesion 
group x schedule interaction (F1.6,15.0  = 0.17 p = 0.725). The results of the planned pairwise 






Table 5.3: Table of significant changes in overall 



































































The post-reinforcement pause (log10 transformed to correct for positive skew) during 
















 Repeated measures ANOVA found a significant effect of schedule (F4.2,54.3 = 7.70 p < 
0.001) no significant effect of lesion group (F1,13 = 0.159 p = 0.697) and no significant lesion 
group x schedule interaction (F4.2,54.3 = 1.44 p = 0.232). The results of the planned pairwise 






Table 5.4: Table of significant changes in  
































































The number of approaches made during the testing session on the first and last 

















Repeated measures ANOVA found a significant effect of schedule (F8.0,104.5 = 38.8 p < 
0.001) no significant effect of lesion group (F1,13 = 1.52 p = 0.239) and no significant lesion 
group x schedule interaction (F8.0,104.5 = 0.905 p = 0.516). The results of the planned pairwise 






Table 5.5: Table of significant overall differences  


























































This experiment was conducted in order to investigate the effects of highly selective 
bilateral lesions of the cholinergic pPPTg on operant learning. Lesions, made using Dtx-UII 
toxin, were highly selective for cholinergic pPPTg neurons, destroying a mean of 93% of ChAT+ 
neurons within the pPPTg while causing little or no detectable non-selective damage. Lesioned 
rats learned the simple FR1 task at the same rate and in the same number of sessions as sham 
operated controls. The only detectable difference between sham and lesioned rats was a slight 
reduction in the total number of approaches made to the food hopper during FR1 sessions. 
However, when performing a more detailed analysis and assessing the number of approaches 
made per trial rather than per session, the effect completely disappeared. At this stage of 
training rats make on around 9-17 approaches per trial. Therefore if the number of approaches 
per trial is constant but the rats make a slightly different number of trials, this difference in the 
number of trials is amplified when assessing the number of approaches per session. As the 
effect dissapeard in the analysis per trial, it is perhaps more reflective of the lesion group 
completing slightly fewer (but not significantly fewer) trials during the early FR1 sessions 
rather than a true indication of a reduction in approach behaviour. When switched to higher 
fixed ratio, variable ratio and finally extinction schedules there was no significant difference 
between the lesioned and sham rats on any measure taken. Moreover, in addition to there 
being no significant differences, there was no indication of a near significant effect or 






Comparison to ibotenic acid pPPTg lesions 
As discussed in the introduction, a considerable volume of research has shown that 
destruction of inactivation of the PPTg without selectivity for neuronal type (for example with 
excitotoxic ibotenic acid lesions or transient muscimol induced inactivation) causes 
impairment in operant learning paradigms and the updating of action-outcome associations. 
The behavioural testing regime utilised in this chapter is a repetition of that used by Wilson et 
al. (2009), the main results of which are summarised in table 5.6. Wilson et al. found 
substantial impairment in ibotenic acid pPPTg lesioned rats when learning FR1, characterised 
by lesioned rats having markedly reduced rates of correct lever pressing, taking significantly 
more training sessions (5.6 versus 3.2) to reach criterion level of performance, having reduced 
number of approaches, an increased RCL and an increased PRP. When advanced through 
higher testing schedules the reduced rate of correct lever pressing persisted throughout all 
schedules except extinction, the increased RCL and PRP were present in FR5 but were largely 
absent in later schedules. It is also worth noting that while ibotenic pPPTg lesioned rats did 
eventually learn FR1 and FR5, despite extensive training they never performed VR10, VR15 or 
VR30 to the same level as sham controls. Clearly, ibotenic pPPTg lesions caused a severe 
impairment in this testing regime, an impairment that could be overcome by extensive training 
in low demand schedules, but which persistently affected performance in high demand 
schedules. The results of this chapter are in sharp contrast to the effects of ibotenic acid pPPTg 
lesions. Dtx-UII lesioned rats at no point had significantly reduced rates of lever pressing, nor 











Table 5.6: Table of behavioural results from the ibotenic acid pPPTg lesioned rats in the Wilson et al. 
(2009) study. Arrows indicate significant difference and direction of difference (compared to sham 
controls). ”-“ indicates no significant difference. 
 
 
Possible reasons for no effect of Dtx-UII lesion on operant learning 
Methodological considerations 
Lesion size 
One possibility for the lack of behavioural effect is that the Dtx-UII lesion was not 
destructive enough within the cholinergic pPPTg to cause an effect – is higher cholinergic cell 
loss needed? The lesions in this chapter destroyed a mean of 93% of ChAT+ pPPTg neurons 
(range: 88% to 98%). Ibotenic acid lesions of the PPTg typically have some cholinergic cell 
survival, indeed in the Wilson et al. (2009) experiment ChAT+ cell loss was a mean of 64% 
(range 58-72%) which is consistent with other studies (see:(Blaha and Winn, 1993; Inglis et al., 
2001) which typically find between 20-50% PPTg cholinergic cell survival after ibotenic acid 
lesion. The Dtx-UII lesions here are considerably more destructive to ChAT+ neurons than 
standard ibotenic acid lesions and therefore it is unlikely that ibotenic lesions are causing a 
cholinergic mediated effect that the Dtx-UII lesions are failing to achieve due to not destroying 
sufficient numbers of neurons.  
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Timecourse of lesion formation and possible compensatory mechanisms 
The Dtx-UII toxin is a protein synthesis inhibitor based toxin, once internalised into the 
neuron cell death occurs slowly over a period of days. Clark et al. (2007) report that 21 days is 
needed to achieve maximum cell loss, while in chapter 4 (which used the same lesion 
procedure as this chapter) extensive (96%) cell loss was observed at 14 days. In contrast to 
this, ibotenic acid is an excitotoxin which binds to glutamate receptors, locking them open and 
causing unregulated calcium influx which becomes neurotoxic. The effects are rapid, the 
process leading to cell death begins immediately as is extensive in under 72 hours (Kohler et 
al., 1979; Garey and Hornung, 1980). Thus Dtx-UII lesions form considerably more slowly than 
ibotenic acid lesions. Is it possible that during the Dtx-UII lesion formation period efferent 
targets of the pPPTg compensate for the gradual reduction in cholinergic outflow from the 
pPPTg, but given the quick nature of the ibotenic lesions and proximity between lesion 
formation and behavioural testing (typical experiments start testing 7 days post-surgery) there 
is not the same opportunity for compensatory mechanisms to develop? While Wilson et al. 
(2009) did start testing ibotenic pPPTg lesioned rats around 7 days post-surgery, because of 
the length of the testing regime these rats were still being tested 28 days post-surgery, with no 
sign that the rats performance was improving with time (indeed, performance was poorest in 
the last schedules) suggesting that gradual recovery of full function does not occur after PPTg 
damage. However, this does not rule out the possibility that the different timecourse of lesion 
formation allows for the development of different compensatory mechanisms. Assessment of 
compensatory changes after lesion generally involve either direct measurement of transmitter 
level (by for example microdialysis, electrochemistry, tissue punching), direct assessment of 
changes in receptors (histological visualisation and characterisation of receptors) or 
administration of pharmacological agents to detect alternations in transmitter synthesis 
and/or receptor sensitivity (for example administration of receptor agonists to detect receptor 
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supersensitivity) (see pp100-101). If compensatory mechanisms were to develop after Dtx-UII 
pPPTg lesions, candidate structures for up-regulation of AChRs in response to reduction of 
endogenous innervation would be the midbrain DA systems and the thalamus. Projections 
from the pPPTg to the VTA and SNc DA neurons are a key candidate route for the learning 
impairment observed after excitotoxic PPTg lesions, making it a region of interest in this study. 
Therefore, the possibility of functional compensation is a concern for interpreting these 
results. The possibility of compensatory mechanisms within VTA DA systems will be 
investigated as part of the following chapter.  
 
Theoretical implications 
The most parsimonious interpretation of the results from this chapter is that 
cholinergic pPPTg neurons and connected systems are not essential for operant learning or 
performance. While much focus has been placed on the role of the cholinergic PPTg in the 
modulation of midbrain DA systems, recent histological studies show that in actuality there are 
considerably more glutamatergic than cholinergic projections to the midbrain from the PPTg 
(Wang et al., 2010). It is very possible that loss of these glutamatergic projections or a 
combined loss of both cholinergic and glutamatergic transmission underlies the learning 
impairments after non-selective PPTg manipulation. The implications of this, in combination 




The experiment in this chapter was conducted to assess the effects of selective 
cholinergic lesions of the pPPTg on instrumental learning. This objective was successfully met. 
In sharp contrast to previous studies using non-selective excitotoxic lesions, no impairment in 
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learning of operant schedules was observed after highly selective cholinergic lesions of the 
pPPTg. The interim conclusion from this is that the cholinergic pPPTg and connected structures 
appear not to be substantially involved in operant learning. This conclusion will be further 











Nicotine and the CNS 
Nicotine is an agonist of the nicotinic acetylcholine receptor (nAChR) family of 
acetylcholine receptors (AChRs). While endogenous Ach activates both muscarinic (mAChR) 
and nicotinic Ach receptors, nicotine is selective for nAChR subtypes. nAChRs are formed as 
combinations of 5 α(2-10) and β(2-4) subunits or as 5 repetitions of the single α7 subunit (Gotti 
et al., 2006; Miwa et al., 2011). Each combination of subunits has a different set of 
pharmacological properties. For example, the seemingly subtle difference between α42β23 and 
α43β22 results in the former having a 10 fold higher sensitivity to nicotine than the latter (Miwa 
et al., 2011). The distribution of nAChRs is widespread across brain, reaching from the spinal 
cord to the olfactory bulb (Gotti et al., 2006). Figure 6.1 summarises the distribution of the 
most frequently found arrangements of receptor subunits and their sensitivity to nicotine. 
Activation of an nAChR induces an ion channel response in the microsecond to sub-
microsecond range and so nicotine can rapidly induce cellular response (Albuquerque et al., 
2009). Once nicotine has activated a nAChR, the receptor is typically desensitised for a period 
of time which  is dependent on the receptor subtype and level of previous exposure to nicotine 
(Dani and Heinemann, 1996; Vezina et al., 2007; Govind et al., 2009; Miwa et al., 2011). Long 
term exposure to nicotine (a difficult term to define, but it could be as short as several days 
(Miwa et al., 2011) for certain doses / concentrations) or even perhaps a single exposure 
(Govind et al., 2009) causes a process that appears to be able to extend this period of 
desensitisation into “persistent inactivation” in certain subsets of nAChRs (particularly 
α4β2)(Gentry and Lukas, 2002; Govind et al., 2009). Increased expression of nAChRs have been 
found after chronic nicotine exposure, with the greatest increases believed to occur also in 
α4β2 subtypes (Albuquerque et al., 2009). This may be a functional means of maintaining a 
stable balance in conditions of drug induced extended receptor inactivation. Perhaps most 
interestingly, different subtypes of nAChR upregulate to different levels (for example α4β4 
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nAChRs have poor levels of upregulation (Albuquerque et al., 2009)) and some actually 
downregulate (e.g. α6β2)(Mugnaini et al., 2006). Thus, repeated exposure to nicotine does not 
simply cause a rightwards shift in the dose-response curve in all brain systems, but results in 
complex and differential alterations. Because upregulated and downregulated nAChRs will 
respond differently to reduced nicotine levels after chronic drug exposure, this may in part 
explain the diffuse range and timescale of symptoms experienced by smokers upon cessation 















Figure 6.1: Distribution of major locations of known nAChRs throughout the CNS. Image reproduced 




Nicotine induced locomotion 
In rats, systemically administered nicotine alters locomotion in a predictable manner. 
After the first administration, doses within the range of 0.1 – 0.8 mg/kg induce locomotor 
depression, which, after repeated administration, develops into hyperlocomotion (Benwell and 
Balfour, 1992; Porter, 2007; Vezina et al., 2007). The effects on locomotion are believed to be 
a result of nicotine binding to nAChRs in the VTA which causes activation of the 
mesoacumbens pathway and in turn  leads to increased DA levels in the NAcc (Benwell and 
Balfour, 1992; Rose and Corrigall, 1997). Support for this hypothesis is strong: administration 
of the nAChR mecamylamine blocks the locomotor effects of nicotine (Clarke and Kumar, 
1983), and 6-OHDA lesions of the NAcc also block the locomotor effects (Clarke et al., 1988). 
However, infusion of nicotine directly into the NAcc has no effect on locomotion, whereas 
infusion into the VTA (but no other site tested in that study) has the same effects as 
systemically administered nicotine (Reavill and Stolerman, 1990); for review see: (Vezina et al., 
2007). The majority of nAChRs on VTA DA neurons contain either the β2 or β4 subunit in 
combination with α3-7 subunits. However, the β3 subunit and homomeric α7 receptors are 
also present (Wooltorton et al., 2003). Upregulation of VTA nAChRs after repeated nicotine 
exposure is believed to be a key part of the process resulting in sensitisation and the increased 
locomotor response to the same dose of drug (Govind et al., 2009). Nicotine also activates 
nAChRs on VTA glutamate neurons (Grillner and Svensson, 2000) and GABAergic neurons 
(Mansvelder et al., 2002). It has been proposed that nicotine has a prolonged action on 
glutamatergic VTA and VTA projecting neurons which in turn increases glutamate driven VTA 
DA activation. In addition to this, nicotine’s action on VTA GABAergic (inhibitory) neurons has 
been shown to be short transient activation followed by prolonged desensitisation leading to 
depression of inhibition (Mansvelder et al., 2002). Therefore, the action of nicotine in the VTA 
is more complex than simply acting directly upon DA neurons and driving DA output, but 
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instead may involve several parallel events: immediate excitatory action on DA neurons, 
prolonged activation of DA neurons mediated by glutamatergic activity and persistent 
depression of inhibitory GABAergic input (Mansvelder et al., 2002; Fowler et al., 2008), with 
the net result being rapid and sustained increase in mesoaccumbens DA levels. 
 
The pPPTg and nicotine induced locomotion 
Non-selective, ibotenic acid lesions of the pPPTg have been shown to alter the 
standard locomotor response to nicotine (Alderson et al., 2008). After pPPTg lesion, the initial 
locomotor depressant effects of the drug (seen during the first 2 sessions in control rats) were 
absent; subsequent locomotor sensitisation developed in both control and pPPTg lesioned 
rats, but first evidence of hyperlocomotion was seen on session 3 in pPPTg lesioned rats and 
not until session 7 (the final session) in sham controls (Alderson et al., 2008). The VTA receives 
strong cholinergic and glutamatergic innervation from the pPPTg, which can modulate and 
enhance midbrain DA activity (Charara et al., 1996; Parent et al., 1999; Floresco et al., 2003; 
Maskos, 2008; Wang et al., 2010); See general introduction pp36-38 for full discussion). The 
altered locomotor response and change in rate of sensitisation to systemic nicotine in pPPTg 
lesioned rats was interpreted to be the result of compensatory changes in the VTA leading to 
supersensitivity of nAChRs as a result of loss of endogenous cholinergic innervation from the 
pPPTg. As a consequence of this supersensitivity nicotine would have an enhanced effect 
(reduced initial locomotor depressant and advanced rate of sensitisation) which is what was 
observed in pPPTg lesioned rats. 
An alternative explanation is that nicotine has a direct effect on pPPTg and disruption 
of this action, either alone or in combination with supersensitivity of VTA receptors, may 
account for the altered locomotor response to nicotine observed after pPPTg lesion. For 
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example nicotinic activation of glutamatergic or cholinergic pPPTg neurons may alter VTA 
activity and the subsequent release of DA in the mesoaccumbens pathway. The results 
obtained by Alderson et al. (2008) are unable to distinguish between these two 
interpretations.   
If it were the case that supersensitivity of nAChRs within the VTA had developed in 
response to loss of endogenous cholinergic innervation from the pPPTg, the same physiological 
changes, and therefore the same behavioural effect, would be predicted after selective 
cholinergic pPPTg lesions. If, however, it is the case that the previously observed changes in 
the locomotor response to nicotine are a result of loss of a pPPTg to VTA glutamatergic 
pathway, or the combined loss of cholinergic and glutamatergic innervation of the VTA, no 
behavioural effect of selective cholinergic pPPTg lesions would be predicted. 
 
Investigating possible functional compensation after Dtx-UII pPPTg lesion 
In chapter 5 it was found that highly selective lesions of the cholinergic pPPTg 
produced no deficits in the learning of simple or complex operant reinforcement schedules. 
One possibility for the lack of behavioural effect is that compensatory mechanisms developed 
in response to the long Dtx-UII lesion formation and testing period. Could it be possible that 
the remaining ˜10% of cholinergic cells were able to support normal behaviour? This is unlikely 
(primarily because ibotenic acid lesions sparing more than 10% of cholinergic cells produced 
strong deficits in the same behavioural task over a prolonged period of testing). However, due 
to the different method of lesion formation this possibility should be investigated before being 
excluded. As discussed in Chapter 4 (pp100-101), loss of neurons can lead to dramatic 
compensatory changes whereby normal level of post-synaptic transmitter and behavioural 
function are maintained despite substantial neuronal loss. One key candidate for maintaining 
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behavioural function is the upregulation and development of supersensitivity of post-synaptic 
receptors. Upregulation of VTA AChRs is believed to occur after excitotoxic PPTg lesion (Blaha 
and Winn, 1993; Blaha et al., 1996) which is thought to be responsible for the enhanced 
locomotor response to nicotine (Alderson et al., 2008). Utilising this VTA mediated behaviour 
offers a means of assessing the effects of selective cholinergic pPPTg lesions on VTA nAChRs. 
 
Chapter aims 
In this chapter, the methodology of Alderson et al. (2008) is repeated with rats bearing 
bilateral selective cholinergic Dtx-UII pPPTg lesions. This has two aims: (1) to investigate if the 
changes in nicotine induced locomotion seen after non-selective ibotenic acid lesions are also 
seen after selective cholinergic Dtx-UII lesions. (2) to investigate the possibility of upregulation 
developing in VTA nAChRs after loss of pPPTg cholinergic innervation. Experimentally naive 
rats were given Dtx-UII lesions of the pPPTg. Subsequent extensive habituation to the 
locomotor testing cages and injection procedure was conducted before systemic nicotine was 
administered in a day-on day-off regime (saline on off days) for 7 sessions. With the exception 
that different locomotor testing cages are used (commercially available chambers with an 
array of 15 infrared light beams rather than in-house made chambers (of a similar size) with 2 
light beams) this was an exact replication of the testing protocol used by Alderson et al. (2008). 
Enhanced response to nicotine after selective cholinergic pPPTg lesion (revealed by increased 
locomotion in response to the drug, compared to sham controls) would reveal supersensitivity 
in the VTA; no change in response to nicotine would support the view that VTA nicotinic 
receptors had not supersensitised after loss of endogenous innervation from pPPTg. The 
results are discussed with comparison to non-selective ibotenic pPPTg lesions and the effects 







Twenty-four adult male Lister-Hooded rats (Harlan Olac Ltd, Bicester, UK) were used, 
with a mean weight of 355g (range 331 – 389g) at time of surgery. Animals were housed and 
maintained as described in the general methods. 
 
Surgery 
Lesion surgery was performed as described in the general methods. Sham pPPTg 
lesioned rats (n = 8) were infused with 200 nL sterile PB, lesioned rats (n = 16) were infused 
with 200 nL 3% Dtx-UII (in sterile PB). The co-ordinates for the pPPTg were: -0.8 mm from the 
IAL, ± 1.9 mm from the midline, -6.5 mm below dura (as used in chapter 4 and 5) and the order 
of infusion (left hemisphere, right hemisphere) was alternated across rats. 
  
Behavioural testing 
To allow full formation of the lesion, behavioural testing began 21-24 days post-
surgery. During this time animals were monitored daily for signs of ill health or other lesion 
related complications. Locomotor testing was conducted in the locomotor monitoring 
photocell cages described in the general methods. Daily testing sessions were 60 min in 
duration, conducted in a dimly illuminated room and each session had a proportionally equal 
number of sham and lesioned rats. Rats were given three habituation sessions where they 
were placed in the locomotor cages without any injections, this was followed by seven sessions 
where rats were injected with 0.9% w/v saline (s.c.; 1mL/kg) immediately prior to testing. After 
completing this habituation period nicotine testing began. Nicotine sensitisation was 
performed in a day-on day-off routine whereby rats received nicotine (s.c.; 0.4 mg/kg in 0.9% 
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saline; nicotine hydrogen tartrate, Sigma–Aldrich, UK; dose refers to salt) or saline (0.4 mg/kg 
0.9% saline) on alternating days for 14 days. The order of testing was counterbalanced so that 
on any given day half the rats received nicotine and half saline. All injections were performed 
in a procedure room opposite the locomotor testing room, each rat was individually taken to 
the procedure room, injected, then taken to and placed in the locomotor testing cage, which 
started recording beam breaks immediately. Thus each rat was always injected in the same 
room, and no rat was ever in the presence of another rat receiving an injection. 
  
Histology 
All histological procedures followed the methods described in the general methods. 
Briefly, after completing behavioural testing rats were transcardially perfused with fixative and 
brains stored in sucrose solution. Subsequently, 30 µm coronal sections were cut through the 
area of the PPTg and ~1mm beyond in anterior-posterior plane. Parallel 1:4 series were 
processed immunohistochemically for ChAT and NeuN reactivity. NeuN stained sections were 
then counterstained with cresyl violet and all stained sections mounted onto glass slides and 
viewed under a light microscope. Software assisted counts of ChAT+ neurons throughout the 
PPTg enabled quantification of the lesions. A lesion was considered acceptable if >~80% of 
ChAT+ pPPTg neurons were destroyed bilaterally and there was minimal, if any, non-selective 
damage evident on the NeuN/cresyl sections.  
 
Behavioural data analysis 
Data were analysed using PASW 18 for Windows (SPSS Inc., Chicago, Illinois USA). A 
range of repeated measures ANOVAs with appropriate post hoc tests were performed. Details 
of particular factors analysed are reported in the text. For locomotor data the number of beam 
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breaks per session were SQRT transformed to correct for positive skew in the data (identified 
by the Shapiro-Wilk test). Results were considered significant when p ≤ 0.05. 
 
Results 
All animals recovered well from the surgical procedure. During the 21 day lesion 
formation period a small yet significant decrease in bodyweight growth was observed. See 
figure 6.2. Repeated measures ANOVA found a main effect of group (F1,13 = 6.0, p = 0.029), day 










Figure 6.2: change in bodyweight in the 21 day post-surgery period. * indicates significant difference 
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Lesion analysis  
Seven rats had selective bilateral lesions of the cholinergic pPPTg. These lesions 
destroyed a mean of 89.5% of ChAT+ pPPTg neurons (range 78.8% to 94.8%) with only very 
small, if any, evidence of non-selective damage on the NeuN/Cresyl stain. Figure 6.3 (p160) 
shows representative lesion and sham tissue. The remaining rats in the lesion group were 
excluded from all analysis due to having unilateral lesions (n = 2); partial ChAT+ lesions (range 
˜34-70% cell loss, n = 5); having unilateral non-selective damage (n = 1) or death before being 
processed for histology (n = 1). This rat was found dead in the homecage after completing 
behavioural testing but before histological processing began. This was 8 weeks post-surgery, 
before the death (which happened when the rat was unattended in the home cage) the rat 
had appeared healthy (stable weight and no indications of stress) and so it was not believed to 
be related to surgery or testing (a view reached after consultation with the unit NACWO). 
 
 
Characterisation of lesion 
 The distribution of cholinergic neurons throughout the PPTg is shown in figure 6.4. The 
number of remaining pPPTg ChAT+ cells in the lesion group was calculated and expressed as a 
percentage of the sham mean. This is shown in figure 6.5. T-tests (on raw data, not 
percentages) confirm that lesioned rats had significantly fewer ChAT+ pPPTg cells than sham 
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Figure 6.4: Distribution of ChAT+ neurons throughout the PPTg. ChAT counts = Numbers of ChAT+ 









Figure 6.5: Number of ChAT+ pPPTg cells as a percentage of sham mean. Left = left hemisphere; right = 







Figure 6.3: Example sections of a sham and a Dtx‐UII lesioned rat. Rows a – c show ChAT stained sections of
anterior PPTg (row a), central PPTg (row b) and posterior PPTg (row c). Row d shows a NeuN / Creyl double
stained section immediately parallel to row c, at the level of the posterior PPTg and greatest ChAT cell loss.






The rate of locomotion and rearing during the habituation sessions (where rats had 3 
sessions of no injections followed by 7 sessions with saline injections) is shown in figure 6.6 
and 6.7. For beam breaks during the daily habituation sessions a repeated measures ANOVA 
found a main effect of session (F6.41,83.40 = 6.46, p < 0.001) but not group (F1,13 = 0.63, p = 0.44) 
and no session x group interaction (F6.41,83.40 = 1.27, p = 0.28). Restricted planned pairwise 
comparisons found that sessions 1, 2 and 3 differed from some, but not all, later sessions (1 
from 6 and 8; 2 and 3 from 8) and that from session 4 onwards there were no differences 
between sessions. The same analyses on the rearing data found a main effect of session 
(F6.56,85.32 = 3.86, p  = 0.001) but not group (F1,13 = 2.09, p = 0.17) and no session x group 
interaction (F6.56,85.32 = 0.96, p = 0.46). Restricted planned pairwise comparisons failed to find 
any significant differences between sessions, however habituation sessions 1 and 3 did 
approach significance compared to the final session (p = 0.095 and 0.057 respectively). These 
data show that Dtx-UII lesions of pPPTg had no effect on spontaneously generated locomotion 
or rearing during the habituation sessions. Moreover, they show that by the end of the 
habituation sessions rats performance was stable, confirming habituation to the testing 






























































Figure 6.6: Beam breaks (SQRT transformed) made during the habituation sessions. Hab = habituation 










Figure 6.7: Rearing (SQRT transformed) during the habituation sessions. Hab = habituation session; 
Hab+sal = saline injection and habituation session. Graph shows group means ± SEM. 
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Nicotine testing sessions 
Figure 6.8 shows the mean number of beam breaks (basic movements) during the 
nicotine and saline testing sessions. Repeated measures ANOVA found a significant effect of 
session (F6,78 = 27.39, p < 0.001) a drug x session interaction (F6,78 = 44.52, p < 0.001) a near 
significant effect of drug (F1,78 = 4.58, p = 0.052) and that all effects involving group were non-
significant  (group (F1,13 = 0.58, p = 0.46);  drug x group (F1,78 = 2.76, p = 0.121); group x session 
(F6,78 = 1.75, p = 0.122); drug x group x session (F6,78 = 0.76, p = 0.601)). Bonferroni corrected 
paired sample t-tests comparing the effect of nicotine and saline during each session found 
that during the first session both the lesion and sham groups displayed hypolocomotion (sham 
t7 = -4.82, p = 0.014; lesion t6 = -8.56, p < 0.01) which developed into hyperlocomotion during 
the later testing sessions (sham session 5: t7 = -6.33, p < 0.01. Lesion session 6: t6 = -6.10, p = 
0.007). 
 
Nicotine induced locomotion 
To further assess whether nicotine induced a different level of change in locomotion in 
the lesion compared to the sham group, for each rat the beam breaks made in each saline 
session was subtracted from the corresponding nicotine session. Group means are shown in fig 
6.9. Repeated measures ANOVA found a main effect of session (F6,78 = 46.02, p < 0.01) but no 

















































Figure 6.8: Basic movements (SQRT transformed) made during the nicotine testing sessions. Graph shows 
group means ± SEM. * indicates significant difference between saline and nicotine in the sham group in 
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Individual responses to nicotine 
In order to investigate whether there was a pattern within each group (for example a 
small number of outliers affecting the group mean or a particular pattern displayed by 
individual rats) the response to nicotine of each rat was plotted and inspected. No clear 
pattern emerged; all rats displaced similar locomotor patterns and there was no sign of a large 
degree of variance within the lesion group, indeed the sham group often had higher variance 
and a greater spread on individual days than the lesion group. Figure 6.10 shows the rates of 
locomotion of each rat on the first and last nicotine testing days, data from other days (not 










Figure 6.10: Responses to nicotine of every rat on the first and last day of nicotine injections. Each point 




Initial response to nicotine 
The lack of significant group effect in the analyses performed suggests that 
supersensitivity to nicotine had not developed in VTA nAChRs. However, as the effects of 
repeated nicotine are complex and long lasting, it is likely that by the second administration of 
nicotine the chain of changes the drug itself produces on nAChRs had already started. This 
could potentially mask any more subtle effects caused by the effects of the Dtx-UII pPPTg 
lesion. An additional analysis restricted to the first nicotine testing session was therefore 
performed to assess the effects of nicotine in Dtx-UII lesioned rats before any long term 
nicotine induced changes had developed. Figure 6.11 shows the level of locomotion after 
initial nicotine administration and the nicotine induced change in locomotion. Univariate 
ANOVA comparing the effect of nicotine on the level of basic movements finds no effect of 
group (F1,13 = 0.69, p = 0.422). Likewise, univariate ANOVA finds no effect of group on nicotine 




















Figure 6.11: Basic movements (left) and nicotine induced change in locomotion (right) during the first 
testing session. Graph shows group means ± SEM. 
 
Chapter discussion 
This experiment was conducted to investigate the effects of selective cholinergic 
pPPTg lesions on the locomotor response to repeated systemic nicotine administration. Dtx-UII 
lesions destroyed ~90% of pPPTg ChAT+ neurons. Extensive habituation to both the testing 
environment and injection procedure was performed prior to the start of alternating nicotine 
(0.4mg/kg) and saline testing sessions. No differences in baseline levels of locomotion or 
rearing were found during the habituation sessions. During the testing sessions, nicotine 
caused hypolocomotion after first administration, which developed into hyperlocomotion 
across the testing sessions. The same levels of locomotion and the same pattern of 
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the pPPTg produced no changes in nicotine induced locomotion or the rate of sensation to 
nicotine. 
 
 Relation to previous work 
The results of this study are in contrast to those of Alderson et al. (2008) who found 
that non-selective ibotenic acid lesions of the pPPTg altered the locomotor response to 
nicotine. The locomotor depression normally seen after initial administration was absent and 
hyperlocomotion to repeated nicotine was accelerated, developing on session 3 rather than 
session 7. The authors offer several interpretations, the primary one being that their result 
would be predicted if supersensitivity of VTA nAChRs had developed in response to loss of 
endogenous cholinergic innervation from the pPPTg. Support for supersensitivity of DA nAChRs 
after PPTg loss also comes from an older study finding an increase in nicotine induced DA 
efflux in dorsalmedial striatum (measured with chronoamperometry and microdialysis) after 
nicotine infusion directly into the SNc of whole-PPTg lesioned rats (Blaha and Winn, 1993). The 
findings from the current study are not compatible with the hypothesis that upregulation of 
VTA nAChRs occurs after loss of endogenous PPTg cholinergic innervation and that this 
underlies the alterations of nicotine induced locomotion observed after ibotenic pPPTg lesions. 
One methodological consideration is that the Dtx-UII lesion might not be as destructive even 
to cholinergic neurons as ibotenic lesions, resulting in less compensatory upregulation. 
Alderson et al. (2008) do not quantify the size of cholinergic loss in their study, but experience 
of the ibotenic lesion technique and other published results normally find that ibotenic lesions 
are not markedly destructive to cholinergic PPTg neurons and call loss in the region of 50-70% 
is quite normal (Blaha et al., 1996; Wilson et al., 2009a). The selective cholinergic lesions in this 
experiment had a mean cell loss of 90%, which is generally higher than that obtained with 
ibotenic acid. It is therefore unlikely that the difference in behavioural effects is the result of 
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smaller cholinergic lesions in this study. Consequently, it is reasonable to conclude that the 
different results are a consequence of the different type of lesion (no major loss of 
glutamatergic or GABAergic neurons after selective cholinergic lesion).  
 
Does nicotine have a direct effect on PPTg? 
A question raised by these results is where the locus of the effect is after non-selective 
pPPTg lesion: is it due to loss of nicotine’s direct action on non-cholinergic pPPTg, or is it the 
result of changes in VTA after pPPTg lesion (for example, alterations in nicotine induced 
glutamatergic activation of DA neurons caused by loss of glutamatergic input from pPPTg). At 
the most fundamental level, in order for nicotine to have a direct effect on PPTg, PPTg neurons 
must express appropriate nicotinic receptors. This is indeed the case - both cholinergic and 
non-cholinergic PPTg neurons express mRNA for α7 and β2 nAChR subtypes; while non-
cholinergic neurons also extensively express α4 receptors, only around 5% of cholinergic 
neurons express this subtype (Azam et al., 2003). As the α4β2 receptor subtype is considerably 
more susceptible to upregulation by nicotine than the α7β2 subtype (Azam et al., 2003; 
Albuquerque et al., 2009) the differential pattern of receptor expression suggests that 
upregulation is more likely to develop in non-cholinergic rather than cholinergic PPTg neurons. 
Behaviourally there is also evidence that nicotine has a direct effect on PPTg. In a conditioned 
place preference paradigm, nicotine infused directly into the PPTg (but not in control infusions 
2 mm dorsal) caused a place preference for the side of the CPP apparatus paired with drug 
infusion (Iwamoto, 1990).  
 
The PPTg and nicotine self-administration 
Much of the literature on nicotine and the PPTg addresses the potential role of the 
PPTg in nicotine intravenous self-administration (IVSA). In rats pre-trained to intravenously 
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self-administer drug, infusion of the GABA agonist muscimol into PPTg reduced the rate of 
nicotine, but not cocaine, self-administration (Corrigall et al., 2001). The contrast between 
drugs suggests that the reduction in IVSA was specific to nicotine and not a general reduction 
in level of reward related performance. Likewise, lesions made with the ethylcholine mustard 
aziridinium ion AF64A which were reported to be selective for PPTg cholinergic neurons also 
reduced rates of nicotine self-administration (Lanca et al., 2000b). While this toxin was claimed 
to make selective cholinergic lesions, this and other laboratories have found it causes non-
selective neuronal and also physical damage (including to fibres of passage) in the area of the 
PPTg (Rodriguez et al., 1998; Alderson et al., 2006); see chapter 1, p15 for full discussion of 
AF64A). In contrast to these findings it has been shown that ibotenic acid lesions restricted to 
the pPPTg enhanced nicotine self-administration (Alderson et al., 2006). Differences in 
experimental design may explain this apparent inconsistency: In the studies finding a reduction 
in nicotine IVSA after PPTg inactivation there were no additional conditioned stimuli 
programmed to accompany the drug delivery (however the houselight did extinguish for 60 
sec). In the lesion study finding enhanced responding after pPPTg lesions, animals were pre-
trained to high levels of lever pressing for food reward and drug delivery was simultaneous 
with illumination of a bright light above the lever and retraction of both levers for 20 seconds. 
Thus in this experiment reward delivery was accompanied with many conditioned stimuli. It is 
known that in conditions where nicotine delivery is paired with prominent stimuli (CS light or 
tone) robust self-administration can develop, but lack of any CS leads to considerably lower 
and unstable rates of administration (Liu et al., 2007). This fits current views of nicotine having 
reinforcement enhancing properties rather than being a particularly strong reinforcer in its 
own right, with drug delivery associated with mildly rewarding CS significantly enhancing rates 
of self-administration compared to conditions with no CS  (Palmatier et al., 2006; Farquhar et 
al., 2011). Therefore, the seemingly contradictory findings of PPTg lesion reducing lever 
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pressing in some studies (Lanca et al., 2000b; Corrigall et al., 2001) and enhancing it in others 
(Alderson et al., 2006) may in actuality be the result different training and experimental IVSA 
protocols (particularly the use of CS lights) and the way these interact with PPTg lesion. 
Regardless of the nature of what underlies this inconsistency, these studies show that PPTg 
manipulation affects responding for nicotine. As the same manipulations do not affect levels of 
responding for cocaine or food pellet reward (Corrigall et al., 2001; Alderson et al., 2006) this 
change is not a global deficit in reward related lever pressing, but is instead selective for 
performance of lever pressing when it is associated with nicotine. This body of work confirms 
that the PPTg has a close functional relationship with nicotine, it does not, however, show that 
this is due to nicotine having a direct effect on PPTg. These results could still be the explained 
by the consequence of, for example, alterations in the effect of nicotine in PPTg afferent 
structures after loss of endogenous cholinergic innervation (as is suggested by (Alderson et al., 
2006). To confirm that nicotine can and does activate PPTg neurons a direct measurement of 
this is required.  
 
C-fos expression in the PPTg after nicotine administration 
C-fos is an immediate early gene transiently expressed by many neurons upon 
activation, due to the relative ease of immunohistochemically marking the protein produced 
by the gene, it has become a frequently used indicator of neuronal activation in response to 
experimental manipulations (for review see:(Okuno, 2011). Single administration of systemic 
nicotine induces c-fos expression in PPTg over and above that of control rats (Lanca et al., 
2000a). Interestingly, the same study found that over 95% of nicotine activated PPTg cells 
were non-cholinergic. Further analysis speculated that the number of activated non-
cholinergic neurons represented the entire non-cholinergic PPTg population. Therefore all 
non-cholinergic and less than 5% of cholinergic neurons were activated by systemic nicotine. 
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NADPHd (a selective stain for nNOS expressing neurons) was used as a histochemical marker of 
cholinergic neurons, while a reliable and often used marker (eg(Alderson et al., 2008), 
combining it with c-fos immunohistochemistry is less common. Histochemical NADPHd is a 
very dark stain and could potentially mask double labelled neurons. Porter (2007) repeated 
and extended the Lanca et al study, using a double labelled double immunohistochemical stain 
to mark nNOS (for cholinergic neurons) and c-fos. Double labelling of ChAT and c-fos would be 
the ideal solution, however antibody compatibility issues make this unfeasible with the c-fos 
antibody used in those studies (Latimer MP, Personal communication; 2009). Porter’s results 
confirm and extend those of Lanca et al. (2000a): acute and chronic (5 days of daily injections) 
nicotine induced c-fos expression in PPTg, with levels of fos and cholinergic co-expression 
around 1% in both condition (Porter, 2007). These studies strongly suggest that within PPTg 
nicotine preferentially acts upon non-cholinergic rather than cholinergic neurons. However, 
the very low expression of c-fos in cholinergic neurons may not be a reliable indicator of no 
activation. One intriguing finding when reading the literature on c-fos expression in PPTg 
cholinergic neurons is that while studies have found c-fos expressed in these neurons 
(confirming that they can express the c-fos protein) doubled labelled fos and cholinergic cells 
are almost always a small minority of all c-fos labelled PPTg neurons, typically around 5% 
(see:(Shiromani et al., 1992; Shiromani et al., 1996; Yamuy et al., 1998; Maloney et al., 1999; 
Lanca et al., 2000a; Nakahara et al., 2001; Torterolo et al., 2001; Hayward and Castellanos, 
2004; Mena-Segovia et al., 2004b; Verret et al., 2005; Deurveilher et al., 2006; Heise and 
Mitrofanis, 2006; Brudzynski et al., 2011). The only condition to show the reverse pattern 
(more cholinergic than non-cholinergic activation) is in a REM sleep rebound study, this found 
a relatively small number of PPTg c-fos cells (n = 64, considerably smaller than the numbers 
reported in other studies) and 75% of these were also ChAT+ (Datta et al., 2009). This 
reinforces that PPTg ChAT cells can express c-fos, however, taking all of these studies together 
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the general finding of very low level c-fos expression in PPTg cholinergic cells raises questions 
about how to interpret the results. The induction threshold for c-fos is now considered high in 
comparison to other immediate early genes (such as zif268) (Okuno, 2011), some neurons do 
not reliably express c-fos and there are also conditions where activation does not lead to c-fos 
expression (for example relative increases in activation of already active neurons and realise 
from chronic inhibition (Kovacs, 2008)). These features of c-fos expression have led many 
authors to reinforce the view that no staining for c-fos should not be used as evidence of no 
activation (Cullinan et al., 1995; Kovacs, 2008; Okuno, 2011). Nakahara  et al. (2001) analyse 
PPTg co-expression of c-fos and ChAT and c-fos and GABA and discover that even in control 
animals ChAT and c-fos co-expression is remarkably low compared to GABA and c-fos co-
expression (5% of c-fos+ neurons were also ChAT+ 50% of c-fos+  were GABA+), which they 
claim is evidence that PPTg cholinergic neurons do not easily or reliably express c-fos and so is 
not a good marker of activation of these neurons.  
It is possible that the low level of co-expression of c-fos and ChAT in behavioural 
studies gives insight into the function of these neurons, for example indicating that acute 
behavioural changes do not activate this neuronal population whereas longer lasting more 
global processes (such as REM rebound sleep) do. However, until additional analysis (for 
example with other immediate early genes or electrophysiological characterisation of neuronal 
responses to nicotine) add further support, the nicotine c-fos studies should be taken as a 
potential indication that nicotine does not activate PPTg cholinergic neurons rather than a final 
conclusion.  
Support for the view that nicotine does indeed activate PPTg cholinergic neurons (in 
apparent contrast to the c-fos studies) comes from a slice preparation study and a 
microdialysis study. In slice preparation application of nicotine has been shown to depolarise 
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both cholinergic and non-cholinergic mesopontine tegmentum neurons (Ishibashi et al., 2009). 
Unfortunately, this study cannot give insight into whether nicotine preferentially acts upon 
non-cholinergic neurons, but as 100% of the cholinergic neurons tested were affected by 
nicotine it does suggest that this neuronal population is readily susceptible to the drug. 
Nakahara et al. (2001) used microdialysis to measure ACh levels in the VTA after ICSS of the 
MFB and compared this with levels of ChAT and c-fos co-expression in the PPTg and LDTg (a 
major source of ACh in the VTA). They found 1 h of ICSS produced a significant increase in ACh 
levels in the VTA and a significant increase in non-cholinergic Fos expression in PPTg and LDTg. 
However, levels of c-fos expression in cholinergic PPTg/LDTg neurons were low (again around 
5% in control rats and 7% in the ICSS group). Given that PPTg was clearly activated by the MFB 
ICSS, that VTA ACh levels rose sharply and the most likely source of this ACh is the PPTg/LDTg 
cholinergic output, they argue that the most reasonable explanation for the low expression of 
c-fos in PPTg/LDTg cholinergic neurons was due to an inability of these neurons to reliably 
express c-fos rather than due to not being activated. However, they cannot rule out the 
possibility that the ACh was released presynaptically in the VTA or that it came from other less 
prominent sources.  
 
Reanalysis of the role of the pPPTg in nicotine induced locomotion 
The results of the experiment conducted in this chapter show that selective bilateral 
loss of cholinergic pPPTg neurons does not affect the locomotor response to nicotine or the 
rate of nicotine sensitisation. This suggests that the changes in nicotine induced locomotion 
previously reported after non-selective ibotenic acid lesions are the result of glutamatergic or 
GABAergic pPPTg loss. There are strong glutamatergic projections from pPPTg to VTA which 
from excitatory synapses with both DA and non-DA neurons, while less is known about 
GABAergic projections (and there are considerably fewer GABAergic than glutamatergic or 
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cholinergic neurons in pPPTg) these also project to the VTA (Charara et al., 1996; Winn, 2006; 
Wang and Morales, 2009; Wang et al., 2010). As discussed in the chapter introduction, within 
the VTA the effects of nicotine are more complex than simple activation of DA neurons by 
binding to nAChRs expressed on DA containing neurons and is hypothesised to consist of three 
components: direct activation of DA neurons; activation of glutamatergic neurons which 
subsequently enhances glutamatergic mediated drive of DA neurons; activation followed by 
long term inhibition of GABAergic signalling leading to a reduction of GABAergic inhibition of 
DA neurons. Disruption of the balance between these processes could result from loss of 
glutamatergic innervation from pPPTg. If compensatory upregulation of glutamate receptors 
developed after excitotoxic pPPTg lesion the nicotine induced VTA glutamate release would 
subsequently lead to enhanced activation of the DA mesoaccumbens pathway and increased 
locomotion. This hypothesis is in fitting with the results of Alderson et al. (2008). In addition to 
considering the effects in VTA, as discussed above, nicotine clearly has an effect on the PPTg 
and changed activity within the PPTg or in the projections to VTA and elsewhere rather than 
changed activity of receptors in the VTA may explain some of the effects of pPPTg lesions on 
nicotine induced locomotion. Support for this comes from studies finding changes in midbrain 
DA meditated increases in striatal DA levels following manipulation of PPTg and LDTg mAChRs 
(Forster and Blaha, 2000, 2003).  
Further investigation of pPPTg-VTA interactions and the role these play in the effects 
of nicotine could be achieved with selective manipulation of receptors (for example intra-VTA 
infusion of the ionotropic glutamate receptor antagonist kynurenate prior to nicotine 
administration) and targeted rather than systemic nicotine delivery (delivering nicotine directly 
into VTA and pPPTg rather than s.c.). Establishing the locus of nicotine’s effect (does nicotine 
in the pPPTg have any effect on locomotion? What effect does excitotoxic pPPTg lesion have 
on intra-VTA nicotine infusion?) and the effects of manipulation of signalling within the VTA 
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(what happens to nicotine induced locomotion when VTA glutamate signalling is depressed?) 
would disassociate some of the multiple effects of nicotine on these brain regions.  
 
No evidence of upregulation of VTA nAChRs after bilateral selective cholinergic pPPTg lesion 
A sub-aim of this chapter was to specifically investigate whether there was evidence of 
upregulation of VTA nAChRs after loss of endogenous cholinergic innervation from the pPPTg. 
One interpretation of the lack of behavioural effects of selective cholinergic lesions on operant 
learning (chapter 5) was that the slow formation of the Dtx-UII lesion and delay between lesion 
and testing enabled greater functional compensation to develop compared to the quick nature 
of ibotenic acid lesions and testing. Based on previous studies showing increased striatal DA 
levels after cholinergic stimulation of midbrain DA neurons in PPTg lesioned rats, and of an 
altered response to VTA mediated nicotine induced locomotor changes in PPTg lesioned rats, it 
was hypothesised that upregulation would be revealed by an increased response to nicotine in 
the lesion group. That no such increase was observed, both when analysed across all nicotine 
sessions or when the analysis was restricted to the first nicotine session, suggests that no 
substantial upregulation and therefore no extensive functional compensation had developed. 
It is possible that upregulation at a level not high enough to produce a measurable behavioural 
change had occurred, this could be further analysed with a more direct measure of ACh levels 
in the VTA (for example with electrochemistry) but such low levels of change are unlikely to 










Chapter conclusions  
This aim of this chapter was to establish if selective cholinergic lesions of the pPPTg 
produced the same changes in nicotine induced locomotion as non-selective excitotoxic 
lesions and attempt to integrate the results into the broader literature on the PPTg and 
nicotine. The Dtx-UII lesions were highly selective for cholinergic pPPTg neurons and reduced 
pPPTg ChAT+ neuron count but an average of ˜90%. In the behavioural response to nicotine 
there was no significant difference between sham and lesioned rats: nicotine did not induce 
higher levels of locomotion in the lesion group and the rate of sensitisation was unchanged. 
This supports the view that the behavioural changes seen after excitotoxic pPPTg lesions were 
the result of loss of glutamatergic and GABAergic (with or without the combined loss of 
cholinergic) neurons rather than solely the loss of cholinergic neurons. Further support for the 
non-involvement of the cholinergic pPPTg in nicotine induced locomotion comes from c-fos 
studies showing that both acute and chronic nicotine induces c-fos expression in non-
cholinergic, but not cholinergic PPTg neurons. However, as there is evidence that nicotine 
directly acts upon cholinergic mesopontine tegmentum neurons the results of the c-fos studies 
need to be treated with caution.  
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The laterodorsal tegmental nucleus 
The laterodorsal tegmental nucleus (LDTg) is located below the fourth ventricle, and is 
largely embedded within the periaqueductal gray. LDTg neurons are present as far back as the 
locus coeruleus and extend forward to the level of the pPPTg and dorsal raphe nucleus; at the 
anterior level, the LDTg extends out of the periaqueductal gray to merge, below the superior 
cerebellar peduncle with the pPPTg to form the so-called subpeduncular tegmental nucleus 
(Mesulam et al., 1983; Paxinos and Watson, 2005); for review see:(Maskos, 2008). It is thus 
both medial and dorsal to the PPTg, with some overlap in the anterior-posterior plane. In 
terms of composition and connectivity, the LDTg shares several key features with the PPTg, 
particularly possession of cholinergic neurons. LDTg cholinergic neurons were designated the 
Ch6 group by Mesulam et al. (1983) - the PPTg cholinergic neurons being the Ch5 group - and it 
is the second major cholinergic structure in the mesopontine tegmentum. 
 
Structure of LDTg 
In a manner comparable to the PPTg, the LDTg is comprised primarily of an 
interdigitated collection of cholinergic, glutamatergic and GABAergic neurons with a 
heterogeneous distribution of these neuronal types along the anterior-posterior plane (Wang 
and Morales, 2009). Glutamatergic and GABAergic neurons comprise the bulk of the LDTg and 
are roughly equal in proportion (38% and 40% of total neuronal population, respectively) with 
cholinergic neurons in a more distant third place (22%) (Wang and Morales, 2009). However, 
like the PPTg, much of the older literature on the LDTg refers to it as a prominently cholinergic 
structure and it is only recent histological studies which have highlighted the need to change 
this view. Cholinergic neurons are most densely packed in the region of the dorsal medial LDTg 
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(mLDTg) with those extending outside this region along the superior cerebellar peduncle 
forming a more sparse and scattered arrangement (Inglis and Semba, 1997; Wang and 
Morales, 2009). LDTg cholinergic neurons share many common properties with PPTg 
cholinergic neurons: The use of in situ-hybridisation has shown both LDTg and PPTg cholinergic 
neurons have very low rates of co-expression of either glutamate or GABA (<3%) (Wang and 
Morales, 2009); both LDTg and PPTg cholinergic neurons express the UII receptor (Clark et al., 
2001); both also express NOS (Vincent and Kimura, 1992) (almost non-existent in non-
cholinergic mesopontine tegmentum neurons); cholinergic neurons of both structures have 
very low levels of expression of the calcium binding proteins calbindin, parvalbumin and 
calretinin (Dun et al., 1995; Fortin and Parent, 1999) (which are expressed by non-cholinergic 
mesopontine tegmentum neurons) and cholinergic neurons of neither structure express the 
P75 low affinity nerve growth factor found on basal forebrain cholinergic neurons (Richardson 
et al., 1986; Knusel and Hefti, 1988).  
 
Connectivity of LDTg (and comparison to PPTg) 
The connectivity of the PPTg has been extensively discussed previously (chapter 1, 
pp5-11) and will only be mentioned here in comparison to LDTg connections. The literature on 
mesopontine tegmentum connections is extensive and there are aspects common to many of 
these reports which should be mentioned before reviewing it. As in the case with the PPTg, 
there is no reliable histochemical or immunohistochemical marker of LDTg glutamatergic or 
GABAergic neurons. Therefore, before the frequent use of in-situ hybridisation (which does 
have reliable markers of the three main neuronal types) any distinction between neuronal type 
is generally not made or only considered in terms of “cholinergic” versus “non-cholinergic”. 
The LDTg makes both ipsilateral and contralateral projections, but the distinction between the 
two is not always assessed, making a comparison of ipsilateral and contralateral not possible 
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for all projections. Finally, many studies only address either the PPTg or the LDTg. Therefore, if 
a projection between the LDTg and another structure is characterised with no mention of the 
PPTg, it is unclear if this is because there was no projection originating in the PPTg, or if the 
PPTg was not assessed. Consequently distinctions between PPTg and LDTg projections will only 
be mentioned when they have been explicitly documented.  
Inputs to the LDTg are not well characterised, with many articles referring to several 
key studies from the 1980s and 1990s (Satoh and Fibiger, 1986; Cornwall et al., 1990; Semba 
and Fibiger, 1992). These provide an extensive list of structures containing neurons showing 
positive for tracer after retrograde injection into the LDTg (some structures were also verified 
with anterograde tracer). While excellent studies for their time, the techniques and methods 
used are now somewhat dated and unfortunately mean a detailed assessment of connections 
cannot be ascertained from them. More recently, a small selection of detailed investigations 
looking at particular structures have been conducted. A brief summary of the most relevant 
inputs from all of these studies will be given; however the original research articles should be 
consulted for the full details of the tracing studies (in particular see:(Cornwall et al., 1990; 
Semba and Fibiger, 1992).  
Inputs to LDTg arise from a broad range of brain regions extending from the brainstem 
to the prefrontal cortex. Both the LDTg and PPTg receive “massive inputs” from the reticular 
formation and entire brainstem, with no clearly defined differential pattern of connections 
(Semba and Fibiger, 1992). In terms of midbrain systems, both the LDTg and PPTg receive input 
from SNr (with an apparent dominance of caudal SNr projections to LDTg, whereas PPTg 
receives output from the entire SNr). In addition to this, PPTg receives input from other BG 
structures that do not appear to project so heavily to LDTg (Semba and Fibiger, 1992; Mena-
Segovia et al., 2004a; Kita and Kita, 2011). The lateral habenula, lateral hypothalamus, 
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midbrain central grey and rostromedial tegmental nucleus all project to LDTg, with the 
habenula appearing to have preferential projections to LDTg over PPTg (Cornwall et al., 1990; 
Semba and Fibiger, 1992; Jhou et al., 2009a; Jhou et al., 2009b). The amygdala projects to PPTg 
and LDTg, with an apparent dominance to PPTg (Semba and Fibiger, 1992; Zahm et al., 2001) 
and frontal and medial prefrontal cortex project more strongly to LDTg than PPTg (Cornwall et 
al., 1990; Semba and Fibiger, 1992). 
The outputs of the LDTg are somewhat better characterised and can be classified as 
projecting to: (1) other brainstem sites, (2) midbrain, BG and thalamus, (3) other subcortical 
and cortical areas. (1) LDTg innervates other brainstem and pontine nuclei, including 
contralateral LDTg and PPTg, PnO, RMTg, interpeducular nucleus, and structures involved in 
early visualmotor processing (interstitial nucleus of the medial longitudinal fasciculus, 
paramedian regions of the pontine reticular formation and medial terminal nucleus) (Cornwall 
et al., 1990; Semba and Fibiger, 1992; Jhou et al., 2009b). (2) Both the LDTg and PPTg send 
strong cholinergic and non-cholinergic projections to midbrain DA neurons. As discussed, these 
form a topographical gradient whereby aPPTg preferentially projects to SNc, pPPTg projects to 
VTA and SNc and the LDTg essentially only innervates the VTA with only very few projections 
to SNc (Satoh and Fibiger, 1986; Gould et al., 1989; Cornwall et al., 1990; Oakman et al., 
1995a); for review see:(Maskos, 2008). Both structures innervate the thalamus (indeed 
essentially all thalamic nuclei receive innervation from the cholinergic mesopontine 
tegmentum (Hallanger et al., 1987; Hallanger and Wainer, 1988), again with what appears to 
be a differential (but not well defined) pattern of projections: For example LDTg innervates the 
mediodorsal and anterior thalamic nuclei (which in turn is not substantially innervated by the 
PPTg) (Shibata, 1992) but LDTg also innervates other thalamic nuclei and the hypothalamus 
which are conjointly innervated by PPTg. While the LDTg projects to the STN, this is to a 
considerably smaller extent than the projections arising from PPTg (Bevan and Bolam, 1995; 
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Kita and Kita, 2011). LDTg sends cholinergic and possibly non cholinergic projections to the 
superior colliculus (however projections from the PPTg are twice as numerous) and this 
projection is predominantly ipsilateral (Motts and Schofield, 2009). LDTg and PPTg connections 
to the PnC place the cholinergic mesopontine tegmentum in part of the primary startle 
circuitry (Fendt et al., 2001; Bosch and Schmid, 2008). (3) LDTg and PPTg innervate the 
cholinergic basal forebrain (Woolf and Butcher, 1986) and LDTg innervates the prefrontal 
cortex (Semba and Fibiger, 1992), “hippocampal cortex” and septum (Cornwall et al., 1990) 
(which do not appear to be innervated by PPTg; however PPTg manipulation does affect 
hippocampal theta activity, but this is believed to be mediated through secondary structures 
such as RPO (Nowacka et al., 2002)). Within these projections there are a large number of 
collateral projections: single LDTg (especially cholinergic) neurons form collateral projections 
to several of the key output structures (Bolton et al., 1993), which is also the case for single 
PPTg cholinergic neurons (Mena-Segovia et al., 2008b).  
While both LDTg and PPTg share many prominent connections, a subtle divergence 
between them emerges. In addition to the common connections, PPTg is far more intricately 
connected to basal ganglia circuitry than LDTg and in turn the LDTg is more integrated to limbic 
and visuomotor control circuits than the PPTg. This has led some authors to speculate that 
PPTg and LDTg may share common functions but that PPTg may be more specialised for 
‘motor’ functions whereas LDTg would have a stronger contribution to ‘limbic’ processing 
(Nemcova et al., 2000; Jenkins et al., 2002). The definition of motor is ambiguous here and 
could lead to confusion (for example, does it mean simple motor movement, or include motor 
processes such as action selection?). However, if it is replaced with ‘BG interfaced’ the 
distinction is still useful in highlighting the preferential interconnection between the PPTg and 
BG and LDTg to limbic structures. 
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Functions of the LDTg 
Historically the LDTg (along with the PPTg) has been considered to form a major 
component of the ascending reticular activating system and contemporary research finds that 
both structures are associated with changes in the generation of cortical EEG across 
behavioural states and are active during REM sleep (Maloney et al., 1999; Verret et al., 2005; 
Mena-Segovia et al., 2008b). However, given its diverse connections, the LDTg is in a position 
to influence far more than cortical EEG. Bilateral non-selective excitotoxic LDTg lesions have 
been shown to reduce baseline levels of locomotion (measured in photocell cages) and abolish 
the locomotor changes induced by systemically administered nicotine (Alderson et al., 2005). 
In a different study, measurement of locomotion by observational scoring over a 2 min period 
found excitotoxic LDTg lesions did not affect locomotion, but increased amphetamine induced 
stereotypy and decreased morphine induced stereotypy (Forster and Blaha, 2000). 
Chronoamperometric measurement of NAcc DA release in the same experiment found 
diminished DA release to morphine and enhanced DA release to amphetamine in the lesion 
group. This firmly linked LDTg manipulation to altered striatal DA activity, believed to be 
mediated through efferent connectivity to VTA. In fitting with LDTg having a functional 
connection to the VTA, inactivation of the LDTg by combined muscimol and baclofen infusion 
has been shown to essentially block VTA burst firing (Lodge and Grace, 2006). Several recent 
reviews have stressed the importance of cholinergic modulation of the VTA (Maskos, 2008; 
Mena-Segovia et al., 2008a) claiming it is a ‘master modulator’ of the DA system. There is good 
evidence from slice preparations that midbrain DA neurons cannot switch to burst firing mode 
without cholinergic innervation, a substantial proportion of which originates in the LDTg and 
pPPTg (see general introduction, pp36-38 for further discussion). Based on this it would be 
expected that combined depletion of LDTg and pPPTg cholinergic neurons would cause severe 
VTA dysfunction with behavioural consequences including learning impairment and altered 
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response to dopaminergic manipulating drugs. Given the extensive innervation of thalamus 
and the VTA, combined with the theoretical reasoning for involvement of these systems in DA 
modulation, it is surprising there are not more cognitive behavioural assessments of animals 
bearing LDTg manipulations (indeed, there are more studies on the LDTg and bladder state 
(Koyama et al., 1999) than there are on LDTg and instrumental learning). Excitotoxic lesions of 
the LDTg do affect the startle response – reducing PPI but not affecting startle amplitude 
(Jones and Shannon, 2004) and similar results have been shown after PPTg inactivation 
(Diederich and Koch, 2005); see general introduction, pp18-19 for discussion of PPTg and PPI). 
The types of behaviour discussed above show that there is a striking similarity between 
behaviours associated the LDTg and those associated with the PPTg, and given the common 
neuronal compositions and connections, this is not surprising. However, the similarities 
between the LDTg and PPTg should not mask the subtle yet important differences, which can 
be broadly summarised as:  (1) LDTg to midbrain DA connections are generally restricted to the 
VTA, whereas the PPTg projects to both VTA and SNc; (2) While the LDTg is connected to some 
major BG sites, the PPTg is much more closely integrated into the BG; (3) While both structures 
innervate the thalamus, the pattern of nuclei targeted changes across the PPTg and LDTg; (4) 
There are no reported assessments of the effects of LDTg manipulation on learning; it is 
unclear if this is due to having not being investigated or due to the non-publication of negative 
results; (5) In the literature the PPTg is discussed in terms of locomotion far more than the 
LDTg. This is largely due to the notion that the PPTg forms part of the functionally defined 
mesencephalic locomotor region. Strong evidence stands against considering the PPTg as a 
motor structure and indeed the finding that LDTg and not PPTg lesion affects baseline levels of 
locomotion immediately highlights the lack of robustness in this distinction between PPTg and 
LDTg. As LDTg and PPTg share many common properties while also retaining features unique 
to each structure, this has led some authors to suggest that some functions may be distributed 
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– or shared – across the entire PPTg-LDTg system, with the combined effects being a “dynamic 
balance” of function (Nemcova et al., 2000; Jenkins et al., 2002). The experiments conducted 
in chapter 5 and 6 addressed the possible functional role of cholinergic pPPTg to VTA 
projections and found that selective cholinergic lesions of the pPPTg were without behavioural 
effect. The next logical step in the investigation of mesopontine tegmentum to midbrain DA 
cholinergic projections is therefore to cause greater disruption of the cholinergic projection to 
midbrain by lesioning the cholinergic LDTg in addition to the pPPTg. A near total lesion of both 
structures would remove the most substantial cholinergic input to midbrain DA, an input 
believed to be a ‘master modulator’ of these systems and essential for the switch of DA 
neurons from baseline to burst firing.  
 
Dtx-UII in the LDTg 
There are no published studies of selective cholinergic lesions of the LDTg or reports 
using Dtx-UII in the LDTg. However, because LDTg cholinergic neurons selectively express the 
UII receptor (Clark et al., 2001) there is good reason to believe Dtx-UII should be as effective in 
the LDTg as it is in the PPTg. 
 
Specific chapter aims 
The aims of this chapter are to establish the feasibility and parameters for creating 
selective cholinergic lesions of the LDTg, and combined selective cholinergic lesions of the 
pPPTg and LDTg. The feasibility applies to both the surgical procedure itself and effects on the 
rats health during the lesion formation period. While selective cholinergic pPPTg lesions are 
without ill effect on health, it was unknown what the effects of combined LDTg and pPPTg 
lesions would be. 
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Getting at the LDTg 
In the rat, because of its location ventral to the fourth ventricle and proximity to both 
the lambdoid and midline suture, surgically targeting the LDTg is challenging. Fixing the rat in 
the flat skull position (bregma and lambda at equal elevations) and lowing a syringe or pipette 
down the dorsal-ventral plane can lead to extensive bleeding from the major midline blood 
vessels and penetration of the ventricle, which in turn can lead to seeping of toxin up the 
syringe needing tack into the ventricle itself. There are reports of the LDTg being successfully 
lesioned with excitotoxins in this manner (Alderson et al., 2005). However, most laboratories 
use an approach where the arm of the stereotaxic frame is angled in the mediolateral plane, 
which results in the LDTg being targeted from a dorsolateral position and the needle (or 
pipette) passing beside the ventricle rather than through it (Blaha et al., 1996; Inglis and 
Semba, 1997; Jones and Shannon, 2004) (It should be noted that this technique angles the 
infusion in a different plane to the technique used in chapters 4, 5 and 6 in which the pipette 
approaches the target in the anteroposterior plane). This, however, does not avoid the 
problems with bleeding from around the lambdoid suture. As one aim here is to create 
combined LDTg and pPPTg lesions, doing this in the flat skull position would require extensive 
drilling above the lambdoid and midline sinus (essentially removal of the entire skull over 
lambda and ~2 mm lateral on either side). Instead the decision was taken to target the LDTg in 
the same manner as had been successfully used for the PPTg in previous chapters – keeping 
the arm of the stereotaxic frame vertical and raising rats’ noses to an elevated position such 
that the angle between the horizontal plane of the IAL and the incisor was 8˚ 29ʹ. Thus the 
craniotomies are drilled in front of lambda and the risk of disruption of major blood vessels in 
combined pPPTg/LDTg surgeries reduced. Keeping the arm vertical does not avoid proximity to 
the ventricle and the possibility of diffusion of toxin into it, but it is hoped that the use of fine 
tipped glass pipettes and a delay between infusion and removal of the pipette will help 
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overcome this. The study which targeted the LDTg directly through the ventricle used glass 
pipettes and was successful in creating well placed excitotoxic lesions (Alderson et al., 2005). A 
third option, being piloted in at least one laboratory, involves angling the arm of the 
stereotaxic frame in both the mediolateral and anteroposterior plane, this avoids both the 
lambdoid blood vessel and the ventricle (Clark SD, personal communication, 2010). However 
this “double angle” method introduces another margin for error as well as testing the accuracy 
of the stereotaxic frame, and so this approach was decided against at this stage. 
 
Area of the LDTg to target 
 When lesioned with excitotoxins it has been reported that two small infusions along 
the length of the LDTg produce lesions with less damage to surrounding structures than one 
larger infusion (Inglis and Semba, 1997). However, as the majority of LDTg cholinergic neurons 
are located within the mLDTg, and as Dtx-UII should be selective for UII expressing neurons 
(making possible damage to surrounding structures less likely) the initial experiments were 
conducted with a single infusion aimed at the mLDTg. A subsequent second and third 
experiment attempted to use two infusions to cover more of the LDTg.  
 
LDTg lesion experiment 1 
Methods 
Subjects 
Twelve adult male Lister-Hooded rats (Harlan Olac Ltd, Bicester, UK) were used with a 
mean weight of 444g (range 410-489g) at the time of surgery. Animals were housed and 





 As there are no published reports targeting the LDTg with the rats nose raised in the 
stereotaxic fame, there are no previous studies to base an infusion co-ordinate on. Therefore, 
a co-ordinate was estimated based on that used for the pPPTg and consultation of the rat 
brain atlas of Paxinos and Watson (2005). In order to verify and refine this, an infusion of cresyl 
violet dye was performed under terminal anaesthesia (using the surgical procedure described 
in the general methods) in 2 rats. After transcardial perfusion with fixative (following the 
procedure in the general methods) sections were cut through the LDTg, mounted on glass 
slides and examined under a light microscope. See figure 7.1 for example placement. Based on 
the results of this analysis the following co-ordinates were considered acceptable possibilities 
for toxin infusion: (1) -1.0 mm from IAL; ±0.4 mm from midline; -5.9 mm from dura, (2) -1.1 
mm from IAL; ±0.4 mm from midline; -5.9 mm from dura, (3) -1.2 mm from IAL; ±0.4 mm from 







Figure 7.1: Photograph of tissue from a brain infused with cresyl violet dye for co-ordinate refinement. 
The approximate location of the mLDTg is indicated by the black dashed spheres. The left red arrow 
indicates the presence of cresyl violet immediately ventral to the mLDTg, the right red arrow indicates 






Anaesthesia was induced and lesion surgery performed as described in the general 
methods. Rats were bilaterally infused (order of infusion counterbalanced across rats) with 
300nL of Dtx-UII at the co-ordinates stated above. Four rats were infused at co-ordinates (1) 
and (2) and 2 rats at co-ordinate (3). No sham surgeries were performed, analysis of previous 
sham rats from pPPTg experiments served as the control group. 
 
Histology 
All histological procedures followed the methods described in the general methods. 
Briefly, after allowing >21 days for lesion formation (during which time no adverse effects 
were noticed), rats were transcardially perfused with fixative and brains stored in sucrose 
solution. Subsequently, 30 µm coronal sections were cut through the area of the LDTg, PPTg 
and ~1mm beyond in anterior-posterior plane. Parallel 1:4 series were processed 
immunohistochemically for ChAT and NeuN reactivity. Sections were mounted onto glass 
slides, NeuN stained sections were then counterstained with cresyl violet and all sections 
viewed under a light microscope. Cholinergic cell loss was judged by assessment on the ChAT 
stained sections, non-selective damage was assessed by inspection of the NeuN/Cresyl stained 




Four rats had evidence of damage to the LDTg cholinergic neurons: in 2 cases these 
were selective cholinergic lesions (no evidence of damage on NeuN stain over and above loss 
of cholinergic neurons) and the remaining two had some evidence of non-selective damage. 
The location of the non-selective damage below the LDTg in one of these rats suggested that 
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the centre of the infusion was below the LDTg. In all cases the lesions were often 
asymmetrical, causing considerable damage on one side and only moderate or small amounts 
of damage on the other, again the infusions appeared to be too ventral and possibly cantered 
at the most ventral areas of or even just below the LDTg. However, 1 rat had no evidence of 
ChAT or NeuN damage but on the NeuN stain had what appeared to be evidence of pipette 
tips located within the LDTg. The 5 remaining rats had no evidence of lesion at all. In these rats 
it was generally not possible to definitively confirm the end of the pipette track. Given the 
small size of the 40 - 50 µm tipped glass pipettes and angle of insertion meaning the track is 
only visible briefly on each section, it is not uncommon to be unable to follow the track 
damage to a certain end point. The vicinity to the ventricle proved establishing the end of the 
track even harder for the LDTg infusions. No clear pattern emerged when comparing to the co-
ordinates used, one lesion was from the AP IAL -1.0 mm group, 2 from the IAL -1.1 mm group 
and 1 from the IAL -1.2 mm group. 
 
 




Figure 7.2: Photograph of ChAT stained sections form a control rat (left panel) and a rat infused with Dtx-





Conclusions of LDTg lesion experiment 1 
 This experiment established that the Dtx-UII toxin can destroy cholinergic LDTg 
neurons and moreover, can destroy these neurons without creating extensive non-selective 
damage. However it failed to created successful, extensive bilateral selective cholinergic LDTg 
lesions. While the co-ordinates used placed the infusion in the vicinity of the LDTg, there was 
an apparent trend for the infusion be too ventral and possibly even missing the LDTg in some 
rats. Based on this, a second lesion experiment was performed with two additional co-
ordinates: -1.1 mm from IAL; ±0.4 mm from midline; -5.7 mm from dura and -1.1 mm from IAL; 
±0.4 mm from midline; -5.5 mm from dura (the most successful co-ordinate used here with the 
DV raised by 0.2 mm and 0.4 mm respectively). It was also decided to attempt combined 
pPPTg and LDTg lesions by infusing DTx-UII into the pPPTg (using the same method as that 
used in chapter 4) in addition to the LDTg in a subset of these rats. 
 
LDTg lesion experiment 2 
Subjects 
Twelve adult male Lister-Hooded rats (Harlan Olac Ltd, Bicester, UK) were used, with a 
mean weight of 345g (range 308-371g) at the time of surgery. Animals were housed and 
maintained as described in the general methods.  
 
Surgery 
Anaesthesia was induced and lesion surgery performed as described in the general 
methods. Rats were split into the infusion groups described in table 7.1 and had 300 nL of 3% 
DTx-UII infused bilaterally at the appropriate stereotaxic co-ordinate, the order of infusion (left 
hemisphere, right hemisphere, LDTg first, pPPTg first) was counterbalanced across rats. No 
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sham surgeries were performed, analysis of previous sham rats form pPPTg experiments 
























Table 7.1: Surgical groups in LDTg lesion experiment 2. All co-ordinates are measured in mm and are in 




All histological procedures followed the methods described in the general methods. 
Briefly, after allowing >21 for lesion formation (during which time no adverse effects were 
noticed), rats were transcardially perfused with fixative and brains stored in sucrose solution. 
Subsequently, 30 µm coronal sections were cut through the area of the LDTg, PPTg and ~1mm 
beyond in anterior-posterior plane. Parallel 1:4 series were processed immunohistochemically 
194 
 
for ChAT and NeuN reactivity. Sections were mounted onto glass slides and NeuN sections 
were then counterstained with cresyl violet and all sections viewed under a light microscope. 
Cholinergic cell loss was judged by assessment on the ChAT stained sections, non-selective 




In a very similar manner to LDTg lesion experiment 1, damage to the LDTg was either 
only partial or unilateral. Four rats had partial selective cholinergic lesions with evidence of 
ChAT cell loss in both hemispheres, but this cell loss never approached a near complete level 
(see figure 7.3). These rats were from the new co-ordinate groups DV +0.2 mm (n = 2) and DV 
+0.4 mm (n = 2). 2 rats had unilateral LDTg damage (both from the original LDTg co-ordinate) 
with only low levels of non-selective damage. Of the combined LDTg and pPPTg lesions, 1 rat 
had a successful pPPTg lesion and a partial LDTg lesion which, at both targets, was selective for 
cholinergic neurons. The remaining combined LDTg/pPPTg rats had low levels of pPPTg 
cholinergic cell loss (n = 2) or no clear pPPTg cell loss (n = 2) and in all cases no extensive LDTg 
damage. The 1 remaining rat (LDTg only, co-ordinate from previous LDTg experiment used) 















Figure 7.3: Photograph of ChAT (left panels) and NeuN/cresyl (right panels) stained sections form a 
control rat (top panels) and a rat infused with Dtx-UII into the LDTg (bottom panel). Arrows indicate the 
location of the LDTg. 
 
 
Conclusions of LDTg lesion experiment 2 
 Lesion experiment 2 resulted in a higher proportion of rats having some signs of LDTg 
damage, which was nearly always selective for cholinergic neurons. The altered co-ordinate -
1.1 mm from IAL; ±0.4 mm from midline; -5.7 mm from dura appeared to be the most 
successful. However the small group sizes meant establishing a clear difference between this 
co-ordinate and the second new co-ordinate -1.1 mm from IAL; ±0.4 mm from midline; -5.5 
mm from dura (DV 0.2 mm higher) was not possible. The original LDTg co-ordinate had the 
lowest success rate and often resulted in unilateral damage. That only 1/4 rats in the 
combined LDTg/pPPTg lesion groups had a good pPPTg lesion (with the rest having small or no 
signs of lesion) was surprising and the low levels of LDTg loss in these rats was disappointing. It 
was feared that combining the LDTg and pPPTg lesions might lead to extensive non-selective 
damage (due to the large volume of Dtx-UII being infused into the mesopontine tegmentum). 
There is no clear explanation for the low levels of cell loss seen in the pPPTg other than (based 
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on the lesions in chapter 5 and 6) Dtx-UII does not have a 100% success rate (even when the 
target structure is hit) and in each batch of surgery a small yet considerable proportion of rats 
have had to be excluded from the analysis for having no or small signs of lesion. However, the 
success rate here of 1/4 is considerably less than normal (around 75% of rats normally have at 
least some signs of lesion). One explanation for the LDTg lesions being partial rather than 
complete may be that not enough toxin is infused. The area of LDTg being targeted (mLDTg) 
has considerably (46%) more cholinergic neurons than the pPPTg, and they may also be more 
densely packed than pPPTg cholinergic neurons (Wang and Morales, 2009). Therefore, it is 
possible the dose of toxin used for the pPPTg is insufficient for the LDTg. In order to investigate 
this, it was decided to run another lesion study increasing the amount of toxin infused into the 
LDTg. This was achieved in two ways: the first was to infuse 300 nL into two co-ordinates 
within the LDTg (at each of the new co-ordinates used in this study, it was feared that a single 
of infusion of 600 nL would lead to non-selective damage); the second was to increase the 
toxin concentration from 3.0% to 3.2%. The seemingly cautious increase of toxin concentration 
by 0.2% was based on the results of chapter 4 which show that a Dtx-UII concentration of 4.0% 
causes substantial non-selective damage in the pPPTg. 
 
LDTg lesion experiment 3 
Subjects 
Eight adult male Lister-Hooded rats (Harlan Olac Ltd, Bicester, UK) were used, with a 
mean weight of 323g (range 313-330g) at the time of surgery. Animals were housed and 






Anaesthesia was induced and lesion surgery performed as described in the general 
methods. Rats were split into the infusion groups described in table 7.2 and had 300nL of Dtx-
UII infused bilaterally at the appropriate stereotaxic co-ordinate and toxin concentration. The 
order of infusion (left hemisphere, right hemisphere, LDTg first, pPPTg first, was 
counterbalanced across rats). No sham surgeries were performed, analysis of previous sham 
rats form pPPTg experiments served as the control group. One rat died the night after surgery: 
this was from the combined 3.0% LDTg/pPPTg infusion group. There had been extensive 
bleeding from the midline sinus during surgery and this rat was noticeably quieter than the 

















Table 7.2: Infusion groups in LDTg lesion experiment 3. All co-ordinates are measured in mm and are in 




All histological procedures followed the methods described in the general methods. 
Briefly, after allowing >21 for lesion formation (during which time no adverse effects were 
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noticed), rats were transcardially perfused with fixative and brains stored in sucrose solution. 
Subsequently, 30 µm coronal sections were cut through the area of the LDTg, PPTg and ~1mm 
beyond in anterior-posterior plane. Parallel 1:4 series were processed immunohistochemically 
for ChAT and NeuN reactivity. Sections were mounted onto glass slides and NeuN sections 
were then counterstained with cresyl violet and all sections viewed under a light microscope. 
Cholinergic cell loss was judged by assessment of the ChAT stained sections, non-selective 






  The results of the third pilot study are very similar to the first two. Four out of the 
seven rats which had LDTg infusions had evidence of selective cholinergic damage to the LDTg, 
again this was only partial (estimated at not more than 50% ChAT cell loss) and the remaining 
3 rats had no clear signs of any LDTg lesion. Of the 5 rats which received combined LDTg/pPPTg 
infusions, 3 had partial selective cholinergic lesions with the remaining 2 having no clear sign 
of damage. None of the pPPTg lesions resulted in near-total loss of ChAT+ neurons and had an 
estimated 25-60% of ChAT+ cells remaining. Two of the partial pPPTg lesions were in rats 
which also had partial LDTg lesions (shown in figure 7.4). The 3.2% concentration produced 
more reliable cell loss than the 3.0% (every rat infused with 3.2% had some damage in either 
LDTg or pPPTg, whereas 2 of the 3.0% group had no signs of lesions) however it should be 
noted that none of the pPPTg lesions (even those infused with 300nL of 3.2% toxin) were as 











Figure 7.4: Photograph of ChAT (panels A‐D) and NeuN/cresyl (panels E‐H) stained
sections form a control rat (panels A,B,E,F) and a rat infused with Dtx‐UII into the LDTg




Conclusions of LDTg lesion experiment 3 
 Despite doubling the volume and increasing the concentration of Dtx-UII used, the 
third pilot study failed to produce extensive lesions of the LDTg. Moreover, the pPPTg lesions 
were smaller and less reliable than in previous chapters. This is true even for the rats which 
had 300 nL of 3.2% toxin infused into the pPPTg. As this is a stronger concentration and a 
higher volume than has successfully produced pPPTg lesions in previous chapters (chapters 5 
and 6 both had extensive selective cholinergic lesions with 200 nL of 3.0% toxin) it is a 
somewhat surprising finding. Taken together the continued finding of very low levels of 
cholinergic cell loss despite evidence of successful pipette placement suggests that there is 
now a systematic failure in the lesion procedure.  
 
Chapter discussion 
The aim of this chapter was to verify that the Dtx-UII toxin is effective at selectively 
lesioning cholinergic LDTg neurons and to establish the feasibility and parameters for creating 
combined selective bilateral lesions of both the pPPTg and LDTg. These aims were partially 
met: bilateral delivery of toxin into the LDTg from a glass pipette was successful, the Dtx-UII 
toxin destroyed cholinergic neurons without creating significant non-selective damage, 
confirming that this toxin is effective in the LDTg. However, lesions in general were small and 
unreliable, rats receiving infusions into both the pPPTg and LDTg showed only small lesions in 
each structure which was not overcome by increasing both the concentration and volume of 







Possible reasons for partial lesions 
 There are several explanations to be considered for the lack of substantial cholinergic 
lesions within the LDTg. (1) It is possible that the toxin is ineffective in this structure, though 
this is unlikely because the cholinergic neurons express the UII receptor to which the toxin 
binds (Clark et al., 2001). Moreover, some cholinergic cell loss is seen, confirming that the 
toxin can destroy these neurons. (2) It is possible that the amount of toxin delivered was 
insufficient to destroy the sheer number of cholinergic neurons within the LDTg. This was 
addressed by the third lesion experiment which systematically increased both the volume and 
concentration of toxin used and found that with over double the amount of toxin infused into 
the LDTg the lesions were not substantially different to smaller infusions. While the density of 
cholinergic neurons within LDTg is likely to affect the amount of toxin required to destroy 
them, it seems this alone is not an explanation for the small lesions. (3) It is possible that the 
toxin is not being delivered into the LDTg or is diffusing away rapidly (for example into the 
ventricle). This is a serious concern: the presence of signs of pipette tips within the LDTg 
suggests that the toxin is being delivered correctly, but the possibility of seepage into the 
ventricle is harder to asses. Circumstantial support for this not being a problem comes from an 
LDTg excitotoxic lesion study, where 400 nL of toxin (i.e. less than the total volume of some of 
the infusions performed here), again delivered into the LDTg from a glass pipette which went 
through the ventricle, was sufficient to create extensive non-selective LDTg lesions (Alderson 
et al., 2005). However, it should be noted that while the Alderson et al. (2005) study 
succeeded in creating excitotoxic LDTg lesions, examination of all the histological results from 
that and other unpublished studies in this laboratory, together with reports from other 
laboratories, show that this is a problematic and often unsuccessful procedure (Inglis and 
Semba, 1997). A way of reducing the possibility of diffusion into the ventricle would be to 
target the LDTg at an angle along the mediolateral plane (Inglis and Semba, 1997). However, 
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none of these concerns address the second finding from these experiments: the very low levels 
of cholinergic cell loss observed in the pPPTg of rats which had Dtx-UII infused into both the 
pPPTg and LDTg. In the second pilot study (there were no combined lesions in the first pilot) 
1/4 pPPTg lesions was successful, in the third pilot study 1/6 pPPTg lesions were successfully 
bilaterally, this was despite using stronger toxin (3.2% rather than 3.0%) and larger infusions 
(300 nL rather than 200 nL) than had proved successful in previous chapters. One possibility is 
that the addition of the LDTg infusion renders the pPPTg infusion unsuccessful, however, this 
seems very unlikely. A second possibility is that the stock of Dtx-UII had deteriorated and lost 
potency or become inactive for another unknown reason. A period of 14 months elapsed 
between the last successful pPPTg lesions (chapter 6 – nicotine locomotion) and the combined 
pPPTg and LDTg infusions attempted here. In contrast to this, all the successful pPPTg lesions 
(chapters 4, 5 and 6) were conducted within an 11 month period before the 14 month gap. It is 
unclear how long the Dtx-UII should maintain potency, ex vivo testing of the toxin to assess its 
potency requires cell lines not available here (Clark SD, personal communication). One solution 
would be to continue the experiments with a new batch of Dtx-UII. The toxin is not 
commercially available, being manufactured and supplied through collaboration with Dr Clark 
at University of California, Irvine (now at SUNY, University at Buffalo) who is willing and able to 
construct fresh toxin. However, the manufacturing time is around 3 months (Clark SD, personal 
communication). Given that a new batch of toxin would also need en vivo testing (which would 
take approximately 6 weeks), due to the time constraints of this thesis it was not possible to 







Since conducting these experiments a poster presentation at the 2011 annual Society 
for Neuroscience meeting (Washington DC) reported that Dtx-UII toxin had successfully been 
used to destroy around 80% of LDTg cholinergic neurons bilaterally (Steidl et al., 2011). While 
the histological assessment of non-selective damage had not been completed, this confirms 
that the Dtx-UII is able to cause extensive lesions to the LDTg. This gives further support to the 
view that if the co-ordinates and procedures reported here were repeated with new Dtx-UII, 








Summary of aims and results: 
The aim of this work was to examine the role of the PPTg in associative learning, with 
particular emphasis on: (1) establishing if a functioning PPTg is required for normal action-
outcome learning and (2) examining the contribution of cholinergic pPPTg neurons to learning. 
Using a contingency degradation paradigm, it was shown in chapter 3 that a 
functioning pPPTg is essential for the updating of associations between actions and outcomes. 
In this paradigm the relationship between action (lever press) and outcome (pellet delivery) 
was degraded such that, in the degraded condition, pellets were delivered with the same 
probability whether the rat executed a correct response or not. Rats with intact monitoring of 
the actions they perform and the outcomes these produce are highly sensitive to this 
manipulation and accordingly reduce the number of actions they perform. This pattern was 
evident in saline treated rats: rates of lever pressing significantly reduced across degradation 
sessions and were significantly lower than contingent controls in the extinction test. In 
contrast, pPPTg inactivation (by direct microinfusion of muscimol) blocked sensitivity to 
contingency degradation: lever pressing was not significantly different between the contingent 
and non-contingent groups at any point in contingency training or the extinction test. This was 
not a deficit in ability to lever press, for rats in the muscimol contingent and non-contingent 
groups pressed at the same rate as the saline contingent group. Rather, it was a specific deficit 
in adapting behaviour in response to the change in contingency, a defining characteristic of 
impairment in updating the association between actions and outcomes. In addition to this 
main finding, the finding that muscimol contingent and saline contingent rats continued to 
lever press at the same rate, reinforces two additional points suggested by previous studies: 
(1) loss of the pPPTg has no impact on the ability to lever press; (2) inactivation of the pPPTg 
does not affect the motivation to work for or the incentive salience value of rewards. 
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These results extend significantly the previous studies showing learning impairments 
after PPTg lesion (for review see: chapter 1, pp20-25). Rats bearing bilateral excitotoxic PPTg 
lesions were unable to learn or perform radial maze tasks in which reward location varied on 
every trial, making the relationship between action (which arm of the maze to enter) and 
outcome (successful reward retrieval) unpredictable (Keating and Winn, 2002; Taylor et al., 
2004). Alderson and colleagues (2004) found that rats with PPTg lesions were impaired at 
learning to lever press on a FR2 schedule of reinforcement for intravenous amphetamine, but 
unimpaired if they had learned prior to lesion that lever pressing was rewarded. However, 
both naïve and trained PPTg lesioned rats were unable to respond properly when on a 
progressive ratio schedule of reinforcement in which the relationship between outcomes and 
actions (the number of presses required) constantly changed (Alderson et al., 2004). More 
recently, it has been shown that pPPTg lesioned rats were slow to learn to lever press during 
the initial stages of simple operant learning, and though with extended training they did learn 
the task, they were subsequently again slow to adapt their rates of lever pressing in response 
to changes in reinforcement schedule (Wilson et al., 2009a). These findings can be explained 
by a deficit in A-O learning: it is during initial learning and when situations change that the 
updating of A-O association is performed and where impairment would slow learning.  
In chapter 4 the parameters for and feasibility of creating bilateral lesions highly 
selective for cholinergic pPPTg neurons were established. Subsequently, the effect of these 
lesions on locomotion and sucrose consumption was assessed. Substantial loss of cholinergic 
pPPTg neurons (~95%) was achieved, with little or no evidence of non-selective damage. These 
lesions produced no overt health consequences during (of after) the 21 day lesion formation 
period - the only detectable effect during this time was a small (yet significant) transient 
reduction in bodyweight growth rate. Analysis of rates of spontaneously generated locomotion 
(measured in photocell cages) and consumption of 20% sucrose solution (measured in 
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homecage) revealed no differences between sham control rats or rats with selective 
cholinergic lesions in pPPTg. 
An assessment of the ability of rats bearing highly selective lesions of cholinergic 
pPPTg neurons to learn various fixed and variable ratio schedules of reinforcement was 
assessed in chapter 5. Selective lesions of cholinergic pPPTg neurons, created prior to any 
operant training, had no effect on initial learning of an FR1 reinforcement schedule or the 
subsequent adaption to and performance of various fixed and variable ratio schedules up to 
and including VR30. Lesioned rats learned, performed and adapted to changes in the 
reinforcement schedules in a manner indistinguishable from sham operated controls. An 
extinction test showed they also had a normal pattern of extinction. Using the same operant 
testing protocol, this laboratory has previously shown that non-selective ibotenic acid lesions 
of the pPPTg produced a clear and persistent learning impairment: pPPTg lesioned rats took 
significantly longer to learn FR1, and, despite learning it to criterion level, were slow to adapt 
rates of lever pressing in response to increases and changes in the reinforcement schedules. 
Despite extensive training they never performed VR30 at the same rate as sham controls 
(Wilson et al., 2009a). The results of chapter 5 show that the cholinergic portion of the pPPTg 
is not required for normal instrumental learning. Much emphasis has been placed on the role 
of cholinergic PPTg and LDTg neurons in modulating the activity of midbrain DA neurons. This 
is point is returned to and discussed in subsequent sections. 
In chapter 6 an assessment of nicotine sensitization was performed in rats with 
selective lesions of cholinergic pPPTg neurons. This had 2 aims: (1) to assess the effects of loss 
of cholinergic pPPTg neurons on sensitization to nicotine. It has previously been shown that 
ibotenic acid pPPTg lesions reduced the initial locomotor depression caused by nicotine and 
enhanced subsequent hyperlocomotion (Alderson et al., 2008), which was hypothesized to be 
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a result of upregulation of nAChRs in the VTA; (2) to assess whether there is evidence of 
development of compensatory mechanisms in response to the formation of selective 
cholinergic lesions of pPPTg neurons. The results showed that there was no difference 
between sham and lesioned rats in either baseline levels of locomotion, response to nicotine 
induced changes in locomotion or the rate of sensitisation to nicotine. A further restricted 
analysis was performed on the response to the first administration of nicotine. This was to rule 
out the possibility that the effects of repeated administration of nicotine were masking any 
subtle effects caused by the lesion. Once again no difference was found between rats with 
selective cholinergic lesions in pPPTg and sham operated controls. These results suggest that 
the previously observed changes in the locomotor response to nicotine after ibotenic acid 
pPPTg lesions (Alderson et al., 2008) were not the direct result of loss of endogenous 
cholinergic innervation of the VTA. Instead, it would appear the involvement of the pPPTg in 
the locomotor response to nicotine is more complex than originally thought. These results are 
discussed fully in chapter 6 (pp168-177) which should be consulted for more details. 
In order to try and achieve greater disruption to the cholinergic mesopontine 
tegmentum, in chapter 7 an attempt was made to create selective lesions of cholinergic 
neurons in both pPPTg and the neighboring LDTg. Together these structures form the bulk of 
the cholinergic innervation of midbrain DA systems (and thalamus). While there was clear 
evidence that the Dtx-UII toxin had been delivered into both structures, the combined pPPTg – 
LDTg lesions were only partially successful. Cholinergic cell loss was observed throughout the 
pPPTg – LDTg complex, but it never approached near total cell loss. Due to the proximity of the 
LDTg to the fourth ventricle there was concern that toxin was seeping out of the LDTg before it 
had been internalized by cholinergic neurons. However, the finding that cholinergic cell loss in 
the pPPTg was only partial and did not achieve nearly as substantial levels as had previously 
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been obtained (with the same procedure) suggests that at least part of the reason for partial 
lesions was due to reduced potency of the stock of Dtx-UII toxin.  
 
Further discussion and wider interpretation of results 
How might pPPTg be involved in A-O learning? 
The pPPTg is well positioned to contribute to action-outcome learning. Of particular 
interest are the strong cholinergic and non-cholinergic projections to the midbrain VTA and 
SNc DA neurons (Oakman et al., 1995a; Charara et al., 1996; Wang et al., 2010); see:(Mena-
Segovia et al., 2008a). Phasic activity of these DA neurons in response to reward related 
sensory input leads to adaptation of firing patterns during learning about the events leading up 
to reward acquisition: initial phasic firing in response to unpredicted reward declines as phasic 
firing in response to stimuli that predict the reward develops. Subsequently, absence of the 
expected reward after a reward-predicting stimulus leads to decreased firing at the time of 
expected reward delivery (Schultz, 1999, 2010). As discussed in chapter 1 (pp32-35), this 
phasic firing pattern is regarded by many as a “reward prediction error” signal, which together 
with subsequent projections to the striatum, is considered to form the basis of associative 
reward related learning. However, this view is not unanimous and alternative explanations 
focus on the hypothesis that the phasic DA response might severe to function as a signal used 
to determine if, and which, self-initiated motor actions led to unpredicted salient changes in 
the environment (including gaining a reward) (Redgrave and Gurney, 2006; Redgrave et al., 
2008). The shortness of the short latency phasic DA response raises the question of what is the 
neural source of information used for generating the phasic DA signal. As reviewed by 
Redgrave et al. (2008) and discussed in chapter 1 (pp33-35), cortical and striatal regions which 
subserve object identification and reward information do not reliably respond to stimuli until 
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80 - ~200 ms after presentation, and therefore cannot be used in the generation of the phasic 
DA signal at a typical latency of 70 – 100 ms . Subcortical inputs are deemed to be the likely 
source of such rapid input. The SC, involved in early visual processing and which responds (at 
least in part) in a novelty dependent manner to spatially located movement and luminance 
changes, has direct projections to midbrain DA neurons (May et al., 2009). However, as SC 
responds to visual transients rather than static features or object identification, it is therefore 
considered to contain insufficient information for the calculation of a DA firing pattern based 
on the predication of an identified reward (Redgrave and Gurney, 2006; Redgrave et al., 2008). 
Given the anatomical connections between the PPTg and midbrain DA neurons, the type of 
information that the PPTg may be conveying to these midbrain systems must be considered. 
Studies from primate electrophysiological recordings have revealed that, during a two-value 
reward-driven behavioural task, different populations of PPTg neurons fired in response to 
stimuli that predicted the reward and to the delivery of the actual reward itself. Furthermore, 
firing rate was dependent on reward magnitude – stimuli predicting large reward led to 
greater firing than stimuli predicting small reward (Kobayashi and Okada, 2007; Okada et al., 
2009; Okada et al., 2011). Moreover, PPTg neurons rapidly adapted to reversal of the stimulus-
reward size pairing, confirming they were indeed responding to reward magnitude information 
rather than solely physical aspects of the stimuli (Okada et al., 2011). These findings show that 
PPTg responds to salient aspects of sensory inputs. Of particular interest and relevance here 
are the responses to reward prediction stimuli, reward delivery and information regarding 
reward magnitude. This raises the hypothesis that PPTg can extract these components from 
incoming sensory information and send them into midbrain DA systems for use in a reward 
prediction error calculation. This is supported by the response latencies of PPTg neurons: 
responses to auditory and visual stimuli have been reported within the range of 8 – 100 ms 
(Dormont et al., 1998; Pan and Hyland, 2005) therefore placing them at or before the firing 
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latencies of the phasic DA response (Pan and Hyland, 2005; Kobayashi and Okada, 2007). 
Direct evidence for the involvement of the PPTg in the generation of the phasic DA signal is 
shown in a study where, in rats which have developed a reliable phasic DA response to reward 
predicting stimuli, unilateral inactivation of PPTg suppressed the phasic response of midbrain 
DA neurons without affecting baseline levels of DA firing (Pan and Hyland, 2005). However, in 
order fully to consider the possible contribution of PPTg short latency input to midbrain DA 
systems, it is necessary to assess what other information may be being supplied concurrently 
and therefore establish what is unique about PPTg input. In addition to the PPTg and SC 
already described, there are currently only a few identified and characterized sources of short 
latency input to midbrain DA systems: (1) the lateral habenula, which displays an almost 
‘inverse’ RPE signal in that it is inhibited by reward predicting stimuli and exited by stimuli 
predicting that there will be no reward (Matsumoto and Hikosaka, 2007). While once thought 
to project directly to VTA, it now appears that the habenula in a large part relays to VTA via the 
RMTg (Balcita-Pedicino et al., 2011; Hong et al., 2011); (2) In addition to this relay of habenula 
output, RMTg is a direct source of predominantly GABAergic innervation of midbrain DA 
neurons (Jhou et al., 2009b; Lavezzi and Zahm, 2011). RMTg is activated by aversive stimuli 
such as footshock and by cues which predict footshock, inhibited by reward and reward 
predicting stimuli (Jhou et al., 2009b). As it has a predominantly inhibitory output, this has led 
to the hypothesis that it feeds aversive information into VTA to inhibit motor activation; (3) 
The parabrachial nucleus (Zahm et al., 2011) which has been shown to transmit information 
regarding noxious stimuli into midbrain DA systems (Coizet et al., 2010); (4) Two other inputs 
midbrain DA systems - the BNST and LH orexinergic ouput, will be mentioned and discussed 
here, for, while it is unclear if they have short latency responses to sensory stimuli, they 
influence midbrain DA activity in an ongoing manner which is dependent on internal state and 
therefore directly affect the ability of concurrent input to midbrain DA systems to elicit a 
212 
 
response. Part of the extended amygdala the BNST projects to the VTA  (Georges and Aston-
Jones, 2002) and processes information related to stress levels (for review see:(Hammack et 
al., 2010) and is involved in stress-induced relapse to drug seeking behaviour in stressful 
situations where drug cues are present (Erb and Stewart, 1999; Erb et al., 2001). Orexinergic 
(excitatory neuropeptide hormone) innervation arrives at the VTA (and PPTg/LDTg) from the 
LH (Boutrel et al., 2010) and potentiates the effects of other DA inputs as a function of the 
circadian state – increased DA activation occurs during waking compared to resting periods 
(Moorman and Aston-Jones, 2010) and when there are higher metabolic needs such as hunger 
(Boutrel et al., 2010). This gives a mechanism for increasing reward related behaviour at times 
when the animal is suitably awake and aroused (Moorman and Aston-Jones, 2010). While this 
discussion has focused on only the best characterized inputs to midbrain DA systems that can 
influence short latency input (for more see: (Geisler and Zahm, 2005; Zahm et al., 2011) it 
reveals that DA systems are a convergence point for multiple sources and types of input – 
sensory signaling novelty, reward, reward prediction, aversion as well as information regarding 
the ongoing internal sate – stress levels, circadian rhythm, deprivation/hunger levels and 
presumably many more. This high level of integration enables midbrain DA systems 
simultaneously to monitor several ongoing factors, with convergent inputs modulating, 
enhancing and inhibiting one another, leading, only in certain combinations to the generation 
of a phasic DA signal used for salience signaling and reward prediction. So far, the PPTg is only 
identified input which contains reliable polymodal sensory information and responds 
excitatorily to reward prediction and reward delivery information. The exact functions and 
nature of interactions of each of these inputs remains to be discovered. However, in terms of 
PPTg input to midbrain DA systems, the behavioral results from the contingency degradation 
study – that rats with pPPTg inactivation could continue to perform an already learned task but 
did not update associations between actions and outcomes – adds a behavioural component 
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to the view that pPPTg supplies midbrain DA systems with predictive and actual reward 
delivery information which can subsequently be used to form a phasic DA response which 
drives associative learning. Moreover, the contrast in effects on learning between non-
selective excitotoxic pPPTg lesions and selective cholinergic lesions of pPPTg reveals that the 
information conveying projection from pPPTg appears to be non-cholinergic in nature. 
 
  
Cholinergic versus non-cholinergic projections to midbrain DA: the role of acetylcholine  
The finding that selective loss of the cholinergic neurons within pPPTg has no effect on 
the learning or performance of fixed and variable ratio operant reinforcement schedules 
(chapter 5) is in sharp contrast to the persistent learning impairment seen in the same 
behavioural task after non-selective excitotoxic pPPTg lesions (Wilson et al., 2009a). As 
discussed in chapter 1 (pp36-38), the cholinergic neurons of the mesopontine tegmentum are 
believed to form a “master modulator” of midbrain DA neurons (Maskos, 2008; Mena-Segovia 
et al., 2008a). Activation of AChRs decreases the input resistance of inactive DA neurons, 
increases the firing rate of active neurons (Futami et al., 1995; Sorenson et al., 1998) and, in a 
smaller proportion of neurons, leads to calcium channel dependent increase in burst firing 
(Zhang et al., 2005). In mice genetically engineered to lack the β2 nAChR subunit (and 
therefore be largely insensitive to the effects of endogenous cholinergic innervation), midbrain 
DA burst firing was virtually absent (Mameli-Engvall et al., 2006) but was restored by lentiviral 
induced re-expression of β2 nAChRs (Mameli-Engvall et al., 2006; Maskos, 2007). While 
cholinergic innervation is necessary for, regulates and facilitates increases in midbrain DA 
activity, the actual primary trigger to increase firing appears to be convergence of several 
inputs and predominantly driven by concurrent excitatory glutamatergic input (Futami et al., 
1995; Sorenson et al., 1998; Kitai et al., 1999; Maskos, 2008; Mao et al., 2011) and by the 
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facilitation of pre-synaptic release of glutamate (Schilström et al., 2003; Mameli-Engvall et al., 
2006; Mao et al., 2011). Glutamatergic inputs target midbrain DA systems from a wide variety 
of areas from the brainstem to the prefrontal cortex: these structures include (but are not 
restricted to): central gray; cuneiform nucleus; dorsal raphe; lateral hypothalamic area; lateral 
habenula; medial hypothalamus; medial septum; parabrachial nucleus; prefrontal cortex; 
PPTg/LDTg; reticular formation and ventral pallidum (Sesack and Pickel, 1992; Charara et al., 
1996; Parent et al., 1999; Geisler et al., 2007; Omelchenko and Sesack, 2007). In contrast to 
this, as previously described, cholinergic input to midbrain DA arises principally from the 
mesopontine tegmentum and follows a clear topographical gradient: aPPTg targets SNc, pPPTg 
targets both SNc and VTA while LDTg predominantly targets the VTA (Oakman et al., 1995a); 
see chapter 1 and: (Mena-Segovia et al., 2008a). Taking these differences between cholinergic 
and glutamatergic function this into consideration, the contrast between the effects of 
selective cholinergic and excitotoxic pPPTg lesions on learning are easier to interpret. Despite 
near total-loss of pPPTg cholinergic neurons, midbrain DA systems are likely to still receive 
considerable cholinergic innervation. Indeed, loss of pPPTg cholinergic neurons results in an 
overall loss of only 20% of cholinergic mesopontine tegmentum neurons. The number of 
neurons projecting to the SNc would remain largely unchanged (as this projection arises 
primarily from the unlesioned aPPTg), and the loss of the pPPTg would decrease the possible 
number of cholinergic neurons projecting to VTA by a maximum of around 26% (numbers used 
for calculation taken from:(Wang and Morales, 2009). If this input is predominantly 
modulatory in nature then the rather subtle loss of pPPTg input may have led to no overt 
changes in DA functionality. However, after ibotenic acid lesions, both the cholinergic and 
glutamatergic inputs are destroyed, leading not only to a reduction in modulatory cholinergic 
input, but also loss of the excitatory glutamatergic signal. This can also be considered in the 
context of studies on the reinforcing effects of self-administered nicotine. Animals will not 
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reliably self-administer nicotine either systemically (Dougherty et al., 1981; Palmatier et al., 
2006) or directly into the VTA (Farquhar et al., 2011) showing that it is not a strong primary 
reinforcer. However, if nicotine is concurrent with another mildly rewarding stimuli (for 
example conditioned light stimulus) the overall rewarding properties of both are enhanced and 
lead to greater responding for the combination of stimuli than either presented individually 
(Palmatier et al., 2006). Likewise, sub-reinforcing doses of cocaine can become reinforcing if 
delivered concurrently with a non-reinforcing dose of nicotine (Zachariou et al., 2001). These 
findings have led to the hypothesis that the effects of nicotine are primarily reinforcement 
enhancing rather reinforcing in themselves. One intriguing finding is that this reinforcement 
enhancing effect occurs even when nicotine is delivered non-contingently with the additional 
reinforcer. Indeed, it has been shown that contingent and non-contingent nicotine (yoked 
control to the contingent group) administration have equal levels of reinforcement enhancing 
abilities (Chaudhri et al., 2006). What this shows is that simply the presence of nicotine, rather 
that the simultaneous delivery with another stimuli, is enough to enhance the reinforcing 
aspects of other primary or conditioned reinforces. Add in to this that administration of 
cholinergic antagonists reduces the rewarding properties of other (non-cholinergic) drugs 
(Zachariou et al., 2001) and these studies point to a simple pattern: the level of cholinergic 
innervation sets the level at which other stimuli will drive learning: nicotinic antagonists 
reduce reinforcing effects and nicotinic agonists enhance reinforcing effects. From this it is 
reasonable to propose a model where cholinergic innervation sets the ‘volume’ of learning, 
but it is the non-cholinergic excitatory inputs which signal what is actually learnt about. The 
relatively subtle loss of cholinergic innervation after Dtx-UII lesions of the pPPTg may be 
insufficient to cause a noticeable effect in a simple learning paradigm. It is also very likely that 
different AChR subtypes play appreciatively different roles in this process – there is some 
evidence that cholinergic reinforcement enhancing effects are limited to nAChRs whereas 
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stimulation of muscarinic (alone or in combination with nicotinic) AChRs may have stronger 
primary reinforcing effects. This explains the finding that carbachol (a mAChR agonist) has 
stronger primary reinforcing effects than nicotine (a nAChR agonist) (Farquhar et al., 2011).  
 
How has knowledge of PPTg function been advanced? 
 Advances have been made in two directions: (1) pPPTg has been shown to be crucially 
involved in the formation of action-outcome associations, making it the deepest known 
structure in the brain to be essential for this process; (2) a clear distinction between the 
functions of pPPTg cholinergic and non-cholinergic systems has been shown.  
 In recent years it has become firmly established that the PPTg can be “functionally 
dissected” into discrete components. The different composition and connections of anterior 
and posterior portions map onto behavioural function. Briefly: pPPTg receives rapid polymodal 
sensory input and projects into VTA and SNc DA neurons; in contrast to this, aPPTg 
preferentially receives cortico-striatal and extended amygdala outflow, has comparably 
restricted projection the DA neurons of the SNc, but in addition projects to motor control sites 
lower the brainstem (Winn, 2008; Wilson et al., 2009b). Behavioural results are entirely 
consistent with this distinction: ibotenic pPPTg lesions impair instrumental learning (indicative 
of disrupted input of sensory information into BG / cortico-striatal systems) whereas aPPTg 
lesions have no effect on learning rate but produce evidence of behavioural disinhibition 
(suggestive of altered inhibitory BG outflow) (Wilson et al., 2009a; Wilson et al., 2009b; Winn 
et al., 2010). The work presented here further scrutinizes the functional nature of the pPPTg 
input to BG systems, reaching the conclusion that a parsimonious interpretation of one 
function of pPPTg is to process incoming sensory information, extract specific salient aspects of 
it and interface this with appropriate systems. It is important to note that while the work here 
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has been primarily focused on connections to BG and brainstem systems, PPTg has a not-to-be 
neglected projection to all areas of the thalamus. The discovery that loss of cholinergic pPPTg 
neurons has no discernible effect on the rate of instrumental learning adds a new dimension to 
the functional dissection of the PPTg. It shows that even within pPPTg there are two separable 
functional systems - the non-cholinergic which is directly involved in instrumental learning and 
the cholinergic, which either has no involvement in instrumental learning or performs as part 
of a wider cholinergic modulatory system. As glutamatergic pPPTg neurons are nearly 3 times 
as numerous as GABAergic (Wang and Morales, 2009; Wang et al., 2010) and as the excitatory 
pathway from PPTg to midbrain DA appears to be glutamatergic (Scarnati et al., 1986), the 
evidence strongly suggests, but cannot conclusively show, that the pPPTg component critical 
for learning is glutamatergic.  
It is clear that PPTg is more than a simple relay station or part of an extended 
modulatory system. Indeed, going in the other direction, it is possible to speculate as to the 
extent to which PPTg could function as an independent controller. PPTg is a highly integrated 
part of the basal ganglia family (Mena-Segovia et al., 2004a) but it is also hard wired into 
brainstem structures including those involved in motor control (Humphries et al., 2007; Wilson 
et al., 2009b; Winn et al., 2010) and startle response (Koch et al., 1993; Swerdlow and Geyer, 
1993b; Fendt et al., 2001; Bosch and Schmid, 2008). This makes it a uniquely placed 
component of both BG and brainstem systems and in a pivotal position to influence and 
execute information transfer into and between these systems. Furthermore, the ability of PPTg 
to recognize the significance of external sensory events shows that a degree of analysis is 
performed. It is interesting to wonder what a structure with these connections and analytical 
ability may be capable of. There are situations where an immediate rapid response to a 
sensory event is beneficial, for example, escaping signs of imminent danger where there is 
insufficient time fully to process the stimuli and consider all options. In this situation PPTg 
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could elicit escape by executing motor actions in the reticular formation at a very short 
latency, perhaps even before conscious awareness of the stimuli has been developed. 
However, in situations where more detailed processing or integration with wider brain systems 
and internal information is required (for example execution of instrumental actions based on 
hunger state or long term planning) this sensory information could be interfaced into cortico-
striatal and thalamic circuitry. Furthermore, basal ganglia output mediated through PPTg gives 
PPTg access to the entire domain of processed information going through and leaving BG, 
making it the last fully integrated BG structure before this information leaves the system. This 
gives PPTg the ability to relate this outflow to immediate ongoing sensory input and brainstem 
events, then allow the information flow to continue out of BG, block it, or even re-enter it back 
into basal ganglia, cortico-striatal or thalamic systems for further processing (Wilson et al., 
2009b; Winn et al., 2010). While simply a conceptual model of possible PPTg function, a 
framework in general agreement with this offers an explanation of the wide range of 
behavioural changes which occur after damage to the PPTg.  
The ability of PPTg to operate both as part of a sensorimotor gating mechanism and a 
modulator of dopamine systems can lead to speculation about a relationship between PPTg 
and the symptoms of schizophrenia. PPTg is involved in pre-pulse inhibition (chapter 1, pp18-
19;(Swerdlow and Geyer, 1993b; Diederich and Koch, 2005) and the auditory P50 (P13 in the 
rat) (Miyazato et al., 1999), both measures of sensorimotor gating which are abnormal in 
schizophrenia and have been considered as endophenotypes of the disease (Turetsky et al., 
2007). DA function is abnormal in schizophrenia, however the nature of this is far from clear. 
The original ‘dopamine hypothesis’ of schizophrenia has not withstood the test of time (or 
scientific scrutiny) (see:(Moncrieff, 2009) and instead current interpretations of the role of DA 
in schizophrenia do not view the disease as a direct result of abnormal DA levels but focus 
instead on interactions between DA and other closely connected systems (Willner, 1997), 
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including mesopontine tegmentum cholinergic regulation of midbrain DA systems (Lester et 
al., 2010). Indeed, there is an apparent link between schizophrenia and Ach: schizophrenic 
patients have high rates of cigarette smoking (de Leon et al., 2002; Zhang et al., 2012) which 
has been argued to be a form of ‘self-medication’ of cholinergic agonists (Kumari and Postma, 
2005) and genes linked to α7 nAChRs have been associated with the disease (Freedman et al., 
1997). Forming inappropriate (or non-existent) associative relationships has been proposed as 
an explanation of the development of delusions in schizophrenia (Kapur, 2003; Romaniuk et 
al., 2010) and unusually increased activation of midbrain in response to neutral cues 
(measured with fMRI) has been correlated with the severity of delusional symptoms in 
schizophrenic patients (Romaniuk et al., 2010). Taking into consideration that PPTg neurons 
have a role in sensorimotor gating, the cholinergic modulation of DA systems, and the 
formation of associations, one can wonder if aberrant functioning of the PPTg may lead to 
some of the cardinal symptoms of the disease. 
 
Future directions 
The conclusions reached here present some testable hypotheses. The first is that 
substantial loss of PPTg and LDTg cholinergic neurons should disrupt innervation of midbrain 
DA systems, impairing their ability to switch firing patterns and consequently impairing 
instrumental learning. This could be further investigated and tested by: (1) electrochemical 
measurement of Ach levels in the VTA / SNc after combined PPTg / LDTg lesion. A correlation 
between PPTg / LDTg lesion size, level of Ach and behavioural impairment would establish the 
amount of cholinergic innervation required to maintain normal function (see chapter 3, pp100-
101, for discussion of compensatory mechanisms and the non-linear relationship between cell 
loss and post-synaptic transmitter level); (2) assessing the ability of artificial cholinergic 
innervation to restore normal DA function. The hypothesis proposed is that cholinergic 
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innervation sets the ‘volume’ of learning, whereas glutamatergic input signals what is leaned 
about. If this is the case, then direct infusion of cholinergic agonists into midbrain DA systems 
of rats with combined cholinergic lesions in PPTg / LDTg should be able to temporarily restore 
cholinergic DA innervation and support normal function. This manipulative rather than 
correlative assessment would also explicitly link behavioural impairment after cholinergic PPTg 
/ LDTg lesion to midbrain DA dysfunction. 
Clearly a toxin selective for PPTg glutamatergic neurons would be helpful; currently no 
such toxin exists. Moreover, as these neurons are not known to uniquely express any unique 
receptor type there is also as of yet no immediate way to hypothesize how such a toxin could 
be created. Given the current enthusiasm in optogenetic control of neuronal function – 
described as the Nature Methods “Method of the Year 2010” (Nature_Methods_Editorial, 
2011) - it is worth considering the possible use of such a technique in the PPTg. Optogenetics is 
the “integration of optics and genetics to achieve gain-or loss-of-function of well-defined 
events within specific cells” (Yizhar et al., 2011) with the two techniques of most relevance 
here being channelrhodopsin induced excitation or halorhodopsin induced inhibition 
(Deisseroth, 2011). Thus, once cells are modified to contain the specific light sensitive proteins 
(for example after infection with a lentiviaral vector) neuronal activity can be controlled with 
precise temporal precision by illumination of an implanted LED light source (Pastrana, 2011; 
Yizhar et al., 2011). A recent advancement to this technique is the development, in rat, of a 
two part process which enables the selective optogenetic targeting of a specific neuronal type 
while leaving other interdigitated neurons unaffected. This process involves the stereotaxic 
injection of a Cre-dependent opsin-expressing viral vector into a rat strain where the neuronal 
type of interest has been modified to selectively express Cre recombinase (currently ChAT and 
TH strains exist) (Witten et al., 2011). Therefore, only the neurons expressing the Cre 
recombinase cells in the vicinity of the viral injection site should become light sensitive. This 
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offers a method for selectively enhancing cholinergic output from PPTg (and, indeed LDTg, 
however it should be noted that as this technique involves a stereotaxic injection and light 
source implantation, it does not overcome the problematic location of the LDTg). While 
currently this technique is limited to activation of ChAT and TH cells, the possibility of 
development of specific targeting of other neuronal populations offers intriguing future 
prospects. Moreover, as it is possible to have combinations of several optogenetic techniques 
in the same organism (Pastrana, 2011), the prospect of multimodal control of neuronal activity 
raises the possibility of, for example, blue light induced activation of glutamate cells and 
concurrent yellow light induced deactivation of cholinergic cells (Deisseroth, 2011), and vice 
versa. Combining this with the precise temporal control offered by optogenetics would enable 
a detailed assessment of the effects of specific alternations in cholinergic and glutamatergic 
PPTg output during particular points of a learning paradigm. 
 
Final conclusions and thoughts 
 There are two clear results from this work: (1) the pPPTg is critical for forming 
associations between actions and outcomes, but not the performance of previously learned 
associations; (2) loss of pPPTg cholinergic neurons has no discernible effect on instrumental 
learning. The disruption of action-outcome learning is hypothesized to be due to loss of PPTg 
signaling to midbrain DA neurons, with electrophysiological evidence revealing that this 
information is likely to be regarding reward prediction and reward magnitude aspects of 
stimuli. The contrast in effects on learning between ibotenic acid and selective cholinergic Dtx-
UII pPPTg lesions shows that it is the non-cholinergic (presumed glutamatergic) projections 
that play a crucial role in learning; a finding compatible with the notion that the cholinergic 
projections are modulatory in nature. The PPTg has long been hypothesized to facilitate and 
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control basal ganglia output, it is now evident that PPTg also plays a crucial role in facilitating 
the transfer of information into and through basal ganglia and cortico-striatal circuitry. Indeed, 
PPTg is a highly integrated part of both basal ganglia and brainstem circuitry, making it 
uniquely placed to perform a ‘first pass’ analysis of incoming sensory information and interface 
salient aspects of this with the appropriate circuitry. In addition, the ability of PPTg to monitor 
information exiting basal ganglia enables it to assess its relevance in relation to concurrent 
sensory and brainstem events – a ‘last pass’ analysis - before sending it into motor output 
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